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Abstract 
ATP-sensitive potassium (KATp) channels are known to play a vital role in the 
regulation of insulin secretion from pancreatic 0-cells. Changes in the ratio of [ATP] 
/ [ADP] within the cell are known to regulate the activity of channels, but very little is 
known how the number of channels at the cell surface is regulated. The number of 
channels in the plasma membrane could be regulated in two ways; firstly by 
regulating the overall population of channels within the cells by increasing / 
decreasing the rates of channel synthesis or degradation, and secondly by regulating 
the insertion and removal of channels from the plasma membrane. The aim of the 
current study is to investigate the involvement of both of these mechanisms in 
regulating the cell surface density of KATp channels. 
It is shown that a sudden decrease in glucose concentration causes a rapid stimulation 
of KATp channel synthesis as shown by both immunocytochemistry and protein 
chemistry in both INS-le and isolated mouse pancreatic ß-cells. The intensity of 
fluorescence associated with Kir6.2 and SUR1 was - 2.5 fold greater in cells 
incubated with 3 mM compared to 25 mM glucose. This sudden increase in channel 
numbers is due to an increase in the rate of translation of pre-existing mRNA and may 
be mediated by the activation of AMP-activated protein kinase. Despite the - 2.5 fold 
increase in channel numbers only a small, but non-significant, difference in cell 
surface density was observed as determined by patch-clamp. The internalisation of 
KATp channels with an extracellular HA-epitope was also investigated in stably 
transfected HEK293 cells. Channels were seen to internalise rapidly from the cell 
surface into a perinuclear compartment. The trafficking itinerary of these channels 
has been found to include the sorting endosome, late endosome and elements of the 
trans-Golgi network. Upon inhibition of protein kinase-C activity the internalised 
channels are redirected into a pathway which allows rapid recycling of the channels. 
Trafficking and function of KATP channels has also been shown to be disrupted by 
mutations of Kir6.2 known to cause congenital hyperinsulinism. 
In summary, it has been demonstrated that both regulated expression and trafficking 
are likely to be involved in determining the cell surface density of pancreatic KATP 
channels. 
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1.1 - ATP-sensitive potassium (KATP) channels 
1.1.1 - Identification and cloning of KATP channels 
ATP-sensitive potassium (KATP) currents were first described by Noma (1983) as K+ 
selective channels inhibited by application of ATP to the intracellular face of cardiac 
cell membranes. KATP channels have since been found to be expressed in numerous 
other tissues including many regions of the brain (Ashford et al. 1990a, b, Ohno- 
Shosaku & Yamamoto 1992, Roper & Ashcroft 1995, Zawar et al. 1999), pancreas 
(Cook & Hayles 1984), skeletal muscle (Spruce et al. 1985) and vascular smooth 
muscle (Masuzawa et al. 1990). Since the cloning of the channel (Inagaki et al. 1995) 
it has become apparent that KATP channels are a hetero-octameric complex composed 
of two distinct subunits (see Aguilar-Bryan & Bryan (1999) for review). The channel 
pore is composed of four Kir6. X subunits, members of the inwardly rectifying 
potassium channel family. In addition to the central pore, four sulphonylurea receptor 
subunits (SUR) act as regulators of channel gating, providing much, but not all, of the 
nucleotide and drug sensitivity. The role of each of these subunits is discussed in 
more detail below. 
1.1.2 - The channel pore 
The Kir channel family 
Early analysis of ATP-sensitive currents in both cardiac myocytes and pancreatic ß- 
cells revealed them to be both KK selective and inwardly rectifying (Noma et al. 1984, 
Ashcroft et aL 1984) suggesting the presence of members of the inwardly rectifying 
potassium (Kir) channel family. Kir channels are characterised by their ability to pass 
inward current more effectively than outward current. At membrane potentials 
greater than EK (the reversal potential of K') potassium ions will be driven along their 
electrochemical gradient out of the cell (Hille 2001). Other positively charged ions 
(particularly Mg2) and small molecules such as polyamines (e. g. spermine) may also 
be driven into the Kir channel conduction pathway from the cytoplasm where it is 
thought they block the channel pore disrupting the outward flux of KK (Horie et al. 
1987, Kurata et al. 2004). This gives rise to inward rectification. At membrane 
potentials lower than EK potassium ions are driven into the cell (Hille 2001). 
2 
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Individual Kir channel subunits comprise two membrane spanning helices (TM1 and 
TM2), either side of a re-entrant pore-forming loop (P-loop) which contains the KK 
selectivity filter. The short amino- and longer carboxyl- termini are both intracellular. 
Further insights into the structural features of these channels have been made possible 
by the crystallisation of the archetypal bacterial potassium channels KcsA (Doyle et 
al. 1998) and MthK (Jiang et al. 2002) and more recently the bacterial Kir channel 
homologue Kirbacl. 1 (Kuo et al. 2003) as depicted in figure I. I. The crystal 
structure by Doyle et al. (1998) elucidated the structure of KcsA to a 3.2 angstrom 
resolution and revealed the key principles behind potassium selectivity and the 
architecture of the potassium ion conduction pathway. The channels were composed 
of four identical subunits, forming an `inverted teepee' which contained the selectivity 
filter at its outer end. The narrow selectivity filter itself was lined by the carbonyl 
oxygen atoms of the (-GYG-) motif which was held open by structural constraints 
allowing correct coordination with KK ions but not with Na ions. Below the 
selectivity filter is a large water-filled cavity and KK ions within this cavity are 
stabilized by pore helix dipoles. The selectivity filter contained two KK ions 7.5 
angstroms apart which was sufficiently close to exploit the repulsive forces between 
the two KK to force ion conduction. The innermost membrane spanning helix (TM2) 
forms the permeation pathway with the signature KK channel sequence (-GYG-) 
positioned at the narrow opening near the extracellular face of the protein. From 
investigations into the gating mechanics of these channels, particularly in KcsA 
(which was crystallised in the closed conformation) (Doyle et al. 1998) and MthK 
(which was crystallized in the open conformation) (Jiang et al. 2002), it is thought 
that the channel gate lies at the cytoplasmic ends of TM2, with twisting or lateral 
motions of these portions of the protein responsible for allowing access of ions into a 
water filled vestibule immediately below the K+ selectivity filter as first proposed for 
KcsA (Doyle et al. 1998). A second gate has recently been suggested to reside at the 
K+ selectivity filter itself (Claydon et al. 2003). To date 15 Kir channel genes have 
been cloned and have been subdivided into 7 distinct groups as summarised in table 
1.1. 
3 
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A 
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B 
Figure 1.1 - Predicted structure of Kir channels. A- Predicted topology of a single 
Kir6.2 channel subunit showing intracellular N- and C-termini and the two membrane 
spanning helices (TM I& TM2) flanking the pore loop which contains the potassium 
selectivity filter consensus sequence GFG (normally GYG in other Kir isoforms). B- 
Three dimensional structure of the bacterial Kir channel homologue Kirbac 1.1. The 
top down view (left hand panel) looks down into the conduction pathway through the 
K+ selectivity filter. The side view (right hand panel) shows the transmembrane 
helices forming the upper half of the channel and the N-and C-terminal domains at the 
cytoplasmic side. The three dimensional images were generated using the 
coordinates, I P713, obtained from the protein data bank using Deepview / Swiss- 
PdbViewer software. 
4 
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Cloning of the Kir6Xfamily 
Kir6.1 was first cloned by Inagaki et al. (1995) using a fragment of Kir3.1 (GIRK) 
cDNA as a probe with a rat DNA library and was found to have a very broad tissue 
distribution, hence the designation uKATP (u representing the ubiquitous expression). 
It was however absent in pancreatic ß-cell lines so using Kir6.1 cDNA as a probe, 
Kir6.2 was cloned (originally designated as BIR for ß-cell Kir channel). Kir6.2 was 
found to be relatively abundant in pancreatic islets, particularly ß-cells, as well as in 
the brain, heart and in skeletal muscle. Kir6.1 and Kir6.2 have a relatively high 
degree of sequence homology, - 70 % overall, but significantly higher in the 
transmembrane domains, the pore-region and in the cytoplasmic domains nearest the 
plasma membrane (Tokuyama et al. 1996). 
1.1.3 - The KATP channel ß-subunit 
The sulphonyl urea receptor 
A number of studies described a high affinity sulphonylurea receptor in membranes 
isolated from ß-cells (Kaubisch et al. 1982, Gaines et al. 1988), 0-cell lines such as 
HIT T15 (Santerre et al. 1981) and RINm5F (Ronner et al. 1993), the heart (Fosset et 
al. 1988) and the brain (Lupo & Battalie 1987). The first report of a purified high 
affinity sulphonylurea receptor by Bernardi et al. (1988) described a 150 KDa protein 
isolated from brain. The involvement of the high affinity sulphonylurea receptor in 
KATP channels was suggested by Rajan et al. (1993) and Ronner et al. (1993) who 
characterised sulphonylurea sensitive KATP channel currents, measured by Rb+ efflux 
and single channel recordings, concluding that they were the same as those of the 
pancreatic ß-cell KATP channel. 
Cloning of the sulphonylurea receptors 
Using the N-terminal protein sequence, Aguilar-Bryan et al. (1996) designed a set of 
oligonucleotide primers for amplification of a small segment of the sulphonylurea 
receptor cDNA. This cDNA fragment was then used to screen cDNA libraries of 
hamster, rat, mouse and human leading to the isolation of full length clones of SURI. 
These clones comprised 1581 amino acids in the rodent and 1582 amino acids in the 
human. A second SUR isoform was cloned by Inagaki et al. (1996) using SUR1 
cDNA fragments as probes and was designated SUR2. It has since become apparent 
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that two alternatively spliced forms of SUR2 exist, SUR2A and SUR2B, and that 
these two are differentially expressed (SUR2A - cardiac, SUR2B - smooth muscle). 
The structure and topology of SUR1 
Blast searches of SUR1 sequences revealed that it shared many similarities to proteins 
of the ATP-binding cassette (ABC) family which includes multi-drug resistance 
proteins (MRP) (Fojo et al. 1985) and cystic fibrosis transmembrane conductance 
regulator (CFTR) (Riordan et al. 1989). According to the guidelines for ABC protein 
classification (Tusnady et al. 1997) SUR1 belongs to the same family as the MRP 
proteins, based on its predicted membrane topology, its two nucleotide binding folds 
and its hydrophobic N-terminal domains. The highest degree of homology between 
SUR1 and the other ABC proteins occurs at the nucleotide binding folds (NBF). 
These are characterised by the two Walker motifs (Walker et al. 1982) (Walker A- 
GlyXXG1yXGlyLysSer/Thr; where X is any amino acid, Walker B- YYYYAsp; 
where Y is any hydrophobic amino acid) and the conserved linker region between the 
two Walker motifs (LeuSerGlyGlyGlu). A predicted transmembrane topology of 
SUR1 was proposed by Aguilar-Bryan et al. (1995) based on hydropathy plots and 
several structural determinants. N-linked glycosylation sites found near the N- 
terminus (position N10) suggested that the N-terminus was extracellular and the two 
NBF regions were intracellular. Recent work by Raab-Graham et al. (1999) and 
Conti et al. (2001) has further refined these models, and it is now generally accepted 
that SUR1 has 17 transmembrane helices grouped into three transmembrane domains 
(TMDO, TMD1 and TMD2) containing 5 TM -6 TM -6 TM respectively. The N- 
terminus is extracellular whereas the C-terminus is intracellular. The first NBF 
(NBF1) is thought to be located in the cytoplasm between TMD1 and TMD2 and the 
second NBF is though to be located in the cytoplasm in the proximal C-terminus. 
Figure 1.2 summarises this model. More recently the crystal structure of MSBA, a 
MRP homologue from Vibrio cholera containing only two TMD regions 
corresponding to TMD1 and TMD2 of SUR1, confirmed much of the above model 
(Chang 2003). Two N-linked glycosylation sites in SUR1, one at position N10 and 
the other at N1050, have been confirmed by site-directed mutagenesis to be required 
for channel export from the ER (Conti et al. 2002). 
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Figure 1.2 - Predicted transmembrane topology of SUR]. SUR1 is thought to consist 
of 17 transmembrane helices grouped into three transmembrane domains, TMDO, 
TMDI and TMD2. Two nucleotide binding folds (NBFI and NBF2) are found 
between TMD 1 and TMD2 and in the C-terminus, both of which are cytoplasmic. 
The N-terminus is extracellular and contains an N-linked glycosylation site (`Y). A 
second N-linked glycosylation site is located on an extracellular loop in TMD2. 
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1.1.4 - KATP channel structure 
Both Kir and SUR subunits are required for functional expression 
Following the cloning of the subunits, it was noticed that both the Kir and SUR 
subunits were required for expression of active KATp channels. Expression of SUR1 
in the absence of Kir6.2 yielded no KATP channel currents and it displayed an apparent 
mass of - 140 KDa when examined by SDS-PAGE. When both SUR1 and Kir6.2 
were co-expressed KATP channel currents were elicited. In this case, an examination 
of SUR1 by SDS-PAGE showed additional species with an apparent mass 
corresponding to - 150 - 190 KDa in addition to the previous - 140 KDa species 
(Clement et al. 1997). It has since been shown that these species with an apparent 
higher molecular weight correspond to the glycosylated forms of SUR1. Interestingly 
the glycosylated forms of SURI are only present when the Kir subunit is co- 
expressed, suggesting that the presence of the Kir subunit is a requirement for SUR1 
maturation (Clement et al. 1997). Expression of Kir6.2 alone was also seen to be 
insufficient to form functional channels (Inagaki et al. 1995, Clement et al. 1997). 
Kir forms the channel pore 
The roles that Kir and SUR played in the channels were also the subject of intense 
investigation following cloning of the channel subunits. It was soon confirmed that 
Kir formed the channel pore independently of SUR1. Firstly it was shown by 
Clement et al. (1997) and Shyng et al. (1997) that mutations in TM2 of Kir6.2 
affected the degree of rectification displayed by the channels. This suggested the 
involvement of Kir6.2 in ion conduction, but it did not rule out a role for SUR1 in 
forming the pore itself. This question was answered when Tucker et al. (1997) 
showed that truncation of the C-terminal 26 amino acids (Kir6.2A26) allowed Kir6.2 
to form functional inwardly rectifying, potassium selective channels in the absence of 
SUR1. This demonstrated that SURI was not required for formation of the ion 
conduction pathway. 
KATP channel stoichiometry 
The findings suggesting that Kir expression was required for SUR1 maturation 
suggested that the two subunits were forming into complexes in order to form the 
functional channel. Indeed the mass of the channel multimer, as estimated from 
sucrose density gradients (Clement et al. 1997), was - 950 KDa suggesting a large 
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complex composed of four SUR1 subunits (each of - 170 KDa not including 
glycosylation) and four Kir6.2 subunits (each of -45 KDa). This stoichiometry was 
simultaneously confirmed by a number of groups (Inagaki et al. 1997, Shyng & 
Nichols 1997). Figure 1.3 shows a representation of how it is thought the KATP 
channel octomer may appear. At the centre of the complex are the four Kir subunits 
forming the ion conduction pathway. Associated with each Kir subunit is a single 
SUR subunit, surrounding the channel pore. 
KATP channel assembly and ER export 
From the early studies it was apparent that neither Kir6.2 nor SUR1 could traffic to 
the cell surface in the absence of the other (Inagaki et al. 1995, Aguilar-Bryan et al. 
1996, Inagaki et al. 1996). This implied that the two subunits would have to associate 
with each other and assemble into channel complexes for trafficking to occur. The 
direct physical association between the Kir subunit and the SUR subunit of KATP 
channels has been shown by co-immunoprecipitation studies (Lorenz et al. 1998, 
Lorenz & Terzic 1999). The nature of these interactions are not yet fully understood 
but it is thought that they may involve association of the outer helix of Kir subunit 
(TM1) with the first domain of SUR1 (TMDO) (Babenko & Bryan 2003). Recent data 
also suggest that the proximal C-terminus of SUR2A is required for the assembly of 
functional channels containing Kir6.2 (Rainbow et al. 2004), although previously 
published data found that the C-terminus of SUR1 was not required for assembly with 
Kir6.2 to form heteromultimers (Gilbin et al. 2002). A key element in the process of 
channel assembly and maturation appears to be the glycosylation of SUR at two N- 
linked glycosylation sites (AsnlO + Asnl050 in SURI). It has been reported that 
glycosylation of these sites is required for efficient exit from the endoplasmic 
reticulum (ER), and that removal of either glycosylation site significantly impairs ER 
export (Conti et al. 2002). Another determinant of channel trafficking through the 
biosynthetic pathway is the ER retention motif contained within the distal C-terminus 
of Kir subunits and within an intracellular domain of SUR (Zerangue et al. 1999). 
This motif consisting of -RKR is thought to act as an ER retention signal. The exact 
mechanism is unknown, although it may involve interactions with the epsilon and zeta 
forms of 14-3-3 (Yuan et al. 2003). During channel assembly the retention signals of 
both subunits are masked allowing exit from the ER. Indeed, the existence of this 
retention motif explains why the A26 truncated form of Kir6.2 described by Tucker et 
10 
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al. (1997) is able to traffic to the cell surface in the absence of SUR1, since the -RKR- 
motif is contained within the excised fragment. 
The lifespan of KATP channels 
Studies by Crane & Aguilar-Bryan (2004) examined the turnover of both fully 
assembled channels and individual KATP channel subunits using pulse-chase methods 
in COST cells. It was found that when Kir6.2 was expressed alone, - 60 % was 
degraded very rapidly (t1/2 = 36 min) and the remaining 40 % was longer lived (t%z = 
1.2 hours). When SUR1 was expressed alone it appeared very stable with a t%2 of 
approximately 25.5 hours. When expressed together, both subunits appeared to 
assemble into channels very rapidly, and the rapid loss of Kir6.2 did not occur. Fully 
assembled channels were shown to have a tV2 of approximately 7.3 hours. 
11 
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Figure 1.3 - Proposed arrangement of the KATP channel subunits. The KATP channel 
is thought to comprise four Kir subunits which assemble to form the ion conduction 
pathway with a central pore which is selective for the conduction of potassium ions. 
Each Kir subunit is thought to associate with a SUR subunit which surrounds the Kir 
channel forming the periphery of the channel. 
12 
hr/rodriciion 
1.2 - Channel regulation 
1.2.1 - Physiological regulation 
The activity of KATP channels is regulated by a number of factors. These factors 
primarily include nucleotides and membrane phospholipids (particularly PIP2) 
although several other proteins have been implicated in modulating channel activity 
such as protein kinase A and C and, in the case of SUR1, certain elements of vesicle 
trafficking machinery as described below in more detail. 
Channel regulation by nucleotides 
KATp channels were first identified as potassium selective channels which were 
inhibited by application of ATP to their cytoplasmic face (Cook & Hayles 1984). It 
has since become apparent the KATp channels are regulated by cytoplasmic 
nucleotides, more particularly, the ratio of ATP concentration compared to ADP 
concentration ([ATP] / [ADP] ratio). When ATP levels rise, for example due to an 
increase in glucose metabolism resulting in an increase in the [ATP] / [ADP], channel 
activity is inhibited. When ATP levels drop, for example due to a decrease in glucose 
metabolism, the [ATP] / [ADP] ratio is decreased due to the increased hydrolysis of 
ATP to produce ADP. This decrease in the [ATP] / [ADP] ratio stimulated channel 
activation (see Aguilar-Bryan & Bryan 1999, Campbell et al. 2003 for reviews). 
Recent evidence suggests that channel inhibition by ATP is mediated through a direct 
interaction with the cytoplasmic domains of Kir6.2. In the absence of SUR1, 
channels composed of Kir6.2 (truncated forms which traffic to the surface) show brief 
openings without long bursts and channel activity is inhibited by both ATP and ADP 
(Tucker et al. 1997, John et al. 1998). The ATP binding site, which is contained 
within the cytoplasmic domain of Kir6.2, has been located and its architecture is 
beginning to become clearer. It appears that positively charged residues in both the 
N- (R50) and C-terminus (K185) of Kir6.2 interact directly with ATP (Trapp et al. 
2003). A second study also highlighted K185 along with R201 as important residues 
in ATP binding, suggesting that ATP binding to these residues could cause a 
conformational change in the architecture of the surrounding region thus closing the 
channel (John et al. 2003). In these schemes it is proposed that R50, K185 and R201 
interact with the y-phosphate, ß-phosphate and a-phosphate of ATP respectively (John 
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et al. 2003, Trapp et al. 2003). More recent modelling of the ATP-binding site by 
Antcliffe et al. (2005) supports these observations and also suggests interactions 
between E179 and R301 with the N6 atom of the adenosine ring. 
When Kir6.2 is expressed alongside SUR1, channel openings become longer and 
occur in bursts. Electrophysiological studies showed that the inhibition associated 
with ATP application can be overcome by the addition of Mg-ADP, which can also 
activate bursting behaviour in channels in the absence of ATP (Findlay et al. 1988, 
Terzic et al. 1994). It is now clear that this stimulation of channel activity is mediated 
by the interaction of nucleotides with the NBFs of SUR1. Both of the NBFs, NBF1 
and NBF2, bind ATP although NBF2 hydrolyses ATP at a much higher rate than 
NBF1 (Ueda et al. 1999, Bienegraeber et al. 2000). Although the exact nature of the 
mechanisms leading from nucleotide binding to SUR1 to channel activation is not 
fully understood many models have been proposed which share many common 
features. In essence it is thought that channel activation relies on a functional 
coupling between NBF1 and a positively charged region of the C-terminus of Kir6.2 
which contains the residues R176 and R177 (John et al. 2001). For NBF1 to interact 
with Kir6.2 it appears that it must first have ATP bound, a process which is stabilised 
by Mg-ADP binding to NBF2 (Ueda et al. 1999, John et al. 2001). 
Another class of molecules which have been shown to modulate KATP channel activity 
are the dinucleoside polyphosphates, such as diadenosine tetraphosphate (ANA) and 
diadenosine tetraphosphate (AP3A) (Jovanovic et al. 1997, Jovanovic & Jovanovic 
2001). The action of these molecules has been shown to be functionally significant in 
both cardiac myocytes (Sumiyoshi et al. 1998, Flores et al. 1999, Ahmet et al. 2000) 
and in pancreatic ß-cells (Ripoll et al. 1996, Courtois et al. 2000). The binding of 
dinucleoside polyphosphates has been shown to inhibit KATP channel openings 
(Jovanovic et al. 1997). 
Channel activation by membrane phospholipids 
It has been demonstrated that negatively-charged phospholipids, particularly 
phosphatidylinositol-4,5-bisphosphate (PIP2) activate many Kir channels, including 
KATP channels, by stabilizing the open conformation (Hilgemann & Ball 1996; Fan & 
Makielski 1997, Huang et al. 1998). In the case of KATp channels, as well as an 
14 
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increase in channel open probability a parallel decrease in ATP sensitivity is also 
observed when exposed to PIP2. (Baukrowitz et al. 1998, Shyng & Nichols 1998, Fan 
& Makielski 1997). This suggests that ATP and PIP2 may compete for the same or an 
overlapping binding site. In support of this, mapping of the residues which influence 
PIP2 binding shows a number of similarities to those found to be involved in ATP 
binding. Two residues of particular interest are R201 in the C-terminus, which is 
thought to directly interact with ATP as well as PIP2, and R54 which is very close to 
another residue implicated in ATP binding (R50) (Shyng et al. 2000, Schulze et al. 
2003). 
Channel regulation by other proteins 
The roles that protein kinases, particularly protein kinase A (PKA) and protein kinase 
C (PKC), play in regulating the activity of KATP channels have been extensively 
investigated. A number of groups have shown a stimulatory effect of PKA on KATP 
channel activity. In channels composed of Kir6.2 and SUR1, Beguin et al. (1999) 
found that PKA phosphorylation of S372 in Kir6.2 led to an increase in channel 
activity whereas phosphorylation of S1571 in SUR1 would lead to an alteration to the 
channel properties (e. g. a shortening of the bust duration) and also led to an increase 
in the cell surface channel density. Another study by Lin et al. (2000) showed that the 
increase in open probability of channels containing Kir6.2 associated with elevated 
PKA activity was as a result of phosphorylation of S224, resulting in a decrease in 
channel ATP sensitivity. The smooth muscle KATP channel composed of Kir6.1 and 
SUR2B is also activated by PKA, due to phosphorylation of S385 in Kir6.1 and T633 
and S1465 in SUR2B (Quinn et al. 2004). It has also been demonstrated that 
angiotensin II-stimulated vasoconstriction is mediated by inhibition of PKA, which in 
turn inhibits KATP channels (Hayabuchi et al. 2001). The regulation of KATP channels 
by PKC is somewhat more unclear. A number of groups have reported that PKC 
activation mediates channel inhibition. For example, both Kubo et al. (1997) and 
Hayabuchi et al. (2001) reported that angiotensin II stimulated vasoconstriction was 
mediated by smooth muscle KATp channel inhibition by activation of PKC. Inhibition 
of KATP channels by PKC has also been reported in colonic myocytes and arterial 
smooth muscle (Bonev & Nelson 1996, Jun et al. 2001). In contrast, both Dunne 
(1994) and Light et al. (2000) have reported KATP channel activation by PKC. 
According to Dunne (1994) pancreatic KATP channels, which have since been shown 
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to be composed of Kir6.2 and SUR1, were initially inhibited by PKC activation with 
PMA but recovered with prolonged exposure to the drug, eventually leading to an 
increase in channel activity compared to basal levels. Light et al. (2000) 
demonstrated that PKC activation was associated with an increase in the open 
probability of channels containing Kir6.2 due to the phosphorylation of T180, 
resulting in a decrease in ATP binding. The examples given above where PKC is 
associated with channel inhibition all involve channels thought to contain Kir6.1 as 
the pore forming subunit, whereas all examples where PKC mediates channel 
activation all contain Kir6.2. It may be that the effect of PKC on channel activity 
depends on the composition of the channel. In support of this, Thorneloe et al. (2002) 
have shown that PKC causes a decrease in the open probability of channels composed 
of Kir6.1 / SUR2B whereas it increases the open probability of channels composed of 
Kir6.2 / SUR2B, so it may be that channels containing Kir6.1 are inhibited by the 
action of PKC whereas channels containing Kir6.2 are stimulated. 
It was recently suggested that the binding of the SNARE (soluble NSF attachment 
protein receptor) protein syntaxinlA to KATP channels could inhibit channel activity 
in both pancreatic ß-cells and cardiac myocytes (Kang et al. 2004, Pasyk et al. 2004). 
It was subsequently shown that the action of syntaxinlA in inhibiting KATP channels 
was due to an interaction of syntaxin 1A with the NBFs of the channels thus reducing 
channel open probability (Cui et al. 2004). A similar mechanism of regulation has 
been described for other ion channels including CFTR (Naren et al. 1998) and ENaC 
(Condliffe et al. 2003). A number of other proteins have been shown to interact 
directly with KATP channels in various tissues and cell types, for example the cardiac 
KATP channel has been shown to interact with both creatine kinase (Crawford et al. 
2002) and the actin cytoskeketon (Furukawa et al. 1996). 
1.2.2 - Pharmacological regulation 
K} channel opening drugs 
The potassium channel opening (KCO) drugs are a diverse family of agents which 
activate KATP channels. KCO drugs have been used to treat excessive insulin 
secretion (diazoxide) and also for hair restoration (minoxidil). The most commonly 
studied KCO drugs are diazoxide, minoxidil, pinacidil, nicorandil and cromakalim 
(see Ashcroft & Gribble 2000, Mannhold 2004 for reviews). 
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An interesting property of the KCO drugs is that certain agents appear to be specific 
for certain isoforms of KATP channels. For example, the ß-cell channel, composed of 
Kir6.2 and SUR1, is activated by diazoxide but not by cromakalim or nicorandil 
(Ashcroft & Rorsman 1989). In contrast, the cardiac channel, composed of Kir6.2 
and SUR2A, is activated by pinacidil, cromakalim and nicorandil but not by diazoxide 
(Terzic et al. 1995, Isomoto & Kurachi 1997). Channels containing SUR2B are 
sensitive to all of the above drugs, albeit with differing affinities (Quayle et al. 1997). 
It appears that the responsiveness of each channel to individual KCO drugs depends 
largely on the SUR isoforms contained within the channel. The binding sites for 
some of these compounds have been identified. The binding site for pinacidil was 
isolated to 2 key domains contained within TM 16-17 and part of the cytoplasmic 
loop between TM 13-14 of the SUR2 isoforms by performing binding assays on 
chimeras containing regions of SUR1 (which does not bind pinacidil) (Uhde et al. 
1999). The binding site for cromakalim has also been isolated to the same regions 
(Babenko et al. 1999, D'hanan et al. 1999). The binding site of diazoxide is less well 
known. Sensitivity to diazoxide can be conferred on SUR2A by substituting TM 6-11 
and NBD1 from SUR1 (Babenko et al. 1999). It appears that the action of diazoxide 
is nucleotide dependent. Diazoxide is only effective in opening channels when Mg- 
nucleotides are present at the intracellular face of the cell membrane (Gribble et al. 
1997, Shyng et al. 1997, Trapp et al. 1997) and when either of the NBFs of SUR1 are 
made less able to bind nucleotides by mutation the effect of diazoxide is lessened 
(Trapp et al. 1997, Reimann et al. 2000). This suggests that, in the case of diazoxide 
at least, correct nucleotide binding is required for KCO binding. 
Sulphonylureas 
The sulphonylurea compounds were first used in the Second World War as antibiotic 
agents, where it was noticed that hypoglycaemia was a common side effect. It has 
since become apparent that this hypoglycaemia is due to the inhibition of KATP 
channels by these compounds, and as such they are now commonly used to treat type- 
2 diabetes (see Proks et al. 2002 for review). 
The sulphonylurea compounds are known to bind with a high affinity to the SUR 
subunit of KATp channels (Sturgess et al. 1985, Belles et al. 1987) and at a lower 
affinity to the Kir subunit (Gribble et al. 1997). The binding of sulphonylureas to 
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SUR is isoform dependent; the ß-cell isoform, SUR1, is the only SUR type to bind 
tolbutamide and gliclazide whereas other SUR isoforms (SUR2A and 2B) bind all 
other types of sulphonylureas (Gribble et al. 1997, Gribble & Ashcroft 1999, 
Reimann et al. 2001, Sunaga et al. 2001). This is thought to be due to the existence of 
two types of sulphonylurea binding sites. The first binding site is thought to bind 
sulphonylureas similar in structure to tolbutamide and the second is thought to bind 
only the benzamido sulphonylurea compounds such as meglitinide. SUR1 is thought 
to contain both binding sites whereas the SUR2 isoforms are thought to contain only 
the benzamido binding site (Gribble et al. 1998, Song & Ashcroft 2001). A residue 
thought to be vital in the binding of sulphonylureas to the tolbutamide binding site is 
S1237 in SUR1. Mutation of this residue has been shown to affect the binding of 
tolbutamide (Ashfield et al. 1999), mitiglinide (Reimann et al. 2001) and nateglinide 
(Hansen et al. 2002) and also alter the binding properties of glibenclamide, which 
normally binds to both sites, allowing glibenclamide blockade of the channels to be 
more easily reversible (Ashfield et al. 1999). The blockade of KATP channels by the 
sulphonylureas can also be modulated by other factors which affect the open 
probability of the channels. For example, blockade of the channel is lessened when 
PIP2 levels are elevated leading to an increase in open probability (Krauter et al. 
2001). In contrast to this, elevated levels of Mg-nucleotides have been shown to 
increase the level of block mediated by sulphonylureas (Schwanstecher et al. 1992). 
18 
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1.3 - Tissue distribution and roles 
KATp channels have been shown to be expressed in numerous tissues where they are 
thought to play a wide range of roles. They are found in abundance in specific 
regions of the brain, in cardiovascular tissues, skeletal muscle and in the pancreas. 
Investigation of their roles in each of these tissues has been facilitated by the 
generation of KAIp null mice deficient in Kir6.1 (Miki et al. 2002), Kir6.2 (Miki et al. 
1998), SUR1 (Seghers et al. 2000) or SUR2 (Chutkow et al. 2001). Transgenic mice 
expressing dominant negative Kir6.2 (Miki et al. 1997, Koster et al. 2000) or 
expressing overactive Kir6.2 (Koster et al. 2000 - pancreas, Koster et al. 2001 - heart) 
or overexpression of SUR1 in the forebrain (Hernandez-Sanchez et al. 2001) have 
also been used in an attempt to elucidate the physiological roles of these channels. 
1.3.1 - KATp channels in the brain 
KATP channels have been shown to be expressed in several regions of the brain 
including the neocortex (Ohno-Shosaku & Yamamoto 1992), hippocampus (Zawar et 
al. 1999), Substantia nigra (SNr) (Roper & Ashcroft 1995, Stanford & Lacey 1996) 
and in the hypothalamus (Ashford et al. 1990). 
KATP in the hypothalamus 
KATP channels have been shown to be particularly abundant in the hypothalamus and 
their role here has been reasonably well studied. It is known that the hypothalamus is 
important in regulating the secretion of a number of counter-regulatory hormones 
involved in glucose homeostasis, including glucagon, via the autonomic nervous 
system (Taborsky et al. 1998). Indeed, transgenic mice lacking Kir6.2 (Kir6.2"'" mice) 
have been shown to have impaired glucagon secretion compared to wild-type mice. 
However, glucagon secretion from isolated islets from the same Kir6.2"'' mice was 
comparable to islets isolated from wild-type mice suggesting that the defect in the 
regulation of glucagon secretion lies upstream of the pancreatic a-cell (Miki et al. 
2001). It has been known for some time that glucagon secretion from pancreatic a- 
cells can be increased by inducing hypoglycaemia in the hypothalamus 
(neuroglycopenia) (Borg et al. 1995,1999). This effect has been attributed to a 
population of glucose sensitive neurones in the ventromedial hypothalamus (VMH) 
known as glucose-responsive neurones (GRNs) (Oomura et al. 1969, Minami et al. 
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1986). Dialysis of isolated GRNs with ATP-free pipette solution activated 
tolbutamide sensitive K+ currents in the wild-type cells but not in the Kir6.2''' cells 
indicating that Kir6.2 containing KATP channels are present. The composition of this 
population of KATp channels was confirmed by single-cell RT-PCR which showed 
that GRNs contain KATP channels composed of Kir6.2 and SUR1, the same 
composition as the pancreatic ß-cell. The role of KATp channels in the hypothalamus is 
summarised in a model proposed by Miki et al. (2001) suggesting that "the pancreatic 
ß-cell and the hypothalamus are functionally interactive: the insulin secretion system 
and the glucagon secretion system are integrated into the maintenance of glucose 
homeostasis through a common KATP channel". They propose that as blood glucose 
levels rise, KATP channels of the pancreatic ß-cell are inhibited leading to insulin 
secretion and a corresponding lowering of blood glucose. As the blood glucose level 
falls, activation of KATP channels in the GRNs of the hypothalamus stimulates 
glucagon release by the pancreatic a-cells via the autonomic nervous system, which in 
turn raises the blood glucose level again. In this way blood glucose levels can be 
maintained at an appropriate level. 
KATF channels in the substantia nigra (SNr) 
KATP channels were first localised to the substantia nigra reticulate by Mourre et al. 
(1989) by [3H] glibenclamide binding studies. The presence of a high affinity 
glibenclamide binding site suggests the presence of the pancreatic ß-cell type KATP 
channel. The presence of Kir6.2 and SUR1 containing channels was confirmed by 
RT-PCR (Liss et al. 1999). Due to the proposed role of the substantia nigra as a 
central gating system for propagation of seizures (Iadarola & Gale 1982, De Sarro et 
al. 1984, Depaulis et al. 1994), and that such seizures are commonly associated with 
metabolic stresses such as hypoxia or hypoglycaemia, it was proposed that KATP 
channels may play a role in the supression of seizures in ATP-depleted conditions. 
Studies into the role of KATP channels in hypoxia induced seizures using Kir6.24" mice 
showed that tolerance to brief hypoxia was impaired in the Kir6.2 null mouse. 
Whereas wild-type animals remained sedated throughout the hypoxic challenge, 
making a complete recovery, Kir6.2''" mice responded to the same challenge with a 
myoclonic jerk followed by severe tonic-chronic convulsions and death. The resting 
membrane potential of hypoxia challenged neurones was observed to be depolarised 
in Kir6.24 mice in comparison to wild-type neurones which displayed a tolbutamide 
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reversible hyperpolarization. It has therefore been suggested that KATP channels in the 
substantia nigra reticulate acts as a metabolic sensor which prevents seizure 
propagation during hypoxic stress. 
KATP channels in the forebrain 
Transgenic mice overexpressing SUR1 in the forebrain (Hernandez-Sanchez et al. 
2001) have been shown to be resistant to kainic acid-induced seizures. Whereas wild- 
type mice showed significant loss of hyppocampal pyramidal neurones following 
kainic acid treatment, SUR1 overexpressing mice showed no change. This suggests 
that SUR1 containing KATp channels play a protective role from seizures and neuronal 
damage bought about by acute or chronic stress such as focal or global ischaemia 
(Heurteaux et al. 1993). 
1.3.2 - KATp channels in the cardiovascular system 
KATp channels have been identified in both vascular smooth muscle and in 
cardiomyocytes, but appear to behave very differently to each other. In vascular 
smooth muscle Kajioka et al. (1991) described channels with single channel 
conductance of - 30 pS which required both the removal of ATP and the addition of 
nucleoside diphosphates for activation. This is in contrast with cardiomyocytes where 
single channel conductance is - 70 - 90 pS (Ashcroft & Ashcroft 1990) with only 
removal of ATP required for channel activation. These differences have been 
attributed to varying constituent subunits being present in the channels. Reconstituted 
KATp channels containing Kir6.2 and SUR2A behave similarly to those found in 
cardiomyocytes (Inagaki et al. 1996), whereas channels reconstituted from Kir6.1 and 
SUR2A behave similarly to those found in vascular smooth muscle (Yamada et al. 
1997). That the cardiomyocyte KATp channel contains Kir6.2 is supported by the 
observation that Kir6.2'"- mice lack KATp currents whereas Kir6.1-1- mice retain KATP 
activity (Miki et al. 2002). It was recently reported that KATp channels of human 
coronary artery endothelial cells may consist of Kir6.1 and Kir6.2 heteromultimeric 
pores as well as SUR2B (Yoshida et al. 2004). 
KATP channels of the cardiovascular system have been principally implicated in the 
regulation of both vascular tone (Chrissobolis & Sobey 2003 for review) and the 
contractility of cardiomyocytes (Gross & Peart 2003 for review). In vascular smooth 
21 
Introduction 
muscle, KATP channel activity results in vasodilation, a process which is utilised by a 
number of vasodilatory drugs e. g. pinacidil, minoxidil and cromakalim. Stimulation 
of KATP channels by numerous endogenous substances also contributes to the resting 
tone of vascular smooth muscle. These substances include certain neuropeptides 
(Nelson et al. 1990, Miyoshi & Nakaya 1995) and adenosine (Daut et al. 1990, 
Belloni & Hintze 1991) and may also include nitric oxide (Murphy & Brayden 1995) 
and are thought to act via PKA dependent mechanisms (Kleppisch & Nelson 1995). 
Vasoconstriction may also be mediated by inhibition of KATP channel activity by 
substances which include angiotensin II (Miyoshi et al. 1991) and vasopressin 
(Wakatsuki et al. 1992) via PKC mediated pathways (Hayabuchi et al. 2001). KATP 
channels of cardiac tissues are activated by ischemia and hypoxic shock and the 
resulting K+ efflux results in a shortening of the cardiac action potential. This has the 
effect of helping to prevent damage to the cardiac tissue under periods of ischemia or 
hypoxia suggesting a cardioprotective role for these channels. This protective role of 
these channels may involve trafficking of channels to the cell surface as well as 
changes in their functional characteristics (Budas et al. 2004). It has also been 
suggested that chronic mild hypoxia can increase the expression SUR2A in the heart 
derived H9c2 cell line, which may in turn lead to an increase in functional KATP 
channels (Crawford et al. 2003). The cardioprotective role of these channels may also 
be dependent on both gender and age, with KATP channel numbers decreasing with 
age although this is thought only to occur in females (Ranki et al. 2002). 
1.3.3 - KATp channels in skeletal muscle 
KATP channels in skeletal muscle were first described by Spruce et al. (1985). The 
subunit composition of these channels remains somewhat unclear to this day, although 
the characteristics of the endogenous channels are similar to those of recombinant 
channels reconstituted from Kir6.2 and SUR2B (Inagaki et al. 1996). The main 
function of KATP channels in skeletal muscle appears to be to protect the muscle cells 
during periods of fatigue due to over-contraction. During contractions of the muscle 
cell, metabolism and ATP usage is greatly increased. Due to depletion of ATP, 
channels are activated allowing an outward flux of K+ ions. The effect of the outward 
flux is thought to be two-fold. Firstly the duration of action potential and thus the 
contraction is shortened (Gramolini & Renaud 1997). Secondly hyperpolarization of 
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the cell membrane limits Ca2+ influx into the cell and so prevents Ca2+ overload which 
could otherwise be damaging (Burton & Smith 1997). 
It has also been proposed that KATP channels play a role in the uptake of glucose by 
skeletal muscle, although this idea remains somewhat controversial. It has long been 
known that certain sulphonylurea drugs can help maintain correct glucose 
homeostasis in patients with type-2 diabetes (Wang et al. 1989). It is thought that this 
effect is due to the sulphonylureas acting on peripheral tissues to improve glucose 
uptake whilst lowering insulin resistance, although no direct evidence to implicate the 
skeletal muscle KATP channel in this has yet been presented. Interestingly, the glucose 
lowering effect of insulin appears to be attenuated in Kir6.2"'" mice (Miki et al. 1998) 
and the rate of glucose uptake into the gastronemius muscle of the same mice also 
appears to be increased (Miki et al. 2002). Similarly, SUR2'"- mice (Chutkow et al. 
2001) show lowered fasting and fed serum glucose levels and show improved glucose 
tolerance to a glucose tolerance test. It appears clear that KATP channels play some 
role in glucose uptake into skeletal muscle, but the exact mechanisms remain unclear. 
1.3.4 - KATP channels of the pancreas 
KATP channels are contained in each of the three main types of secretory cell in 
pancreatic islets, namely the a-cell, ß-cell and 8-cell. The secretion of glucagon from 
a-cells (Gopel et al. 2000a) and the secretion of somatostatin from 8-cells (Gopel et 
al. 2000b) are thought to be regulated by KATp channels. It has been shown that KATP 
channels from a-cells contain the Kir6.2 and SUR1 subunits (Bokvist et al. 1999). 
The ß-cell KATP channel and its role in the regulation insulin secretion has been very 
well characterised and will be discussed in greater detail in section 1.4 below. 
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1.4 - The role of KATP channels in insulin secretion 
1.4.1 - Glucose homeostasis 
The importance of maintaining the correct blood glucose levels cannot be overstated. 
The ultimate purpose of glucose homeostasis is to provide neuronal cells with 
adequate supplies of glucose to be utilised as fuel (Unger 1981, Cryer & Gerich 
1985). One reason for this is because neuronal cells lack the ability to utilize 
alternative fuel supplies for themselves; for example through the production of ketone 
bodies or through the metabolism of amino acids and fatty acids, without inducing 
damaging structural and functional changes (Auer 1986). Hypoglycaemia, lowered 
blood glucose, may lead to altered states of consciousness and eventually death 
whereas prolonged hyperglycaemia, elevated blood glucose, may lead to damage to 
cellular proteins due to excessive glycosylation, affecting the structure and function of 
all proteins in all parts of the body. These effects have been well characterised in 
sufferers of diabetes, where, if not correctly controlled, blood glucose may fluctuate 
wildly. As an example of this, the effects of hypoglycaemia can lead to severe 
retinopathy in only a few years in diabetic patients (Cerami et al. 1979, Pettitt et al. 
1980). 
The balance of blood glucose is maintained principally by the contrasting actions of 
two hormones: insulin and glucagon (see Tirone & Brunicardi 2001 for review). In 
simple terms, insulin is released form the pancreatic ß-cell when blood glucose is 
elevated, leading to increased glucose uptake into peripheral tissues such as the liver, 
adipose tissue and skeletal muscle where it is converted into the storage compound 
glycogen by the action of the enzyme glycogen synthetase (Rhodes & White 2002, 
Ferrer et al. 2003). When blood glucose levels are decreased the conversion of 
glycogen back into free glucose is stimulated by the action of the hormone glucagon 
on the peripheral tissues following its secretion from the pancreatic a-cell (Jiang & 
Zhang 2003). Of course the secretion of both of these hormones must be tightly 
regulated if glucose homeostasis is to prove effective. The mechanisms which ensure 
that the level of insulin secretion is appropriate to the level of blood glucose are now 
fairly well characterised and it is understood that one of the principal players in this 
process are the KATP channels of the pancreatic ß-cell. 
24 
Introduction 
1.4.2 - The role of KATP channels in insulin secretion at the pancreatic ß-cell 
KATP channels are vital to correct glucose stimulated insulin secretion (GSIS). This is 
exemplified where disruption or loss of KATP channel activity leads to an 
inappropriate elevation in insulin secretion (as with congenital hyperinsulinism) or 
where KATP channel activity is heightened leading to inappropriately low insulin 
secretion (as may be the case with type-2-diabetes). Put simply, the KATP channel of 
the pancreatic 0-cell can be seen as a switch which turns on or off insulin secretion as 
demanded by blood glucose levels, a process referred to as stimulus secretion 
coupling. 
Figure 1.4 outlines the role of KATP channels in the regulation of normal GSIS in the 
pancreatic ß-cell (see Nichols & Koster 2002 for review). In the scheme outlined in 
figure 1.4, a meal has just been eaten leading to an increase in blood glucose levels. 
The increased availability of extracellular glucose allows an increased rate of glucose 
uptake through specialized glucose transporters at the pancreatic (3-cell surface. This 
glucose transporter has been shown to be GLUT2 in rodents, and it is likely that this 
is also true of humans although this has yet to be conclusively confirmed (Waeber et 
al. 1994, Heimberg et al. 1995, Guillam et al. 2000). The increased uptake of glucose 
into the cell leads to an increase in the cytosolic glucose concentration which 
translates to an increase in the rate of glucose metabolism. The first rate-limiting step 
in glucose metabolism, the conversion of glucose to glucose-6-phosphate, is catalysed 
by the hexokinase enzymes. This process in pancreatic ß-cells differs from that in 
almost all other cell types because it involves a particular hexokinase isoform called 
glucokinase (hexokinase IV). Compared to the other three hexokinase isoforms, 
glucokinase has a much lower affinity for glucose and has a Km value of -6 mM 
glucose which lies within upper end of the normal blood glucose range (Matschinsky 
1990). These properties mean that the activity of glucokinase will increase or 
decrease in response to only very small fluctuations in the cytosolic glucose 
concentration, meaning that it is ideally suited to act as a glucose sensor (see Postic et 
al. 2001 for review). The increased rate of glucose metabolism leads to an increase in 
the rate at which ADP is converted into ATP. This increased rate of conversion has 
the effect of increasing the ratio between the amounts of cytosolic ATP and ADP 
([ATP] / [ADP] ratio). The increase in [ATP] / [ADP] ratio in turn inhibits the KATP 
channels found at the cell membrane, as described in chapter 1.2. 
25 
Introduction 
When open, KATP channels would pass an outward flux of K+, thus hyperpolarising 
the plasma membrane. In the scheme shown in figure 1.4, due to the elevated ATP / 
ADP ratio the KATP channels will be closed and the outward flux of K+ will be halted, 
allowing the plasma membrane to depolarise freely. This depolarisation of the plasma 
membrane allows the opening of voltage dependent Ca2+ channels with a resultant 
influx of Cat+. The increase in cytosolic Ca2+ stimulates the movement to and fusion 
with the membrane of dense-core insulin containing granules via pathways which are 
still largely unclear. 
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Figure 1.4 - Regulation of glucose stimulated insulin secretion (GSIS) in the 
pancreatic ß-cell. Shown is a schematic outlining the role of KATP channels in the 
stimulus secretion coupling of GSIS. An increase in the extracellular glucose 
concentration is accompanied by an increase in the rate of uptake of glucose into the 
cell via glucose transporters, most likely GLUT2 (1). The increase in intracellular 
glucose results in an increase in the rate of metabolism which in turn causes the 
ATP/ADP ratio to rise due to the increased conversion of ADP to ATP (2). The 
increase in the ATP/ADP ratio results in inhibition of KATP channels halting the 
hyperpolarising outward flux of K+ (3). The plasma membrane can therefore 
depolarise much more freely (4) resulting in the opening of voltage-dependent 
calcium channels (VDCC) and an inward flux of Ca2+ (5). This in turn stimulates the 
movement and fusion of insulin containing granules with the plasma membrane (6). 
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1.5 - Pathophysiology of KATP channels 
Defects in KATp channels have been implicated in the onset of two disorders of 
glucose homeostasis, namely congenital hyperinsulinism and diabetes. 
1.5.1 - Congenital hyperinsulinism 
Congenital hyperinsulinism (CHI) is a disorder characterised by inappropriately 
elevated insulin secretion which is independent of blood glucose levels, leading to 
often profound hypoglycaemia. Mutations in Kir6.2 and particularly in SUR1 have 
been shown to be responsible for the majority of cases of CHI with an identified cause 
(see Dunne et al. 2004 for review). Over 100 mutations have been identified in either 
SUR1 or Kir6.2 which cause CHI (Fournet & Junien 2003). These mutations have 
been shown to reduce or abolish KATP channel function, allowing insulin secretion to 
occur without the requirement of the correct metabolic signals. These mutations have 
been shown to affect KATP channels in a number of ways including disrupting 
transport to the cell surface or defects associated with channel function. For example, 
trafficking defects have been reported for the R1394H and L1544P SUR1 mutations 
(Partridge et al. 2001, Taschenberger et al. 2002) whereas a number of other 
mutations associated with NBF of SUR1 (e. g. R1420C and E1506K) may lead to 
functional defects (Huopio et al. 2000, Matsuo et al. 2000). 
For a more thorough and comprehensive introduction to CHI, see chapter 6, which 
describes the characterisation of two CHI causing mutations of Kir6.2. 
1.5.2 - Diabetes 
Type-2 diabetes 
Type-2 diabetes is characterised by elevated blood glucose levels due to impairments 
in both the secretion and action of insulin. The exact causes of type-2 diabetes are 
still unclear but recent advances have begun highlighting a number of genetic 
determinants which are thought to predispose individuals to the disease at a later date 
(see Ashcroft & Rorsman 2004 ab for reviews). Since the action of KATr channels 
are central to the correct secretion of insulin, gain-of-function mutations within either 
of the two channel subunits would be expected to produce diabetes like symptoms due 
to the suppression of insulin secretion, and it appears that this is the case. It is now 
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well established, following an initial period of controversy, that the E23K 
polymorphism of Kir6.2 is linked to the onset of type-2 diabetes (Hani et al. 1998, 
Gloyn et al. 2001, Schwanstecher et al. 2002a, Schwanstecher & Schwanstecher 
2002, Gloyn et al. 2003, Love-Gregory et al. 2003, Nielsen et al. 2003). When 
heterologously expressed in mammalian cells, it has been shown to reduce ATP- 
sensitivity of Kir6.2 two-fold, and it is thought that this is a sufficient reduction to 
vastly attenuate insulin secretion in vivo (Schwanstecher et al. 2002b). It has also 
been suggested that SUR1 polymorphisms may play a role in the onset of type-2 
diabetes (Hani et al. 1997). The E1506K polymorphism first found in a family of 
Finnish origin has been shown to first lead to congenital hyperinsulinism in infancy, 
then to loss of insulin secretory capacity in early adulthood and then finally to 
diabetes in middle age (Huopio et al. 2003). It remains unclear why this form of 
diabetes develops in this manner. 
Other forms of diabetes 
Mutations associated with either channel subunit, particularly Kir6.2, have been 
implicated in the onset of other rarer forms of diabetes. Neonatal diabetes is 
characterized as an insulin-requiring hyperglycaemia which presents in infants within 
the first three months of life (Shield 2000, Polak & Shield 2004). Two distinct forms 
of neonatal diabetes are known, transient neonatal diabetes mellitus (TNDM) and 
permanent neonatal diabetes mellitus (PNDM), and in each case mutations of Kir6.2 
have been identified as the cause in the majority of cases where causes are known 
(Gloyn et al. 2004a, b, Vaxillaire et al. 2004, Gloyn et al. 2005, Massa et al. 2005). 
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1.6 - Trafficking pathways 
The regulation of KATP channel trafficking is poorly understood. The export of newly 
synthesized channels from the ER is governed by the presence of -RKR- retention 
motifs contained within the cytoplasmic domains of both Kir6.2 and SUR1 (Zerangue 
et al. 1999). The act of channel assembly is thought to mask these motifs allowing 
the release of fully formed channels but not individual subunits. It also appears that 
glycosylation of SUR1 is required for the efficient transport of newly synthesized 
channels through the biosynthetic pathway (Conti et al. 2002). The mechanisms 
regulating the endocytic trafficking of KATP channels is even less well understood. 
Recent data (Hu et al. 2003) suggests that the endocytosis of KATP channels is 
regulated by the action of PKC, however, the fate of the internalized channels was not 
investigated in any detail. For this reason the endocytic trafficking of KAIp channels 
will be investigated. 
1.6.1 - Overview of endocytic trafficking 
When proteins are internalised from the cell surface they are directed to different 
destinations within the cell, usually via well defined and tightly regulated pathways. 
Many proteins like the epidermal growth factor receptor (EGFR) are targeted for 
degradation by proteolysis. Some proteins like the transferrin receptor are rapidly 
recycled back to the surface. Others, as in the case of the glucose transporter GLUT4, 
are sequestered into a storage compartment to be released only by application of the 
correct stimulus. The targeting of each protein along its own specific pathway is 
determined by the recognition of specific amino acid motifs by other accessory 
proteins situated in and around each of the organelles of the endocytic pathways. 
Endocytic compartments 
Figure 1.5 shows an overview of the known endocytic trafficking pathways. Proteins 
at the cell surface are internalised by numerous means including clathrin coated pits 
and caveolae, depending on which sub-domain of the membrane the protein is being 
retrieved. Following internalisation proteins enter the endocytic trafficking pathways 
via the sorting endosomes. Here proteins are recognised and concentrated into 
specific domains of the endosome membrane. Some of these domains containing a 
specific complement of accessory and cargo proteins will develop into a population of 
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tubular endosomes, called the endocytic recycling compartment (ERC), which allow 
rapid recycling back to the cell surface. The remainder of the early endosome is 
thought to aggregate into multi-vesicular bodies (MVB) which in turn mature into the 
late endosome. A great deal of material which enters the late endosome will remain 
within as it acidifies and matures into the lysosome, the main site of proteolysis 
within the cell. Some cargo proteins in the late endosome, however, are able to 
escape this degradative pathway and are targeted to the trans-Golgi network (TGN). 
Transport to the TGN is also achieved by a number of proteins which traverse the 
ERC. Once at the TGN proteins may be released into the biosynthetic pathway, enter 
into a futile cycle of trafficking through the endocytic compartments or be routed into 
a specialised storage compartment. The role of each of the endocytic compartments 
mentioned above as well as some details of proteins which traffic through them is 
discussed in more detail below (See Pfeffer 2003 for review covering the above 
general trafficking pathways). 
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Figure 1.5 - An overview of the endocytic trafficking pathways of mammalian cells. 
Endocytosed proteins are first delivered from the plasma membrane (PM) to the 
sorting endosomes (SE) in transport vesicles. From the SE cargo proteins are routed 
toward the endocytic recycling compartment (ERC) to the multi-vesicular bodies 
(MVB), via microtubules (black and white striated bar), or returned directly back to 
the cell surface. Proteins directed towards the ERC may then be returned to the cell 
surface or be trafficked to the trans-Golgi network (TGN). Proteins directed to the 
MVB will continue through to the late endosome (LE) where they will be directed to 
either the lysosome (Lys. ) or the TGN. 
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1.6.2 - Regulators of trafficking 
Two classes of proteins which have been identified as being important in regulating 
endocytic protein transport are the Rab GTPase and the syntaxin families. Each 
compartment has its own distinct collections of each of these proteins and this can be 
used to characterise and distinguish each of the endocytic organelles from one 
another. 
Rab proteins 
Rab proteins are monomeric small-GTPase proteins of the Ras superfamily; they have 
been suggested to play a role in the regulation of vesicle trafficking in both 
endocytosis and exocytosis, where they have been chiefly implicated in vesicle 
docking and fusion. Of the - 60 Rab isoforms which have been identified 12 have 
been localised to the endosomal system (For review see Seabra et al. 2002). 
The Rab proteins are thought to principally be involved in vesicle docking and fusion 
to target membranes (Schimmoller et al. 1998, Gonzalez & Scheller 1999, Mohrmann 
& van der Slujis 1999) although they have been implicated in other steps of vesicular 
transport as discussed below. In the active, GTP-bound, form Rab proteins are 
recruited to specific membrane domains where they selectively interact and recruit a 
wide range of effector proteins which facilitate discrete steps of membrane transport. 
These effector proteins include protein kinases, SNARE proteins and certain 
cytoskeletal proteins (Stenmark et al. 1995, Ren et al. 1996, Echard et al. 1998, 
Christoforidis et al. 1999). As well as vesicle docking and fusion, Rab proteins have 
been implicated in the regulation of the process of vesicle budding (Riederer et al. 
1994, Jedd et al. 1997, McLauchlan et al. 1998, Jones et al. 1999) and in facilitating 
transport of vesicles along the cytoskeleton (Echard et al. 1998, Nielsen et al. 1999). 
Each compartment has its own complement of Rab proteins which also appear to be 
segregated to specific domains within the membranes of each organelle. For example, 
both Rab5 and Rab4 are present in the sorting endosomes but it appears that they 
occupy distinct, non-overlapping regions of the endosomal compartments 
(Sonnichsen et al. 2000). As such, Rab proteins could prove useful as selective 
markers for endosomal compartments in cell biological studies. The distribution of 
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each Rab protein known to interact with specific endosomal compartments are shown 
in figures 1.8 - 1.10. 
Syntaxin proteins 
The syntaxin proteins are members of the SNARE (soluble NSF attachment protein 
receptor) family of trafficking regulators which function to ensure that vesicles fuse to 
the correct membrane domains. There are 15 syntaxins in mammals, each of which is 
localised to specific membranes within the cell (see Teng et al. 2001 for review) 
The syntaxins are all anchored to the cell membrane (except for syntaxin 11) via the 
C-terminus, with the N-terminus extending into the cytoplasm of the cell. They all 
contain several hydrophobic regions which are thought to form coiled-coil a-helical 
structures. One of these domains of - 60 amino acids is the SNARE domain, 
characteristic of all of the SNARE proteins (Weimbs et al. 1997). The SNARE 
domains of the syntaxins interact with SNARE domains of other SNARE proteins on 
target membranes, so called t-SNAREs (usually other syntaxins or SNAP-25 family 
proteins). This complex can then interact with SNARE proteins found of the vesicle 
membranes, the v-SNAREs, commonly members of the vesicle associated membrane 
protein (VAMP) family of proteins to form a core fusion complex (Sutton et al. 1998) 
as shown in figure 1.6. This tethers the vesicle close to the target membrane so that 
vesicle fusion can occur. The N-terminus of some syntaxin proteins has a bundle of 3 
a-helices which is thought to act as an auto-inhibitory domain. This function has been 
best studied in syntaxin 1 (Lerman et al. 2000). The auto-inhibitory domain can fold 
back onto the SNARE domain when the protein is in its "closed" state so it is unable 
to interact functionally with other SNARE proteins. Specific chaperone proteins bind 
to syntaxin in this conformation in order to keep it in the closed conformation. In the 
case of syntaxin 1 the chaperone protein is muncl8. Specific Rab-GTPases can cause 
the chaperone protein to dissociate, allowing the syntaxin to enter the open 
conformation, facilitating SNARE binding. 
34 
Figure 1.6 - The role of syntaxins in vesicle fusion. Shown is a schematic 
representation of the four helical coil structure of the core fusion complex formed by 
the t-SNARE (usually SNAP-25 family) (BLUE), the VAMP (RFD) and a member of 
the syntaxin family ((jREE\). The t-SNARE interacts with syntaxin and this 
complex then in turn interacts with v-SNARE on the vesicle membrane. N- amino 
terminus, C- carboxyl terminus. 
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Since each syntaxin protein is expressed at very specific locations within the cell and 
each syntaxin will bind to only a few other specific SNARE proteins they provide a 
mechanism whereby vesicles can bind selectively to certain membrane domains. 
Because of this limited localisation, they can also be used to identify compartments. 
For example, the trans-Golgi network exclusively expresses syntaxin 6 and 16 and 
syntaxin 12/13 is only found in the early endosomal compartments. The distribution 
of each of the syntaxins in each of the endocytic compartments is shown in figures 1.8 
- 1.10. 
1.6.3 - Endocytosis 
Clathrin mediated endocytosis 
Clathrin mediated endocytosis is the most widely studied and best understood of all 
the endocytic processes, and is known to occur in all cells where it is vital to the 
uptake of numerous nutrients and to the turnover of most cell surface receptors, 
transporters and channels (See Conner & Schmid 2003 for review). Material is 
internalised from the cell surface by the formation of clathrin coated pits, which 
eventually separate from the membrane to form clathrin coated vesicles (CCV). The 
formation of CCV's relies on the recruitment of coat proteins to the cell surface to 
form a lattice of clathrin molecules. Central to this recruitment are the adaptor protein 
complexes of which four isoforms have been isolated (termed API-4). Each adaptor 
protein complex has a distinct subcellular distribution and the isoform responsible for 
endocytic CCV formation is AP2. AP2 is a heterotetrameric complex which is 
targeted to the plasma membrane by the a-adaptin subunit, whereas the ß2-subunit 
mediates clathrin assembly, and interaction with sorting motifs on cargo molecules 
occurs through the g2 subunits. The sorting motifs which are recognized by the µ2 
subunit commonly consist of two leucine residues, so called di-leucine motifs (-LL-) 
and are common in membrane bound proteins. Once AP-2 has been recruited to the 
cell surface by interaction with cargo proteins, clathrin molecules begin to be 
recruited by interactions with AP-2. Clathrin is composed of two proteins, the 
clathrin light chain (CLC) and the clathrin heavy chain (CHC). Each clathrin 
complex is composed of three each of CLC and CHC arranged at 120° angles from 
each other to form complexes termed clathrin triskelions. When the clathrin 
triskelions are recruited to the cell surface in sufficient numbers, they polymerise to 
form a polygonal lattice which deforms the cell membrane, beginning the 
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invagination which will eventually form the CCV. The final scission which will 
result in the separation of the clathrin coated pit from the membrane to form the final 
CCV is dependent on the action of dynamin, a multi-domain GTPase which is 
recruited to the neck of clathrin coated pits where it forms a spiral collar which is 
thought to regulate the membrane fission although the exact mechanisms are still not 
fully understood. 
Caveolin mediated endocytosis 
Caveolae were first described over fifty years ago as flask shaped invaginations of the 
plasma membrane which were abundant in epithelial cells. They are now known to 
be present in most cell types and to occur only in microdomains of the plasma 
membrane which are enriched in cholesterol and sphingolipids into which certain 
proteins are concentrated (reviewed in Anderson et al. 1998). 
The presence of caveolae is dependent on the expression of the protein caveolin. 
Caveolin is a dimeric protein which binds to cholesterol in the inner leaflet of the 
plasma membrane. When bound to cholesterol in the membrane caveolin self 
assembles to form a striated coat which covers the surface of the caveolae. The 
importance of caveolin in the formation of caveolae has been reinforced by the 
establishment of caveolin null mice in which no caveolae were detectable (Drab et al. 
2001). These null mice have no overt phenotype and appear to develop normally, 
suggesting that either caveolae do not play a very important role or that other 
mechanisms can compensate for their loss. Closer examination of caveolin deficient 
cells revealed that their ability to endocytose serum albumin was impaired, suggesting 
a role in transcellular transport (Razani et al. 2002). The rate of internalisation of 
caveolae is very slow compared to other modes (tV2> 20 minutes) and the size of the 
final vesicles are also small (50 - 60 nm in diameter compared to - 120 nm for 
clathrin coated vesicles). As such it is thought that caveolae constitute only a very 
small proportion of total uptake into cells. Indeed, caveolae are often immobile in the 
membrane, requiring tyrosine-phosphorylation of constituent proteins for initiation of 
internalisation (Pelkmans & Helenius et al. 2002). 
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Figure 1.7 - Mechanisms of endocytosis. The main mechanisms of endocytosis are 
depicted. Clathrin mediated endocytosis relies on the recruitment of adaptor proteins 
e. g. AP-2, by cargo proteins at the cell surface. This in turn allows the formation of 
the clathrin coat. Scission of the vesicle relies on the action of dynamin (OW-- ). 
Caveolin mediated endocytosis relies on the action of caveolin for the final vesicle 
scission and does not involve clathrin. Clathrin / caveolin independent endocytosis 
covers all other mechanisms of endocytosis which are independent of the action of 
either clathrin or caveolin. See chapter 1.6.3 for further details. 
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Clathrin / caveolin independent endocytosis 
A number of alternative pathways for the endocytosis of membrane proteins from 
cholesterol-rich lipid rafts are thought to exist, which are independent of the function 
of either clathrin or caveolin. The unique lipid composition of these lipid rafts 
provides a physical basis for the specific sorting of membrane proteins into small 
membrane domains of. 40-50 nm diameter (Edinin et al. 2001). The internalisation 
of the interleukin 2 (IL-2) receptor in lymphocytes is a known example of such a 
clathrin / caveolin independent mechanism. The IL-2 receptor is associated with lipid 
rafts, but is internalised in a clathrin and caveolin independent manner. This is in 
contrast to a number of other lipid raft associated proteins e. g the shiga- and cholera- 
toxins which are known to bind to raft associated glycolipids and are internalised 
along with clathrin coated vesicles (Sandvig et al. 2002, Thomsen et al. 2002). The 
internalisation of the IL-2 receptor is not affected by dominant-negative forms of Eps- 
15 (an important AP-2 complex binding partner which is involved in clathrin 
mediated endocytosis), but it is inhibited by dominant-negative forms of dynamin. It 
has been shown that it is possible to follow these events using GFP-labelled GPI- 
anchored proteins but even with these tools the mechanisms are still poorly 
understood (Nichols & Lippincott Schwartz 2001). 
1.6.4 - Early endosomes 
The early endosomal system is the first destination for the majority of material 
endocytosed from the cell surface. It is thought to comprise two distinct types of 
endosomal compartment, termed here the sorting endosome and the endocytic 
recycling compartment. The main distinction between the two compartments is their 
complement of regulatory proteins. Shown in figure 1.8 is a representation of the 
early endosome compartments and trafficking pathways. 
Sorting endosomes 
The sorting endosomes are the first main branch point in the endosomal trafficking 
system. Endocytosed material is transported from the cell surface in vesicles which 
fuse with the sorting endosomes where cargo proteins are recognised and distributed 
along the correct sorting pathways as shown in figure 1.8. Destinations to which 
proteins are targeted from the sorting endosome are the endocytic recycling 
compartment, the late endosome / multi-vesicular body and the cell surface. 
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The sorting endosomes are short lived, peripheral located, tubular-vesicular structures 
that have a luminal pH of - 6.0 (Johnson et al. 1993, Presley et al. 1997). They only 
accept endocytosed material for -5- 10 minutes, after which they move along 
microtubules becoming more acidic and taking on the characteristics of late 
endosomes. Because of the slightly acidic pH in the sorting endosome lumen, most 
ligands dissociate from receptors, remaining in the lumen whilst the endosome 
matures into a late endosome. This allows the removal of many ligands to the 
lysosome without the need for any specialised targeting mechanisms. Most receptors 
and other cell surface proteins are concentrated into narrow-diameter tubules which 
are excised from the sorting endosome, either returning immediately to the cell 
surface in a direct recycling pathway or becoming part of the endocytic recycling 
compartment (Dunn et al. 1989, Mayor et al. 1993). These narrow-diameter tubules 
have a very high surface area to volume ratio, meaning that whilst a large proportion 
of membrane proteins can be efficiently removed the soluble components in the 
lumen are largely excluded. It is thought that the vast majority of proteins not 
containing any specialised late endosome targeting motifs are removed from the 
sorting endosome in this manner. Those proteins which are not destined for rapid 
recycling remain in the sorting endosome as it matures into a late endosome. 
Proteins which are characteristic of the sorting endosome are early-endosome antigen 
1 (EEAl) and Rab5 which are involved in endocytic vesicle fusion and Rab4 which is 
involved in directing cargo recycling via the endocytic recycling compartment. 
Endocytic Recycling Compartment (ERC) 
The endocytic recycling compartment (ERC) was initially characterised by its 
involvement in the rapid recycling of the transferrin receptor (TfR) (Hopkins et al. 
1983, Yamashiro et al. 1984). Endocytosed membrane proteins are translocated to 
the ERC from the early sorting endosomes. These proteins are then directed either 
towards the cell membrane or the trans-Golgi network (TGN) as depicted in figure 
1.8. 
The ERC is a collection of tubular organelles associated with microtubules with an 
internal diameter of - 60 nm and a luminal pH of - 6.5 (Hopkins et al. 1983, 
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Yamashiro et al. 1984, McGraw et al. 1993). The ERC is a relatively long-lived 
compartment which suggests that both entry and exit of material is dependent on the 
formation of transport intermediates. The machinery responsible for the sorting of 
cargo proteins in the ERC is only poorly understood, although indications suggest that 
it is likely to be fairly similar to that of other compartments. A number of studies 
suggest that clathrin and its various associated adaptor complexes are present in the 
ERC (Pagano et al. 2004), and indeed perturbation of these mechanisms appears to 
alter the recycling kinetics from this compartment. Two proteins which have been 
shown to be important for correct function of the ERC are Rmel, an Epsl5- 
homology-domain protein (Lin et al. 2001), and Rabl1 (Chen et al. 1998, Ren et al. 
1998). Disruption of the function of either of these proteins has been shown to be 
sufficient to interfere with trafficking from the ERC to either the cell surface or the 
TGN. In addition to Rmel and Rabll it appears the Rab6a is also involved in 
transport to the TGN (Mallard et al. 2002). 
Proteins which are characteristic of the ERC include Rab4 and Rabl 1, although these 
are also present to some extent in sorting endosomes and the TGN respectively. 
Rmel serves as a much more selective marker as its expression is limited to the ERC. 
Fluorophore-conjugated transferrin is also commonly used to fluorescently label the 
compartments of the rapid recycling pathway which includes the ERC, although other 
compartments such as the sorting endosome will also be labelled. 
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Figure 1.8 - The early endocytic trafficking pathways. The trafficking pathways of 
the early endosomal compartment are depicted. The key regulatory proteins involved 
in trafficking are shown in red and the syntaxin isoforms associated with each 
compartment are shown in purple. The function of each compartment is described in 
more detail in section 1.6.4. ERC - Endocytic recycling compartment. 
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1.6.5 - Late Endosomes / Lysosomes 
Proteins and ligands which are destined for degradation are targeted to late endosomes 
during sorting at the early endosome. These compartments have a significantly lower 
pH than the early endosomal compartments and are enriched in proteolytic enzymes. 
Shown in figure 1.9 is a representation of trafficking pathways within the late 
endosomal system. 
Multi-Vesicular Compartments 
Multi-vesicular compartments were first described over 50 years ago by the pioneers 
of electron microscopy who observed organelles consisting of a limiting membrane 
containing a large number, often several hundred, of smaller vesicles each with a 
diameter or - 40-90 nm (see Gruenberg & Stenmark 2004 for review). It has since 
been shown that these multi-vesicular compartments represent an intermediate 
compartment of trafficking between the early and late endosomal compartments 
(Bomsel et al. 1990, Aniento et al. 1993). Since they are formed from early 
endosomes they contain a lot of material which has been endocytosed from the cell 
surface but they also receive material from the TGN including a number of lysosomal 
enzyme precursors. In most cases the multi-vesicular compartments mature into or 
fuse with the late endosomal compartment which ultimately leads to lysosomes (see 
Luzio et al. 2003 for review). 
The purpose of the two topologically distinct membrane domains, the limiting 
membrane and the intraluminal vesicles, is not fully understood but several 
possibilities exist. Firstly, transmembrane proteins in the intraluminal membranes 
would likely be susceptible to degradation by lysosomal hydrolases whereas 
transmembrane proteins in the limiting membrane may be more resistant to a similar 
degradation because their exposed regions would most likely contain glycosyl- 
residues and so be resistant to the effect of the proteolytic enzymes (Felder et al. 
1990). Secondly, it has been proposed that the intraluminal vesicles may act as a 
storage compartment for transmembrane proteins which would be released back to the 
cell surface in a controlled manner. Thirdly, it is theoretically possible for the 
proteins in the limiting membrane to participate in receptor signalling events whereas 
those proteins in the intraluminal membranes would be precluded from participation. 
These hypotheses demonstrate how the sorting of endocytosed proteins into the 
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distinct membrane domains provided by the intraluminal and limiting membranes 
could allow both the selective delivery to either the lysosome or the extracellular 
space and also to allow the ability of endocytosed receptors to mediate signalling 
events. 
Late Endosomes 
The late endosomes are morphologically similar to the MVB, indeed some 
controversy exists as to whether the MVB represent a separate compartment from the 
late endosome. However, significant differences exist between the composition of 
late endosomes and MVB. Late endosomes are highly pleiomorphic, consisting of 
regions of cisternal, tubular and multivesicular domains. The lipid and protein 
composition of late endosomes is also very distinct from other organelles, containing 
large amounts of so-called lysosomal glycoproteins e. g. Lamp 1 and Lamp 2 
(Griffiths et al. 1988). The late endosomes are also rich in lysobisphosphatidic acid 
(LBPA) which is not found in any other organelle (Kobayashi et al. 1998, Matsuo et 
al. 2004). Finally the late endosomes act as a major sorting station within the 
endosomal system (Goda & Pfeffer 1988), a process which is discussed in more detail 
below. The luminal pH of late endosomes varies between 5.5 - 6.0. Proteins are 
delivered to the late endosome primarily from the early endosome although some 
proteins are also transported to the late endosome via specialised pathways from the 
TGN. 
Materials destined for degradation by the lysosome are passed through the late 
endosome. Indeed lysosome biogenesis is thought to rely on the maturation of late 
endosomes into lysosomes in a process dependent on both Rab7 and syntaxin7 (Bucci 
et al. 2000). However, all proteins translocated into the late endosome are not 
targeted towards the lysosome. The late endosome acts as a sorting station for a 
number of proteins with direct trafficking to the TGN. One of the best characterised 
of these proteins is the cation independent mannose-6-phosphate receptor (CI-M6PR) 
which chaperones lysosomal enzymes from the biosynthetic pathway at the TGN to 
the late endosome. CI-M6PR contains an acidic motif in its cytoplasmic domains 
which is known to mediate trafficking to the TGN from the late endosome (Schafer et 
al. 1995, Voorhees et al. 1995, Alconada et al. 1996, Mauxion et al. 1996, Dittie et al. 
1997). Also associated with the acidic motif is a casein kinase II (CKII) 
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phosphorylation site (Meresse et al. 1990). When this CKII site is phosphorylated the 
acidic motif is able to interact with a similar acidic motif contained in a chaperone 
protein called PACS-1 (Wan et al. 1998). It is this interaction which allows 
trafficking to the TGN to occur via AP-1 or AP-3 binding to PACS-1 which allows 
clathrin coat formation (Crump et al. 2001). Another adaptor protein known to be 
involved in transport between the late endosome and TGN is Tip47, although little is 
known about its mechanism of action (Diaz & Pfeffer 1998). 
Proteins which are characteristic of the late endosome are CI-M6PR and Rab7 since 
these are enriched in these compartments. Other markers such as Lampl will label 
late endosomes, but will also label lysosomal compartments to a larger extent. 
Lysosomes 
Lysosomes have long been regarded as the terminal degradative compartment of the 
endocytic pathway. They are membrane bound organelles of - 0.5 µm diameter 
containing a variety of acid hydrolases associated with its internal limiting 
membranes. These glycoproteins are grouped into three distinct classes; the limps 
(lysosomal integral membrane proteins), the lamps (lysosomal associated membrane 
proteins) and the Igps (lysosomal glycoproteins) (see Luizio et al. 2003 for 
comprehensive review). Lysosomes are distinguished from late endosomes by the 
absence of CI-M6PR and recycling membrane proteins which are abundant in late 
endosomes but absent in lysosomes (Kornfeld & Mellmann 1989, Luzio et al. 2000, 
Mullins & Bonifacino 2001). When examined by electron microscopy lysosomes are 
morphologically heterogenous and more electron dense than the surrounding 
cytoplasm. They also appear to contain numerous smaller vesicles of membrane 
`whirls'. Lysosomes are thought to constitute - 0.5 -5% of the total cell volume and 
are always located near the microtubule organising centre (Matteoni & Kreis 1987) 
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Figure 1.9 - The late endosomal compartments. The trafficking pathways of the late 
endosomal compartments are shown. The key regulatory proteins involved in 
trafficking are shown in red and the syntaxin isoforms associated with each 
compartment are shown in purple. The function of each compartment is described in 
more detail in section 1.6.5. MVB - Multi-vesicular body, Lys. - Lysosome. 
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1.6.6 - Trans-Golgi Network (TGN) 
The trans-Golgi network (TGN) is the terminal compartment of the Golgi stack and 
as well as being a major site of protein processing in the biosynthetic pathway it also 
acts a major sorting station of the cell. It co-ordinates the regulated export of 
proteins, lipids and membrane domains (see Gleeson et al. 2004 for review). The 
TGN gives rise to a multitude of membrane carriers which mediate both anterograde 
and retrograde trafficking pathways to the cell surface and to other organelles. It has 
also been shown that the TGN plays an important role in the endocytic trafficking 
pathways of many proteins e. g. furin and GLUT4 (Ralston & Ploug 1996, Farquhar & 
Palade 1998, Ramm et al. 2000, Shewan et al. 2003). A schematic representation of 
trafficking pathways to and from the TGN is shown in figure 1.10. 
In order to fulfil its many varied roles it appears that the TGN has developed multiple 
domains arranged in numerous cisternae and so-called vesicle budding domains. 
Electron microscopy has revealed that these vesicle budding domains give rise to a 
number of different membrane trafficking intermediates including distinctly coated 
vesicles (e. g clathrin coated vesicles), uncoated vesicles and tubular extensions. Each 
vesicle budding domain appears to give rise to specific forms of each of these 
trafficking intermediates (Ladinsky et al. 1994, Marsh et al. 2001). The use of GFP- 
tagged Golgi proteins in live cell imaging studies have shown that the TGN 
membrane domains are very dynamic in nature, forming tubules which extend and 
retract continuously (Lippincott-Schwartz et al. 1998, Lippincott-Schwartz et al. 
2000) as well as forming membrane carriers, vesicles and tubules which vary greatly 
in size and shape. These vesicles range from spherical structures which have 
diameters of - 200 nm right up to tubules which extend along microtubules for 100 
µm or more (Hirschberg et al. 1998, Toomre et al. 1999) which are continuously 
leaving and rejoining the TGN. 
Ultrastructural studies of the TGN membranes have revealed `hot spots' of cargo 
export, termed cargo domains from which cargo-laden transport intermediates leave 
the TGN (White et al. 2001, Ladinsky et al. 2002). In these domains cargo proteins 
are segregated from resident proteins (Hirschberg et al. 1998) and basolaterally 
destined and apically destined proteins are also separated from each other (Keller et 
al. 2001, Jacob & Naim 2001, Rustom et al. 2002). The developing picture of TGN 
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protein sorting involves subdomains of the TGN in which cargo proteins are 
segregated and concentrated depending on the trafficking pathways into which it will 
be entered. These specific subdomains of the membrane would allow the recruitment 
of specific coat proteins to facilitate such specialised release processes. 
Apart from the proteins from the biosynthetic pathway, proteins are known to enter 
the TGN from the endocytic trafficking compartments, specifically the endocytic 
recycling compartment (ERC), as in the case of TGN38 and GLUT4 or the late 
endosome, as in the case of CI-M6PR and furin (see section 1.6.7 below). These 
pathways have been fairly well characterised and are discussed in more detail above 
in the relevant sections. 
Proteins which are characteristic for the TGN are the TGN resident proteins such as 
TGN46. Unfortunately as described above the majority of these resident proteins are 
excluded from some regions of the TGN, especially some of the more peripheral 
domains which may be more involved in endocytic protein trafficking. For these 
reasons, syntaxin6 may be used as a marker as it is thought to be universally 
distributed in the TGN, but especially present in the more peripheral TGN-derived 
endosomal trafficking compartments. 
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Figure 1.10 - The trans-Golgi network. The trafficking pathways to and from the 
TGN are depicted. The key regulatory proteins involved in trafficking are shown in 
red and the syntaxin isoforms associated with each compartment are shown in purple. 
The function of each compartment is described in more detail in section 1.6.6. 
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1.6.7 - Known endocytic trafficking itineraries 
Figure 1.11 shows the trafficking pathways of a number of proteins and ligands whose 
endocytic itineraries are fairly well characterised. These are the iron transporter 
transferrin receptor (TfR), a trans-Golgi network resident protein TGN38, the low- 
density lipoprotein receptor (LDLR), the serine protease furin, the glucose transporter 
GLUT4 and the lysosomal protein chaperone the cation-independent mannose-6- 
phosphate receptor (CI-M6PR). Comparison of these endocytic trafficking pathways 
shows what diversity exists with the endocytic trafficking itineraries of endocytosed 
cell surface proteins (see Maxfield & McGraw 2004 for review). 
At the cell surface, the transferrin receptor, LDLR and CI-M6PR bind their ligands, 
diferric transferrin, LDL and lysosomal enzymes respectively. They are then 
concentrated in the membrane and internalised via clathrin coated pits, the mechanism 
by which TGN38, furin and GLUT4 are also internalised. The internalised vesicles 
are first delivered to the sorting endosomes where the slightly acidic pH causes the 
majority of ligands to dissociate from their receptor, although in the case of TfR the 
Fe2+ dissociates from transferrin, but transferrin itself remains bound to the TfR. The 
majority of proteins including TfR, TGN38, LDLR, CI-M6PR and GLUT4 which 
lack certain targeting motifs are quickly removed from the sorting endosome and are 
either transported directly back to the cell surface or to the endocytic recycling 
compartment. Furin on the other hand, remains in the sorting endosome along with 
the dissociated ligands as the compartment matures into multi-vesicular bodies and 
late endosomes. From the late endosome furin is transported to the trans-golgi 
network (TGN) whereas the majority of ligands are transported to the lysosome. 
Those proteins which had been transported to the endocytic recycling compartment 
are also sorted to different destinations. The TfR and LDLR are returned back to the 
cell surface, whereas CI-M6PR, TGN38 and GLUT4 are transported to the TGN. 
Further sorting occurs once these proteins reach the TGN. CI-M6PR, which still has 
lysosomal enzymes bound, is translocated to the late endosome where, because of the 
acidic pH, lysosomal enzymes dissociate allowing the unbound CI-M6PR to recycle 
back to the TGN. GLUT4 is known to be translocated into a specialised insulin- 
responsive storage compartment. The exact nature of this compartment remains 
controversial, although it is thought that it consists of elements of both the TGN and 
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the early endosomal system. TGN38 is thought to largely remain in the TGN, except 
for a small proportion which is transported back to the cell membrane. 
1.7 - Aims of the study 
The overall magnitude of the current carried by KATP channels in any given cell is 
determined by both the open probability of the channel (Po) and by the number of 
channels at the cell surface. The regulation of P. has been fairly well characterised, 
but the factors responsible for regulating the cell surface density of the channel are, by 
comparison, poorly understood. The overall aim of the current study is to investigate 
the mechanism(s) that control the overall density of channels at the cell surface using 
cell biological and functional approaches and how these mechanisms are perturbed by 
genetic mutations that lead to congenital hyperinsulinism (CHI). Specific questions to 
be addressed include: (i) how glucose, the primary stimulant of insulin secretion, 
influences the channel density in pancreatic ß-cells, (ii) how are the channels 
internalised from, and recycled back into, the plasma membrane, (iii) what is the 
pathway via which the channels move during the process of internalisation and 
recycling and finally, (iv) how genetic mutations that cause CHI affect the trafficking 
and / or function of the channel. 
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Figure 1.11 - Endocytic trafficking pathways of well characterised cargo proteins 
and ligands. The trafficking itineraries of several molecules are shown. See chapter 
1.6.7 for further details. SE - Sorting Endosome, ERC - Endocytic Recycling 
Compartment, MVB - Multi Vesicular Body, LE - Late Endosome, Lys. - Lysosome, 
TGN - trans-Golgi Network. 
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2.1 - Materials 
Sterile deionised Milli-Q water (18 M92, Milli Pore), sterile tips, tubes and solutions were 
used whilst handling DNA and RNA. Plastics, glassware and heat stable solutions were 
sterilised by autoclaving. Heat labile solutions were filter sterilised using 0.2 µm 
Acrodisc PF filters (Gelman Science). 
2.1.1 - Tissues 
6-8 week old male BALB/c and C57b16 mice for the isolation of pancreatic ß-cells were 
obtained from Central Biomedical Services, University of Leeds. Female Xenopus laevis 
South African clawed frogs for the isolation of oocytes were also obtained from Central 
Biomedical Services, University of Leeds. 
2.1.2 - Cell lines 
Rin-m (rat insulinoma), COST (simian kidney epithelial), HEK (human kidney epithelial) 
cells were obtained from the European Cell Culture Collection (ECACC, Cambridge, 
UK). INS1 (rat insulinoma) cells were supplied as a kind gift from Dr G. Hardie 
(Dundee University, UK). Early and late passage INSI-e (rat insulinoma) cells were a 
kind gift from Dr C. Wollheim (University of Geneva, CH). HEK293-MSRII cells were 
a kind gift from Glaxo-SmithKline, UK. The HEK293-MSRII cells are a modified form 
of the HEK293 cell line which stably expresses the membrane bound macrophage 
scavenger receptor I. This allows these cells to adhere much more strongly to the growth 
surface which in turn allows more rigorous protocols to be carried out in these cells 
compared to standard HEK293 or tsA cells. 
2.1.3 - Chemicals and solutions 
General laboratory reagents and chemicals were purchased from Sigma, BDH and the 
Anachem Chemicals company unless otherwise stated. Isopropanol and ethanol were 
purchased from BDH. Radio-chemicals were purchased from ICN. 
2.1.4 - Growth media 
Bacto-tryptone and yeast extract were purchased from Amersham and Difco laboratories. 
Bacterial agar was purchased from Oxoid. Electrophoresis grade agarose was purchased 
from Life Technologies. 
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2.1.5 - DNA restriction and modification enzymes 
Restriction endonucleases were purchased from, Promega, Boehringer Mannheim, New 
England Biolabs (NEB), Pharmacia or MBI Fermenters. Pfu DNA polymerase was 
purchased from Stratagene and Taq DNA polymerase from Promega. Calf intestine 
phosphatase (CIP) was purchased from Boehringer Mannheim. T4 DNA ligase and T4 
DNA polymerase were purchased from NEB. 
2.1.6 - Plasmid vectors 
The mammalian expression vectors pcDNA3.1(+), pcDNA6/V5-HisA and pSport2 were 
obtained from Invitrogen / Life Technologies. The pKSglobin vector was constructed in 
the laboratory in order to allow expression of constructs in Xenopus laevis oocyte 
expression systems. This vector was contructed by inserting 5' and 3' untranslated 
regions (UTR) of the Xenopus ß-globin gene either side of the multiple cloning site of 
pBluescriptKS. It has previously been shown the presence of the UTR sequences either 
side of the gene of interest can increase expression efficiency by -300 fold in Xenopus 
oocytes. Plasmid maps are included as an appendix at the end of the thesis. 
2.1.7 - cDNA clones 
Hamster SUR1 (Genbank accession number L40624) was obtained from Dr J. Bryan 
(Baylor College of Medicine) and was subcloned into pcDNA6N5-HisA (Hough 2000). 
Mouse Kir6.2 (Genbank accession number D50581) was obtained from Prof. S. Seino 
(Osaka, JP) (Baylor College of Medicine) and was subcloned into pcDNA3.1. The 
Human pEGFP-C2-TGN46 clone was provided by Dr S. Ponnambalam (University of 
Leeds). Mouse pEGFP-C2-EEA1 was kindly provided by Dr. H. Stenmark (Norwegian 
Radium Hospital, Oslo, Norway). Dog pEGFP-C1-Rab7 clones were obtained form Dr 
B. van Deurs (Copenhagen, DK) and Rat pEGFP-C1-Rmel clones were obtained from 
Dr B. Grant (Reutgers University, NY, USA). Rat pEGFP-C2-Lampl clones were 
obtained from Dr P. Boquet (Institut National de la Sante et la Recherche Medicale, Nice, 
France). Rat pEGFP-C2-Rab4A clones were obtained from Dr M. Skidmore (Cornell 
University, NY, USA). 
2.1.8 - Oligonucleotides 
Oligonucleotide primers for the purposes of polymerase chain reaction (PCR), site- 
directed mutagenesis or DNA sequencing were made to order by Sigma-Genosys or 
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Invitrogen / Life Technologies. Primers were reconstituted in sterile Mili-Q to the 
concentration of 1 nmol µl"1 for long term storage at -20°C. 
The sequences of all oligonucleotides used in the current studies are shown in table 2.1. 
Primer name Primer sequence (5' - 3') 
Rat SURI probel For AGAAGACACGCAGGAAGGAA 
Rat SUR1 probel Rev CTGGAAGGCTGTTCCAGAAG 
Rat SUR1 probe2 For GCCTTCGCTGTCTACACCTC 
Rat SUR1 probet Rev CTGGAAGGCTGTTCCAGAAG 
Kir6.2HAinsert For TACCAGATTACGCTGGAGAGGGCACCAATGTGCCCT 
Kir6.2HAinsert Rev CGTCGTATGGGTAGGGGGCCAGGTCACCGTG 
Kir6.2+1 laa-insert For TGGAGAAAGGCATCACGGACCTGGCCCCCTACCC 
Kir6.2+1laa-insert Rev TGTAAGCATAGATGTCACCGTGGGCGAAGGCGATG 
Kir6.2deltaHF FOR GATTCCTTGTCCTGAGCATCCGTTGAA 
Kir6.2deltaHF REV TTCAACGGATGCTCAGGACAAGGAATC 
Kir6.2-W91R FOR CCATGGTCTGGCGTCTCATCGCCTTCGC 
Kir6.2-W91R REV GCGAAGGCGATGAGACGCCAGACCATGG 
Kir6.2-L147P FOR ATGTCCCCTGGCCATCCCCATTCTCATTGTGCAGA 
Kir6.2-L147P REV TCTGCACAATGAGAATGGGGATGGCCAGGGGCAAT 
Table 2.1 - Sequences of oligonucleotides used during the current study. 
2.1.9 - Bacterial strains 
For general procedures the XL-Blue (Stratagene) and DH-5a (Gibco BRL) Eco1i strains 
were used. Strains were used for growth and propagation of plasmid DNA. 
When grown in liquid media, E. coli cells were incubated in an orbital shaking-incubator 
at 200-250 rpm. 
2.1.10 - Antibodies and labelling solutions 
Anti-Kir6.2 antibodies were custom made by Sigma-Genosys. For Kir6.2, antibodies 
were raised in rabbits against an antigen peptide of the sequence 
EDPAEPRYRARQRRARFVSKK, corresponding to the intra-cellular N-terminal region 
between residues 19-39 of mouse Kir6.2 (Genbank accession number D50581). Anti- 
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SUR1 antibodies raised in rabbits against an antigen peptide of the sequence 
EEAAESEEDDNLSSVLHQRAK were custom made by Sigma-Genosys. This epitope 
corresponds to a region of the first intracellular loop between the first and second 
transmembrane domains (TMDO-TMD1) between residues 975-995 of hamster SUR1 
(Genbank accession number L40624). Rat anti-HA antibodies (clone 3F10) were 
purchased from Roche Diagnostics. Mouse anti-HA alexafluor593-conjugated antibodies 
and FITC-conjugated transferrin were purchased from Molecular Probes. Other FITC 
and Cy3-conjugated secondary antibodies were purchased from Jackson 
ImmunoResearch. Sheep anti-TGN48 antibodies were provided by Dr S. Ponnambalam 
(University of Leeds). Mouse anti-cathepsin-D antibodies were purchased from 
DakoCytomation. Mouse anti-EEA1 antibodies and mouse anti-syntaxin6 antibodies 
were purchased from BD Pharmingen. Mouse anti-CI-M6PR antibodies were purchased 
from Abcam. FITC-conjugated Wheat-germ agglutinin and FITC-conjugated dextran 
were obtained from Sigma Drugs Company. 
2.1.11 - Pharmaceutical agents 
The translation inhibitor cycloheximide was purchased from ICN biomedicals and was 
stored as 25 mg ml'1 stocks in ethanol at -20°C. The transcription inhibitor actinomycin- 
D was purchased from Sigma and was stored as 5 mg ml'' in ethanol at 4°C. The 
transcription inhibitor a-amanitin was purchased from Calbiochem and was stored as 10 
mg ml-1 stocks in DMSO at -20°C. The PKC activator phorbol-l2-myristate-13-acetate 
(PMA) was obtained from Calbiochem and was stored as 1.62 mM stocks (10 mg mr') in 
DMSO at -20°C. The PKC antagonist chelerythrine chloride was purchased from Sigma 
and was stored as 26 mM stocks (10 mg ml-1) in DMSO at -20°C. G418 (geneticin) was 
purchased from Sigma Drugs Company and was stored as 400 mg m1'1 stocks in water at 
-20°C. Blasticidin was obtained from Invitrogen Lifetechnologies and was stored as 5 
mg mr, stocks in DMSO at -20°C. The KATP channel opener diazoxide was obtained 
from Sigma and was stored as 200 mM stocks in DMSO. The sulphonylurea 
glibenclamide was obtained from ICN biomedicals and was stored as 1 mM stocks in 
DMSO. The metabolic poison sodium azide was obtained from Sigma and was stored as 
3M stocks in water. The translational inhibitor cycloheximide was purchased from ICN 
biomedicals and was stored as 25 mg ml's stocks. All stocks were stored as small 
aliquots at -20°C. 
57 
General methods 
2.2 - General solutions 
2.2.1 - Antibiotic solutions 
Antibiotic solutions were used to supplement bacterial growth media in order to maintain 
the growth of plasmid and to enable the selection of antibiotic-resistant bacteria. 
Ampicillin 
A stock solution of ampicillin was made to 50 mg. ml'' in Milli-Q, filter-sterilised (0.2 µm 
filter, Acrodisc), aliquoted into Eppendorf tubes and stored at -20°C. 
Kanamycin 
A stock solution of kanamycin was made to 25 mg. mr' in Milli-Q, filter-sterilised (0.2 
µm filter, Acrodisc), aliquoted into Eppendorf tubes and stored at -20°C. 
2.2.2 - Bacterial growth media 
Bacteria can be maintained with either solid or liquid media, depending on the 
application 
Solid media 
Solid media are used when the growth of bacterial colonies is required. 
2YT-agar selection plates 
Agar (1%) was suspended in 2YT (2X yeast-tryptone) and the suspension was sterilised 
by autoclaving at 115 °C for 20 minutes. The medium was cooled to approximately 
55°C, the appropriate antibiotic added to the desired concentration (see table 2.2) then 
poured into sterile Petri dishes and allowed to set. The plates were then stored for up to 
one month at 4°C. Before use, the plates were pre-warmed to 37°C for optimal growth of 
bacterial colonies. 
Antibiotic Final concentration (pg ml') 
Ampicillin 50 
Kanamycin 30 
Table 2.2 - Selection antibiotics for 2YT-agar plates. 
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Liquid media 
Liquid media are used when bacterial cultures are required for DNA isolation protocols. 
LB medium (Luria-Bertani medium), pH 7.0 
Bactotryptone 10 g 
Bacto yeast extract 5g 
NaCl log 
The reagents above were added to 950 ml of distilled water, or Milli-Q, and the pH was 
adjusted by the addition of 10 M NaOH. The volume was then made up to 1L with 
distilled water and autoclaved at 115°C for 20 min. The media was stored at room 
temperature. 
2YT medium 
Bacto-tryptone 16 g 
Bacto yeast extract 10 g 
NaCl 5g 
The components above were dissolved in 900 ml water and the solution was adjusted to 
pH 7.0 with NaOH. The volume was made up to 1L with water and was then sterilised 
and stored as described above. Alternatively, 2YT medium was made by dissolving 31g 
of 2YT powder (Difco) in 1L of distilled water followed by sterilisation and storage as 
described above. 
Bacterial storage medium 
For long-term storage of bacterial cultures, 0.15 ml of sterilised glycerol was added to 
0.85 ml of an overnight bacterial culture. Cultures were stored at -80°C. In order to 
recover the bacteria, the vial was removed from storage and a sample streaked across the 
top of a 2YT-agar plate containing the necessary antibiotics and grown at 37°C overnight. 
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2.2.3 - Mammalian cell culture medium 
Media for COS7and HEK293 cells 
COST and HEK293 cells were cultured in DMEM media supplemented with L-glutamine 
(cons), NaHCO3 (conc), 10 % heat inactivated fetal bovine serum, 100 U ml'' penicillin 
and 100 pg ml" streptomycin. 
Media for INS, INS-1 e, RIN and primary ß- cell lines 
INS and INS 1e cells were cultured in RPMI 1640 media supplemented with 10 % heat 
inactivated fetal bovine serum, 10 mM HEPES, 2 mM glutamine, 1 mM sodium 
pyruvate, 50 µM ß-mercaptoethanol, 1nM glucagon-like peptide 1 (GLP-1), 100 U ml" 
penicillin and 100 gg ml-1 streptomycin. 
Media for HEK293-MSRII cells 
HEK293-MSRII cells were cultured in DMEM / F-12 media supplemented with 10 % 
fetal bovine serum, 2.56 mM glutamax, 15 mM HEPES and 400 gg ml's G418. 
2.2.4 - Solutions for DNA preparation 
For mini plasmid preparations (mini prep) 
All solutions below are sufficient for 12 preparations. All stock solutions are prepared as 
described by Sambrook and Russell (2001). 
Solution A (Prepare immediately before use) 
H2O 2.8 ml 
Tris-EDTA (100x) 75 µl 
Glucose (2M) 75 µl 
Lysosome 50 µ1 
Solution B (prepare immediately before use) 
H2O 4.5 ml 
SDS (10%) 0.5 ml 
NaOH (1 OM) 100111 
Solution C (prepare immediately before use) 
Ammonium Acetate (7.5M) 5 ml 
RNase (10mg/ml) 25 µ1 
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For large-scale plasmid preparations 
Where possible, the stock solutions used should be sterile. All stock solutions have been 
made as described in Sambrook and Russell (2001). 
Solution 1 
Glucose 9g 
Tris; pH 8.0 (1 M) 12.5 ml 
EDTA (0.5M) 10 ml 
H2O 475 ml 
Solution 2 (prepare fresh) 
NaOH (10M) 1.6 ml 
SDS (10%) 8.0 ml 
H2O 70.4 ml 
Solution 3 (3Mpotassium acetate pH5.2) 
Potassium acetate 147 g 
Acetic Acid 58 ml 
2.2.5 - Electrophoresis solutions 
Solutions for agarose gel electophoresis 
The following solutions are used to examine DNA samples by agarose gel 
electrophoresis. 
Tris-acetate-EDTA (TAE) gel running buffer f er (50 X stock) 
Tris-base 242 g 
Glacial acetic acid 57.1 g 
0.5 M EDTA (pH 8.0) 100 ml 
Distilled water to 1L 
This stock solution is diluted 50 X (to make 1X buffer) in distilled water before use and 
is used to make and run all agarose gels 
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6X DNA gel-loading buffer (pH 8.0) 
0.25% bromophenol blue 
1 mM EDTA (pH 8.0) 
30% glycerol in water 
0.25% xylene cyanol FF 
Polyacrylamide gel electrophoresis (SDS PAGE) 
The following solutions are used to examine protein samples via SDS-polyacrylamide 
electrophoresis. 
Resolving gels 
The constituents of SDS-polyacrylamide gels vary depending on the required percentage, 
typically between 5- 15 %. The resolving gels used to separate KATr channels subunits 
were prepared as 5- 15 % gradient gels and were poured using a peristaltic pump 
attached to a gradient maker (home-made). The volumes shown below are sufficient to 
pour one gel using the Amersham Hoeffer gel casting kit. 
Resolving gel 5% 15 % 
Water 1.15 m1 0 ml 
30 % acrylamide 0.38 ml 1.15 ml 
75 % glycerol 0.15 ml 0.52 ml 
1.5 M Tris (pH8.8) 0.58 ml 0.58 ml 
10 % SDS 23 µl 23 gl 
10 % ammonium persulphate 23 µl 23 µl 
TEMED 2 µl 2 µl 
5% Stacking gel 
Water 1.4 ml 
30 % acrylamide + 
N. N'methylenebisacrylamide (BDH) 330 µl 
1.5 M Tris-CI (pH 6.8) 250 µl 
10%SDS 20µl 
10 % Ammonium persulphate 20 µl 
TEMED 2 µl 
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SDS-PAGE running buffer 
25 mM Tris-Cl (pH 8.3) 
250 mM glycine 
0.1%SDS 
2X alkaline SDS sample buffer (ß-mercaptoethanol free) 
25 mM sodium bicarbonate (pH 10.4) 
4%SDS 
0.2 % bromophenol blue 
20 % glycerol 
Coomassie blue stain 
0.25 % Coomassie Brilliant Blue R250 
45 % methanol 
10 % acetic acid 
De-stain solution 
30 % methanol 
10 % acetic acid 
Salicylic acid solution 
iM salicylic acid in water 
2.2.6 - Reagents for making competent cells 
Transformation buffer (pH 6.7) 
PIPES 10 mm 
MnCl2 55 mM 
CaCl2 15 mM 
KCl 250 mM 
This was prepared in Milli-Q. 
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2.2.7 - Other commonly used molecular biology buffers 
10 X Phosphate buffered saline (PBS) 
PBS was made by dissolving PBS tablets (Gibco BRL) in Mili-Q water, as per 
manufacturers' instructions. 
Tris-CI EDTA, pH 7.5 (TE7 5) 
10 mM Tris-Cl (pH 7.5) 
1 mM EDTA 
Tris-Cl EDTA pH 8.0 (TE8'0) 
10 mM Tris-Cl (pH 8.0) 
1 mM EDTA 
GENECLEAe NEW Wash buffer 
10 mM Tris-Cl, pH 8.0 
2.5 mM EDTA 
100 mM NaCI 
50 % ethanol 
2.2.8 - Solutions for immunocytochemistry 
2% Paraformaldehyde (PFA) 
Dissolve 0.5 g of paraformaldehyde in 1 ml of 0.05M NaOH at 60°C. When dissolved 
add 50 µl of 1M HC1,0.5 ml of 10 X PBS and 3.45 ml of Mili-Q water. 
2.3 - General molecular biology methods 
2.3.1 - Competent cell preparation 
E. coli cells have the capacity to take up foreign DNA. Competent cells are chemically 
treated bacterial cells capable of taking up plasmid DNA when `shocked' with an 
appropriate stimulus such as heat. Competent cells were prepared in the laboratory using 
the protocol by Inoue et al (1991). A glycerol stock (80 % culture, 20 % glycerol) of 
DH5a or XL blue cells (GibcoBRL, Life Technologies) was streaked on a LB plate and 
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incubated overnight at 37°C. One colony from this plate was then streaked onto another 
plate and incubated overnight at 37°C. 200 ml SOB medium was inoculated with 10-12 
colonies from this second plate. The cells were incubated (room temperature, 200 rpm) 
until the A600 (absorbance at 600 nm) reached 0.6. The cells were chilled for 10 min on 
ice prior to being centrifuged (Beckman JA10 rotor, 4000 rpm, 4°C for 10 min) and 
allowed to come to rest without the use of the brake. 16 ml of ice-cold TB was added to 
the pellet and the cells were chilled on ice for a further 10 min before being re- 
centrifuged as above. The supernatant was decanted and the cell pellet resuspended in 16 
ml TB, 1.2 ml DMSO (final concentration of 7 %) was then added dropwise and the cells 
kept on ice for a further 10 min. Cells were frozen in dry ice and then stored in 1 ml 
aliquots at -80°C. Cells with a competency of >107 colonies / µg DNA were used in 
subsequent procedures. The competency of the cells was tested by transforming 1 pg of 
control DNA template (as described in 2.3.2) into 100 µl ofE. coli cells and is calculated, 
by describing the number of colonies per microgram of transformed DNA (cfu µg"1). 
Typical cell competency is 1X 107 cfu µg"1. 
2.3.2 - Transformation of E. coli with plasmid DNA 
For each transformation 100 gl of competent cells were slowly thawed on ice. 1- 10 
gl of DNA (25 - 50 ng) was added and gently mixed and incubated on ice for 30 minutes. 
The cells were then `heat-shocked' at 42°C in a water bath for 40 seconds and then placed 
on ice for a further 2 minutes. 900 µl of LB medium was then added to the cells and they 
were placed in a 37°C shaking incubator for 1 hour. The cells were then pelleted by 
centrifugation at 7K rpm and 900 µl of the supernatant discarded. The pellet was then 
resuspended into the remaining media and plated onto pre-warmed 2YT-agar plates 
(containing appropriate selection antibiotics) with a sterile glass spreader. The inoculated 
plates were then placed in a 37°C incubator overnight to allow growth. 
2.3.3 - Preparation of plasmid DNA 
The alkaline-lysis method was employed for isolating plasmid DNA from bacterial cells. 
The method is a modification of the technique described by Birnboin and Doly (1979); 
Ish-Horoweiz and Burke (1991). 
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Mini preparation of DNA 
5 ml of 2YT or LB medium supplemented with appropriate selection antibiotics was 
inoculated with a single bacterial colony transformed with the plasmid DNA to be 
purified and incubated overnight at 37°C in a shaking incubator. 1.5 ml of the culture 
was centrifuged (bench top microfuge, 4400 g, RT, 1 min) and the supernatant discarded. 
The pellet was resuspended in 200 µl of miniprep solution A and incubated at RT for 5 
min. Cells were lysed by addition of 400 µl of miniprep solution B, gently mixed and 
incubated at room temperature for a further 5 min. Next, 300 µl of miniprep solution C 
was added and the preparation incubated on ice for 10 min before centrifugation (bench 
top microfuge, 16000 g, RT, 15 min). The supernatant was decanted into a fresh tube, 
600 µl isopropanol added and the mixture incubated at RT for 10 min prior to re- 
centrifugation (as above). The supernatant was discarded, the pellet washed with 70 % 
ethanol, dried and resuspended in 40 µl TE 8.0.1 µl of the resulting isolated DNA was 
then examined by agarose gel electrophoresis. 
Large-scale preparation of DNA 
5 ml of 2YT or LB media supplemented with appropriate antibiotics was inoculated with 
a single bacterial colony from a plate transformed with the plasmid DNA to be isolated. 
This starter culture was grown for 16 hrs at 37°C in a shaking incubator. This start culture 
was added to 400 ml 2YT containing appropriate selection antibiotics and grown at 37°C 
in a shaking incubator for a further 16-24 hrs. The cell suspension was centrifuged 
(Beckman JA10 rotor, 4400 g, 4°C, 15 min). The supernatant was decanted and the cell 
pellet resuspended in 10 ml of solution 1. The cells were lysed by addition of 20 ml of 
solution 2, gently mixed for approximately one minute and incubated on ice for a further 
10 min. 10 ml of solution 3 (4°C) was added and the preparation incubated on ice for 5 
min prior to centrifugation (as above). The supernatant was filtered through a clean filter 
paper, then 50 ml of isopropanol was added and the mixture re-spun (as above). The 
supernatant was decanted and the pellet dried. The pellet was resuspended in 2 ml TE 
8.0,50 µl RNAse A (10 mg ml-1 stock) added and the solution incubated at 37°C for 30 
min. Plasmid DNA was purified by organic extraction, once each with phenol then 
phenol-chloroform and twice with chloroform and precipitated by addition of 0.5 ml 20 
% PEG 8000 and 25 gl 1M MgCI2. The DNA was pelleted by centrifugation (bench top 
microfuge, 16000 g, RT, 15 min), washed twice with 70 % ethanol, air-dried, and 
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dissolved in TE 8.0. The DNA concentration was estimated by agarose gel 
electrophoresis 
2.3.4 - Purification of DNA 
GENECLEANTM protocol 
In order to isolate a particular DNA fragment from a mixture, samples were first 
separated by agarose gel electrophoresis. The separated DNA fragments were visualised 
on a UV transilluminator and the band corresponding to the fragment of interest was 
carefully excised using a clean scalpel blade. The gel fragment, containing the DNA of 
interest, was then dissolved in 3X volumes of 6M Nal by heating in a 55°C water bath. 
Once dissolved 10 µl of EZ GLASSMILKTM was added and incubated at room 
temperature with thorough mixing by rotation. The EZ GLASSMILKTM was then 
pelleted by brief centrifugation (16000 g, RT) and the supernatant discarded. The EZ 
GLASSMILKTM pellet was then washed twice in 200 µ1 volumes of ice-cold New-wash 
buffer by resuspension and brief centrifugation (as above). Following the second wash in 
New-wash buffer the EZ GLASSMILKTM pellet was washed twice in ice-cold 70 % 
ethanol as above. Following the second ethanol wash the EZ GLASSMILKTM pellet was 
dried and resuspended in 10 µl of Mili-Q. DNA was eluted from the EZ GLASSMILKTM 
by incubation for 15 minutes in a 55°C water bath. Following centrifugation the 
supernatant (containing DNA) was transferred into a fresh tube and centrifuged again as 
above to remove any remaining traces of EZ GLASSMILKTM. An aliquot of the DNA 
was examined by agarose gel electrophoresis. 
Phenol-chloroform extraction of DNA 
Phenol-chloroform extraction of DNA can be used to remove protein contamination from 
DNA samples, which might interfere with DNA modification or transfection 
experiments. 
The DNA sample to be cleaned was made up to a volume of 200 µl and then thoroughly 
mixed with an equal volume of phenol. This was then centrifuged (16000 g, RT, 5 min). 
The upper, aqueous layer was carefully transferred, avoiding the protein interface, to a 
fresh tube and an equal volume of phenol-chloroform-isoamyl alcohol (50: 48: 2 v/v) was 
added. Following centrifugation, as above, the upper layer was again carefully 
transferred to a fresh tube and an equal volume of chloroform-isoamyl alcohol (48: 2 v/v) 
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was added. Following centrifugation, the upper layer was again carefully removed and 
treated for a second time with chloroform-isoamyl alcohol (48: 2 v/v) as above. 
Following the fmal centrifugation, the aqueous layer was transferred to a fresh tube and 
30 gl of 3M sodium acetate (pH 5.2) were added, followed by 2.5 volumes of ethanol. 
The mixture was then incubated at -20°C for 30 minutes, and the DNA was then pelleted 
by centrifugation, washed with ice-cold 70% ethanol and dried. The DNA pellet was 
then redissolved in 10 µl of Milli-Q and an aliquot examined by agarose gel 
electrophoresis. 
Purification of DNA in aqueous solution by guanidium thiocyanate 
To the DNA sample, to be purified, five volumes of denaturation solution (see below) 
and l01il of GLASSMILKT was mixed and incubated at room temperature for 10 min. 
The rest of the protocol was as the GENECLEANT' protocol (section 2.3.4). 
Denaturation solution contains 6M guanidium thiocyanate, which was made in DMSO 
containing 0.7% of 2-mercaptoethanol and stored in 1 ml aliquots at -20°C. This method 
is particularly good for purification of linearised DNA templates for RNA synthesis, as 
an alternative to phenol/chloroform extraction. 
DNA precipitation 
Isopropanol or ethanol can be used for precipitating DNA (and RNA) in solution. To the 
solution containing the DNA, 2.5 volumes of ethanol (or 0.6 volumes of isopropanol) and 
0.1 volume of 3M NaOAc (pH 5.2) were added, vortexed and incubated for at least 1h 
at -20°C. The DNA was then pelleted by centrifuging at 16000 g for 15 min and the 
supernatant discarded. 0.5 ml of 70% ethanol (-20°C) was then added to the wet pellet 
and centrifuged as above. The supernatant was discarded and the pellet dried at room 
temperature or 37°C. The pellet was then dissolved in the appropriate volume of TE8 ° or 
Milli-Q. A sample of the DNA was then examined by agarose gel electrophoresis. 
2.3.5 - In vitro transcription 
cRNA was transcribed from linearised DNA under the T7 promoter. Linearised DNA 
was obtained either by restriction endonuclease digestion at the 3' end of the insert to be 
transcribed or by PCR based isolation of the insert and promoter sequences where no 
suitable restriction sites are available. The DNA template was cleaned by the guanidium 
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thiocyanate method (2.3.4.3) followed by isolation by the GENECLEANTM protocol 
(2.3.4). DNA was eluted from the EZ GLASSMILKTM into RNase free water. Capped 
cRNA was transcribed in vitro using the T7 MEGAscript kit (Ambion) along with 
m7G(5')ppp(5')G cap analog (Ambion) according to manufacturers instructions. An 
aliquot of the finished cRNA was examined by agarose gel electrophoresis. 
2.3.6 - Agarose gel electrophoresis of DNA 
Gel preparation 
For most purposes 1% agarose gels proved sufficient. For this, 100ml of 1X TAE 
buffer is added to lg of electrophoresis grade agarose and heated until dissolved. The 
molten gel was allowed to cool to - 60°C and 5µl of 10mg mrl ethidium bromide was 
added and mixed by swirling. The gel was then poured into a mould and allowed to set. 
Sample preparation and electrophoresis 
6X loading buffer was added to the DNA sample(s) to be examined to a final 
concentration of 1X and the samples mixed by resuspension. The pre-cast agarose gel 
was placed into the gel electrophoresis tank and barely covered in 1X TAE buffer. The 
DNA samples were loaded into individual wells and electrophoresed at 90 V for - 50 
minutes. For estimation of sample DNA size marker DNA fragments were run alongside. 
Following electrophoresis, DNA fragments were visualised on either a UV- 
transilluminator or a Bio-Rad gel documentation system. 
2.3.7 - Subcloning of DNA 
It is sometimes necessary to take a gene of interest from one plasmid expression vector 
and insert it into another in order to allow expression of the gene in different expression 
systems. This process, termed subcloning, is a multi-stage process. Firstly the gene of 
interest is isolated from the parent plasmid vector by restriction endonuclease digestion 
and purified by the GENECLEAN protocol. Secondly the recipient plasmid vector is 
restricted by endonuclease digestion, ideally so it is left with 5' and 3' ends 
complementary to those of the gene of interest. Its ends are then dephosphorylated and 
finally the recipient vector is purified. 
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Restriction of DNA 
DNA to be restricted was digested with the appropriate enzyme using conditions 
recommended by the manufacturer. For analytical digestions, approximately 1-2 gg of 
DNA was digested for 3 hours in a total volume of 30 µl with 5-10 U of restriction 
enzyme at 37°C. For preparative digestions, 5-10 µg of DNA was digested in a 30-50 µl 
final volume with 10-20 U of restriction enzyme overnight at 37°C. 
Dephosphorylation ofplasmid vector DNA 
Dephosphorylation prevents self-ligation and recircularisation of the restricted vector 
DNA, thereby improving ligation efficiency. Prior to dephoshporylation, DNA 
restrictions were performed in a volume of 30 µl. To this, 5 gl of lOX calf intestinal 
phosphatase (CIP) buffer, 10 gl of Milli-Q water and 5 µ1(5U) of CIP were added, mixed 
and incubated at 45°C for 2 hours. CIP was inactivated by addition of 0.5 M EDTA and 
incubation at 45°C for 10 min. Dephosphorylated DNA was then subjected to the 
guanidium thiocyanate purification. 
Ligation of DNA fragments 
Estimations of the quantity of vector and insert DNAs were made from the intensity of 
bands upon agarose gel electrophoresis. Typical ligation reactions comprised a 3: 1 molar 
ratio of vector: insert DNA, 1 µ1 of l Ox ligation buffer and 1 µ1(1U) of T4 DNA ligase in 
a 10 µl reaction. The reaction was performed at room temperature for 2 hours and 
immediately transformed into competent E. co1i. Control ligations included vector and 
insert alone. 
Subcloning of Kir6.2 constructs 
Kir6.2-HA+11 aa-HMKFLAG was subcloned into the BamHI / EcoRl sites of each 
plasmid vector as shown in figure 2.1. 
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Figure 2.1 - Kir6.2-HA+I1 aa-HMKFLAG suhcloning strateg v. 
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2.3.8 - Polymerase chain reaction (PCR) 
PCR has many diverse applications that can be applied to numerous tasks in the 
laboratory. The following protocol can be used in analytical investigations such as 
checking the orientation of DNA inserts following ligation, or as a preparative tool as in 
the isolation of linearised templates for in vitro cRNA transcription, the generation of 
gene fragments or gene specific probes to be used in further studies. 
PCR reactions were performed in 0.5 ml PCR tubes at a total volume of 50 µl per 
reaction. For each reaction 1- 50 ng of template DNA was required. Together with the 
template DNA, each reaction consisted of 10 pmol each of the forward and reverse 
primer, 200 µM dNTP's mixture, 1X cloned pfu Turbo DNA polymerase buffer 
(Stratagene) and 1 gl (2.5U) cloned pfu Turbo DNA polymerase (Stratagene). Each 
reaction was then overlaid with 40 µl mineral oil. We have used pfu Turbo DNA 
polymerase in preference to Taq DNA polymerase because it has a 3' - 5' "proof- 
reading" activity which results in the high-fidelity replication of DNA. Typically, PCR 
reactions were pre-heated to 95°C prior to addition of the DNA polymerase (hot-start). 
Annealing temperatures for this type of PCR is calculated from the following formula: 
69.3 + (0.41 X %GC base content) - 650/L (where L= length of primer in bases) 
All PCR reactions were performed using either a Perkin-Elmer DNA thermal cycler or a 
Hybaid Omn-E PCR block 
Insertion of the HA epitope into pKS-Kir6.2-HMKFLAG 
The HA antibody epitope was inserted into Kir6.2 by an insertion PCR based protocol as 
is shown in figure 2.2. The DNA template used for HA insertion was pKS-Kir6.2- 
HMKFLAG. Prior to the insertion PCR reaction the oligonucleotide primers 
(Kir6.2HAinsert For and Kir6.2HAinsert Rev) were kinased. The PCR reaction 
comprised 25pmol kinased oligonucleotides, 1x pfu DNA polymerase reaction buffer, 
200 µM dNTP's mixture, 10 % glycerol, 25 ng template DNA and 2.5 U pfu DNA 
polymerase. Each reaction was overlaid with mineral oil and subjected to the following 
reaction parameters: 95°C for 40 seconds, 58°C for 1 minute and 72°C for 10 minutes. 
Following 30 cycles of these parameters, the DNA was finally extended for 7 minutes at 
72°C. Following completion of the reaction, the PCR product was treated with Dpnl 
restriction endonuclease (1 hour, 37°C), and then the main product isolated by the 
GENECLEANTM method. Following isolation the product was transformed into E. coli 
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and DNA prepared by the mini-prep protocol and checked by restriction with BamHI and 
HindIIl. Samples showing the correct digestion pattern were examined for correct 
insertion by DNA sequencing with T7 primers. 
Production of pcDNA3-Kir6.2-HA+11 aa-HMKFLAG 
The 11 amino acid linker region (+1laa) was inserted into Kir6.2-HA by an insertion 
PCR based protocol and is shown in figure 4.2. The DNA template used for +11 as 
insertion was pcDNA3-Kir6.2-HA-HMKFLAG. Prior to the PCR reaction the 
oligonucleotide primers (Kir6.2+1 l as-insert For and Kir6.2+11 as-insert Rev) were 
kinased. The PCR reaction comprised 25pmol kinased oligonucleotides, 1x pfu DNA 
polymerase reaction buffer, 200 µM dNTP's mixture, 10 % glycerol, 25 ng template 
DNA and 2.5 U pfu DNA polymerase. Due to problems associated with a large amount 
of non-specific oligonucleotide binding, a touchdown PCR method was employed in an 
attempt to improve oligonucleotide binding specificity. Each reaction was overlaid with 
mineral oil and subjected to the following reaction parameters: 95°C for 40 sec, 65°C for 
1 min and 72°C for 10 min for 2 cycles; 95°C for 40 sec, 63°C for 1 min and 72°C for 10 
min for 2 cycles; 95°C for 40 sec, 61°C for 1 min and 72°C for 10 min for 2 cycles; 95°C 
for 40 sec, 59°C for 1 min and 72°C for 10 min for 16 cycles. The reactions were finally 
extended for 7 min at 72°C followed by treatment with Dpnl restriction endonuclease (1 
hour, 37°C), and then the main product isolated by the GENECLEANTM method. Correct 
insertion of the +1 laa linker sequence was confirmed by DNA sequencing using T7 
primers. 
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Figure 2.2 - Epitope insertion strategy. Insertion PCR primers with 5' overhanging ends 
encoding for half each of the inserted sequence were designed to bind directly either side 
of the insertion site. Prior to PCR primers were 5' phoshorylated (yellow circles). 
Binding of primers (1) would, following several rounds of PCR, eventually lead to 
insertion of the full epitope (2). 
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2.3.9 - QuikChangeTM mutagenesis 
Site directed mutagenesis was performed using the QuikChangeTM method developed by 
Stratagene and primers were designed accordingly. Primers were required to be between 
25-40 bases in length and have a melting temperature of - 10°C above the standard 
extension temperature of 68°C. Melting temperatures were calculated using the formula: 
Tm = 81.5 + 0.41(%GC) - 675/N- % mismatch 
Where N is the primer length in base pairs, %GC is the overall guanine and cytosine 
content. 
Finally, the desired mutation (deletion or insertion) should be in the middle of the primer 
with -10-15 bases of correct sequence on both sides. 
Each reaction contained 1µl of DNA template (150 ng/µl"1) with 1µl of forward primer 
(10 pmol/gl"1), 1µl reverse primer (10 moi/gr'), 5 111 of 2 mM dNTP's, 5µl of lOX Pfu 
reaction buffer, and 1µl of Pfu Turbo DNA polymerase (2.5 U/µl') and was made up to a 
fmal volume of 50 µl with sterile Mili-Q. Each reaction was overlaid with mineral oil 
(Fluka), placed in a DNA thermal cycler and subjected to the following parameters: 95°C 
for 30 seconds (denaturation stage) followed by 55°C for 1 minute (annealing stage), and 
68°C (elongation stage). The duration of the elongation stage depended on the length of 
the template, with each 1000 base pairs of template requiring 2 minutes of extension 
time. Following 16 cycles of these parameters, the DNA was fmally extended for 7 
minutes at 72°C. Following the end of the PCR each sample was treated with 1 µl of 
DpnI restriction endonuclease (20U) for 1 hour at 37°C in order to digest the parental 
supercoiled DNA. The PCR products were then transformed into competent XL blue 
cells. 
Construction of Kir6.2-HA+I1 as-AHMKFLAG 
For the construction of Kir6.2-HA+11aa-OHMKFLAG a stop codon was inserted into the 
sequence of pcDNA3.1(+)-Kir6.2-HA+11aa-HMKFLAG directly following the final 
codon of Kir6.2 via Quikchange site-directed mutagenesis. This resulted in the loss of 
HMKFLAG from the C-terminus of the Kir6.2 subunit. The mutagenesis reaction 
comprised: 1µl of DNA template (150 ng µl') with 1µi of forward primer (10 pmol µl"1), 
lµl reverse primer (10 mol µl''), 200 µM dNTP's, 1X Pfu reaction buffer, and 2.5U of 
Pfu Turbo polymerase and was made up to a fmal volume of 50 gl with sterile Mili-Q. 
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Each reaction was overlaid with mineral oil (Fluka), placed in a DNA thermal cycler and 
subjected to the following parameters: 95°C for 30 seconds (denaturation stage) followed 
by 55°C for 1 minute (annealing stage), and 68°C (elongation stage). Following 
completion of the reaction the product was treated with DpnI restriction endonuclease for 
1 hour at 37°C before transformation into XL-blue competent cells. Plasmid DNA was 
then amplified from transformed colonies and isolated by the mini-preparation protocol. 
Correct insertion of the stop codon was confirmed by DNA sequencing. 
2.3.10 - DNA sequencing 
DNA sequencing was performed by Lark technologies or by the Department of 
Biochemistry, Oxford University. The sequences of the primers used for DNA 
sequencing are shown in table 2.2. 
Primer name Primer sequence (5' - 3') 
M13F CCCAGTCACGACGTTGTAAAACG 
T7F TAATACGACTCACTATAGGG 
Kir6.2 C-terminus seq. GTGCAGAATATCGTCGGGCTG 
Kir6.2 C-terminus seq 2 CGCTTTGTCCCCATTGTGGCC 
Table 2.3 - Sequences of primers used for DNA sequencing. 
2.3.11 -Northern blotting 
Probe preparation 
Total RNA was extracted from INS1e cells using Tri-reagent (Sigma) as per 
manufacturer's instructions. The extracted total RNA was then reverse transcribed to 
produce cDNA as follows. First, RNA and oligo dT were incubated at 70°C for 5 min 
followed by incubation on ice for a further 5 min. This was used as a basis for a reverse 
transcription-PCR reaction comprising 1X RT buffer, 1X dNTPs, 1X RNase inhibitor 
and 1.5 U RTase (NEB - RT kit). This was then incubated at 37°C-42°C for 1 hour 
followed by 5 min at 95°C before storing on ice. The cDNA produced was used as a 
template for a PCR reaction to produce the short northern blot probes. ß-actin probes 
were constructed as described by Misty et al. (1983). 
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Construction of SUR1 northern blot probes form cDNA by PCR 
SUR1 northern blot probes were produced by a PCR based method using the cDNA 
produced from the reverse transcription as a template. 2 µl of the cDNA was added to a 
50 µl PCR reaction mixture containing 1X Taq polymerase buffer, 200 gM dNTPs 
mixture, 2.5 U Taq DNA polymerase and 20 pmol each of forward and reverse 
oligonucleotides primer. Each reaction was overlaid with mineral oil and subjected to the 
following reaction parameters: 95°C for 40 sec, 56°C for 1 min and 72°C for 1.5 min. 
Following 35 cycles of these parameters the products were fmally extended at 72°C for 7 
min. Following completion of the reaction the products were separated by agarose gel 
electrophoresis and the main product isolated by GENECLEANTM (2.3.4). 
Northern blot protocol 
Northern blot analysis was performed by Dr A. Asipu (St James' University Hospital, 
Leeds) 
Prior to northern blot analysis, INS-le cells were incubated for 2 hours in media 
containing either 3 mM or 25 mM glucose at 37°C. Total RNA was extracted from the 
cells using tri-reagent and the abundance of specific RNAs examined by northern blot 
analysis. Northern blotting analysis was performed as described in Sambrook & Russell 
(1999). 
2.4 - Immunocytochemical methods 
All reagents used were purchased as cell culture grade where possible, or were prepared 
and sterilised by autoclaving or passing through a 0.2 gm filter as appropriate. 
2.4.1 - Maintenance of immortal cell lines 
Routine culture of HEK293 and COST cells 
Cells were grown in 25 cm2 or 75 cm2 culture flasks (Sarstedt) at 37°C in a humidified 
atmosphere of 5% CO2 / 95 % air. When - 70-75 % confluent the cells were passaged as 
described below. The cells were first detached from the growth surface using either Ca2+ 
/ Mg2+-free PBS or Trypsin-EDTA solution [0.05 % (w/v) and 0.02 % (w/v) respectively] 
(both from Sigma chemical company). The detached cells were then resuspended in 5 
volumes of pre-warmed media and an aliquot transferred to a fresh culture flask 
containing 10 volumes of pre-warmed media. The cells were then returned to the 
incubator. 
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INSJe and RIN-m cell culture 
INS1e and RIN-m cells were grown at 37°C in a humidified atmosphere of air /5% C02- 
Cells were re-fed with fresh culture medium on the third and fifth days of culture and 
split on the seventh day having reached 60-70 % confluency. The cells were split as 
follows. The culture medium was decanted and the residual medium removed by rinsing 
with PBS. Sufficient ice-cold trypsin-EDTA solution [0.05 % (w/v) and 0.02 % (w/v) 
respectively] to just cover the cells was added and the cells were returned to the 
incubator. The cells were inspected regularly until detached (typically 2-3 minutes) then 
culture media equivalent to 5 volumes of the trypsin-EDTA used was added. This cell 
suspension was split 1: 3 into fresh culture flasks and supplemented with sufficient culture 
media. 
Long-term liquid N2 storage 
For long-term storage cells were stored under liquid nitrogen (N2). Cells in suspension in 
growth media were centrifuged at low speed until a pellet had formed. The media was 
removed and the pellet was resuspended in cell freezing medium. The cell freezing 
media typically consisted of the standard growth media (DMEM or RPMI1640 
depending on the cell type) supplemented with 20 % FCS and 8% DMSO. The resulting 
suspension of cells in freezing medium was aliquoted in 1 ml volumes into freezing vials 
and stored at -80°C for 48 hours before being transferred into a liquid nitrogen storage 
container. When required, cells were thawed quickly by immersion of the freezing vial in 
a 37°C water bath with gentle agitation. Once thawed, cells were diluted in 20 volumes 
of culture media and placed in culture flask for growth as described above. 
Isolation and maintenance of primary ß-cell cultures 
BALB/C and C57b16/J mice were killed by cervical dislocation in full accordance with 
Home Office schedule 1 guidelines. The pancreas was immediately removed via a 
midline incision, and rinsed twice in Hanks solution (mM: 137 NaCl, 1.2 NaH2PO4,4.2 
NaHCO3,5.6 KCI, 1.2 MgC12,2.6 CaC12,10 HEPES, pH to 7.4 with NaOH) 
supplemented with 2.8 mM D-glucose and 5 mg ml'' bovine serum albumin (BSA). 
Using a 28-gauge needle, the pancreas was then perfused with Hanks solution 
supplemented with 2.8 mM D-glucose, 5 mg ml-1 BSA and 1.5 mg ml"' type-V 
collagenase and incubated at 37°C for 20 minutes in a further 5 ml of collagenase solution 
of the same composition. Following the incubation the tissue was agitated vigorously to 
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provide a suspension of cells. This suspension was then centrifuged gently until all cells 
had formed a pellet, and the collagenase solution was then transferred into a fresh tube. 
The cell pellet was resuspended in Hanks solution supplemented with 2.8 mM D-glucose 
and 5 mg ml" BSA and placed in a dish under a well-lit dissection microscope and 
viewed against a black background. Any large pieces of tissue remaining were returned 
to the collagenase solution for further enzymatic disruption. The remaining tissue debris 
was then examined under the microscope for intact isolated islets, which appear as white 
opaque oval or spherical structures against the finer, pink coloured more dispersed 
exocrine tissue. The islets were then picked by pipette and transferred into fresh Hanks 
solution supplemented with 2.8 mM D-glucose and 5 mg m1' BSA. If dispersal of the 
islets into individual cells was required, they were incubated at 37°C in Ca2+ free Hanks 
(mM: 137 NaCl, 1.2 NaH2PO4,4.2 NaHCO3,10 HEPES, 1 EGTA, pH to 7.4 with 
NaOH) supplemented with 2.8 mM D-glucose and 0.01% trypsin for five min followed 
by gentle agitation with a pipette. Cells were plated straight onto the growth surface 
required for experimentation and were cultured for no more than 5 days in standard INS 1 
culture media (as defined in 3.2.2). 
2.4.2 - Preparation of adherent cells for immunocytochemistry 
Preparation ofpoly-L-lysine coated coverslips 
Borosilicate glass coverslips were first rinsed in 70% ethanol before being overlaid with a 
100 pg ml-1 of poly-L-lysine (MW: 70000-120000) for 2 hours at room temperature. The 
poly-L-lysine solution was then removed and the coverslips rinsed with 1X PBS. 
Immunofluorescent staining of isolated pancreatic ß-cells 
It was noticed that individual cells from dispersed isolated islets attached poorly to either 
untreated or poly-L-lysine coated glass coverslips. For the purpose of fluorescent 
staining, cells from dispersed isolated islets were plated onto microscope slides made 
from permanox plastic (Nunc) which appeared to aid attachment. For identification of (- 
cells amongst other islet cell types (a and S cells) in addition to remaining exocrine 
tissue, cells were counterstained using mouse anti-insulin antibodies (Sigma Drugs 
company). 
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2.4.3 - Transfection methods 
Transfection with anionic lipid transfection reagents 
Mammalian cells were typically transfected with plasmid DNA using Fugene6 
transfection reagent (Roche diagnostics) as per manufacturers' instructions. Briefly, cells 
were plated onto glass coverslips in individual wells of a 24 well culture plate and 
incubated overnight for the cells to adhere. Prior to transfection the growth media in each 
well was removed and replaced with 0.5 ml of fresh pre-warmed growth media. For each 
well, 0.6 µl of Fugene6 transfection reagent was added to 20 µl of optimem serum free 
media and lightly mixed by gentle agitation. To the Fugene6 / optimem mixture, 0.2 µg 
of DNA per well was added and again lightly mixed by gentle agitation. This mixture 
was left at room temperature for 30 minutes before transferring to each well of the 24- 
well plate. 
Calcium phosphate method 
Calcium phosphate transfection of adherent cells was performed using a calcium 
phosphate transfection kit (Stratagene). Briefly, cells were plated into wells of a 6-well 
plate to reach - 50 - 60 % confluency. 2 hours prior to transfection the medium was 
removed and replaced with 1.2 ml of fresh pre-warmed media. The calcium phosphate 
transfection mixture was prepared by mixing 1.7 µg DNA and 10.4 µl 2M CaC12 and 
water up to 85 gl (per well) and adding this mixture to 2X HBS dropwise whilst gently 
mixing. This final mixture was allowed to sit for 25 minutes at room temperature before 
resuspending and adding dropwise to the media covering the cells in the 6 well plate. 
Following 16-24 hours the media was changed for fresh pre-warmed media. Expression 
was assessed following a further 24-48 hours. 
2.4.4 - Establishment / maintenance of a HEK293 cell line stably expressing KnTp- 
HA 
HEK293 cells stably expressing KATP-HA were established by Miss L. Mair (University of 
Leeds). 
HEK-293 cells were cultured in DMEM media supplemented with 10 % fetal bovine 
serum and 100 U ml-1 penicillin and 100 µg ml-1 streptomycin at 37°C in a humidified 
atmosphere of air /5% CO2. HEK293 cells were transfected with pcDNA3.1-Kir6.2- 
HA+11 aa-HMKFLAG and pcDNA6-His6-SUR1 using fugene6 transfection reagent. 
Following 48 hours the culture media was supplemented with 800 µg ml"' G418 and 10 
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gg ml-1 blasticidin to select for those cells expressing both plasmids. Following 
continued treatment with G418 and blasticidin for several days the remaining cells were 
re-plated at a low density and allowed to grow to form colonies. Individual colonies were 
then cultured and assayed for expression of KATP channels. The clone displaying the 
most optimal expression of KATP channels was then maintained in culture media 
supplemented with 200 µg ml"' G418 and 2 µg ml-1 blasticidin. 
2.4.5 - Immunocytochemical methods 
Staining ofpermeabilised cells 
Cells were plated onto glass coverslips and transfected as required 48 hours prior to 
labelling with antibodies. Following any treatments which may be required cells were 
fixed by addition of methanol (chilled to -20°C) for 10 minutes and the cell membranes 
subsequently permeabilised by the addition of acetone / methanol (1: 1) (chilled to -20°C) 
for 5 minutes. As an alternative to methanol to fix the cells 2% PFA has been used. 
Following permeabilisation the cells were blocked with 5% goat serum in 1X PBS for 30 
minutes to block any non-specific binding of antibodies at a later stage. Following the 
blocking stage the cells were incubated with primary antibodies diluted in 5% goat 
serum in 1X PBS for 2 hours at room temperature. Following the primary antibody 
incubation the cells were washed 8X with 1X PBS followed by incubation with 
appropriate fluorescently labelled secondary antibodies diluted in 5% goat serum in 1X 
PBS for 1 hour at room temperature. Following the secondary antibody incubation the 
coverslips were again washed 8X with 1X PBS before being removed from the 24 well 
plate to air dry. Once dry, the coverslips were mounted cell-side down onto 
VECTASHIELDTM hard-set mounting media on a microscope slide. Slides were stored 
at 4°C until viewed by laser-scanning confocal microscopy. 
Staining of unpermeabilised cells 
Some applications required that the membranes of the labelled cells remained intact 
throughout the antibody labelling process. This allows the selective staining of cell 
surface channels as opposed to all channels within cells. 
Cells were plated onto glass coverslips and transfected as required 48 hours prior to 
labelling with antibodies. Following any treatments which may be required cells were 
fixed by addition of 2% PFA for 10 minutes at room temperature. The cells were not 
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permeabilised. Following fixation the cells were blocked with 5% goat serum in 1X 
PBS for 30 minutes to block any non-specific binding of antibodies at a later stage. 
Following the blocking stage the cells were incubated with primary antibodies targeted 
against an extracellular epitope diluted in 5% goat serum in 1X PBS for 2 hours at room 
temperature. Following the primary antibody incubation the cells were washed 8X with 
1X PBS followed by incubation with appropriate fluorescently labelled secondary 
antibodies diluted in 5% goat serum in 1X PBS for 1 hour at room temperature. 
Following the secondary antibody incubation the coverslips were again washed 8X with 
1X PBS before being removed from the 24 well plate to air dry. Once dry, the coverslips 
were mounted cell-side down onto VECTASHIELDTM hard-set mounting media on a 
microscope slide. Slides were stored at 4°C until viewed by laser-scanning confocal 
microscopy. 
Staining sectioned Xenopus laevis oocytes 
Oocytes were injected with cRNA as required and allowed to express for 48-72 hours. 
The oocytes were then fixed by immersion in methanol (-20°C) for >4 hours and 
cryopreserved in PBS containing 30 % sucrose at 4°C overnight. Intact oocytes were 
then embedded in octyl transferase (BDH) and cut into 20 pm sections using a cryostat 
(Bright, UK). The sections were mounted onto microscope slides coated with either 
poly-D-lysine or VECTABOND and subsequently blocked with 5% goat serum in 1X 
PBS for 30 minutes. Following blocking the cells were incubated with primary 
antibodies diluted in 5% goat serum in 1X PBS for 2 hours at room temperature. 
Following the primary antibody incubation the sections were washed 8X with 1X PBS 
followed by incubation with appropriate fluorescently labelled secondary antibodies 
diluted in 5% goat serum in 1X PBS for 1 hour at room temperature. Following the 
secondary antibody incubation the sections were washed 8X with 1X PBS and left to air 
dry. Once dry the sections were overlaid with VECTASHIELD mounting medium and 
covered with a glass coverslip. Slides were stored at 4°C until viewed by laser-scanning 
confocal microscopy. 
Internalisation staining protocol 
Cells were grown on poly-D-lysine coated coverslips for 48 hours prior to staining so that 
they reached a confluency of - 65 - 70 %. For the purposes of labelling the cells the 
medium used was glucose-free DMEM supplemented with 5% goat serum and 1 mM 
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glucose. Culture medium was removed and the cells were rinsed with labelling medium 
and pre-treated with drugs as required. Following any pre-incubation steps, cells were 
incubated in labelling medium supplemented with 0.2 gg ml-1 rat anti-HA antibodies and 
requisite drugs at 37°C for the desired duration to allow internalisation. Unless otherwise 
stated in the figure legend the duration of this internalisation step was 2 hours. Following 
incubation for the desired duration, labelling medium was removed and cells were briefly 
rinsed with 1X PBS before fixing with methanol (-20°C) for 10 minutes. Following 
fixation, methanol was removed and replaced with acetone / methanol (1: 1) (-20°C) for 4 
-5 minutes for permeabilisation. If no permeabilisation was required this step was 
omitted. Following these steps, cells were blocked with 5% goat serum in IX PBS for 
30 minutes at room temperature before labelling with anti-rat FITC or Cy3 conjugated 
antibodies in 5% goat serum in 1X PBS for 1 hour at room temperature. Coverslips were 
then mounted onto microscope slides using VECTASHIELD mounting medium and cells 
were then examined by confocal microscopy. 
Recycling staining protocol 
The protocol used to examine channel recycling by immunofluorescence is summarised 
in figure 2.3. Cells were grown on poly-D-lysine coverslips for 48 hours prior to 
commencement of the experiment. For the purposes of labelling the cells the medium 
used was glucose-free DMEM supplemented with 5% goat serum and 1 mM glucose. 
Culture medium was removed and the cells were rinsed with labelling medium and pre- 
treated with drugs as required. Typically, cells were pre-treated with drugs for 20 
minutes at 37°C prior to commencement of the experiment. Following drug pre- 
treatments cells were incubated with labelling medium supplemented with 0.2 µg ml" rat 
anti-HA antibodies and requisite drugs at 37°C for 2 hours to allow internalisation and for 
antibody labelled channels to reach a steady state distribution through the endocytic 
compartments. Following this internalisation step the cells were rinsed in chilled 1X PBS 
then incubated in chilled acidic stripping buffer (0.5 % acetic acid + 0.5 M NaCI; pH 3.0) 
for 30 minutes to remove any surface bound anti-HA antibodies. Cells were then rinsed 
twice with chilled 1X PBS and twice with chilled labelling medium. Following the 
washes cells were incubated in pre-warmed labelling medium supplemented with 1.25 µg 
ml-1 anti rat-FITC conjugated antibodies at 37°C for the desired length of time. 
Following this incubation, medium was removed and cells were fixed with methanol (- 
20°C) for 10 minutes before permeabilisation with acetone / methanol (1: 1) (-20°C) for 4- 
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5 minutes. Remaining HA bound channels were then labelled with anti-rat Cy3 
conjugated antibodies diluted in 5% goat serum in 1X PBS for 1 hour at room 
temperature. Coverslips were then mounted onto microscope slides with 
VECTASHIELDTM mounting medium and examined by confocal microscopy. 
Live-cell imaging 
Cells were grown in poly-D-lysine coated glass-bottomed culture dishes for 48 hours 
prior to commencement of imaging. Culture media was removed and replaced with C02- 
independent media and the dish was placed into a heated chamber at 37°C mounted onto 
a DeltaVisionTM wide-field fluorescence microscope for 30 minutes to allow 
equilibration. Following equilibration the media was supplemented with 2 µg ml'' mouse 
anti-HA Alexafluor595-conjugated antibodies and incubated for 15 minutes to allow 
antibody binding to cell surface channels. Following antibody binding the media was 
replaced with fresh pre-warmed C02-independent media and imaging of labelled cells 
began. 
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Figure 2.3 - Schematic of the recycling staining assay protocol. Shown is an outline of 
the protocol used to examine the recycling of KATP-HA channels by 
immunocytochemistry. First, cells expressing KATP-HA are plated onto poly-L-lysine 
coated coverslips (1). The cells are then incubated with rat anti-HA antibodies (2) so that 
surface channels become labelled. The labelled channels are then allowed to internalise 
for 2 hours so that the endocytic trafficking pathways become filled with labelled 
channels (3). The cells are then chilled to 4°C to halt trafficking and anti-HA antibodies 
at the cell surface are stripped using an acidic stripping buffer (4). Channel trafficking is 
reinitiated by incubating the cells at 37°C in media supplemented with anti-rat FITC- 
conjugated antibodies to label any recycled channels (5). Depending on the duration of 
this stage labelled channels may be reinternalised into the cells. Following the recycling 
step the cells are fixed, permeabilised and the remaining anti-HA bound channels are 
labelled with anti rat Cy3-conjugated antibodies (6). This population of channels 
represents those channels which did not recycle to the cell surface. 
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2.4.6 - Imaging fluorescently labelled cells 
Confocal microscopy 
The main advantage which confocal microscopy offers over conventional fluorescence 
microscopy is that it is capable of imaging with a very high resolution the light emitted 
from a single plane through a specimen as opposed to the specimen as a whole. In the 
case of laser scanning confocal microscopy this is achieved by exciting fluorophore 
compounds bound to structures within the cell and collecting the emitted light through 
the use of a laser beam which scans through the sample line by line. The emitted light is 
collected by the objective lens of the microscope and is focused through a small pinhole 
which blocks any light which originated from above or below the plane of focus. The 
light which passes through the pinhole is then collected by detectors and the image 
corresponding to the plane of focus through the sample is reconstructed. This is 
summarised in figure 2.4. By sequentially imaging several planes of focus in the sample 
it is possible to reconstruct 3-dimensional images of cells. 
Imaging fixed cells via confocal microscopy 
Labelled cells were viewed using either a Leica TCS NT or a Zeiss 510-META laser 
scanning confocal microscope (LSCM) under an oil-immersed 63x objective lens (NA = 
1.40). FITC (494 nm excitation: 519 nm emission) was excited using an argon laser 
fitted with 488 nm filters and Cy3 (550 nm excitation: 570 nm emission) was excited 
using a helium / neon laser fitted with 543 nm filters. 
2.4.7 - Quantification of fluorescence intensity 
Quantification of fluorescence intensity was attempted by measuring the mean pixel 
intensity of individual cells using the ImageJ software package (NIH). Individual cells in 
representative confocal images were outlined by hand and the mean pixel intensity 
calculated. All values for each population were collated and means and standard errors 
for each population were calculated and expressed as a percentage of the maximum 
value. For these studies all cells were imaged using identical confocal microscope 
settings. The settings were tailored so that the intensity of each pixel was within the 
range of sensitivity of the fluorescence detectors, i. e no pixel showed saturation of 
fluorescence. 
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Figure 2.4 - Beam path in a laser scanning confocal microscope. A laser beam of a 
particular wavelength (purple dotted line) is targeted via a dichroic beamsplitter so that it 
illuminates the sample exciting fluorophore molecules that it encounters resulting in the 
emission of light of a different wavelength. This light travels up through the objective 
lens, through the dichroic beamsplitter and up through a second lens which refocuses the 
light. Light originating from the plane of focus (red line) is refocused so that it may pass 
through the narrow opening of the confocal pinhole where it is recorded by the detector. 
Light coming from focal planes above (ureen line) and below (blue line) the plane of 
focus are not focused through the pinhole and so are largely blocked from reaching the 
detectors. The resulting image will therefore be composed almost entirely of light 
emitted from a very narrow focal plane. 
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2.5 - Protein chemistry 
2.5.1 - SDS-polyacrylamide gel electrophoresis (SDS-PAGE) methods 
SDS-PAGE gels were produced as described in section 2.2.5 above. Gels were mounted 
into the gel running apparatus as per manufacturers' instructions (BioRad or Hoeffer) and 
sufficient SDS-PAGE running buffer was added to both the central reservoir and the 
surrounding tank. 20 µl of each sample was then added to each individual well as 
required along with 10 µl of marker proteins. Gels were then run at 200V until sufficient 
separation of prestained marker proteins had occurred. 
2.5.2 - Detection of radiolabelled proteins 
For the . detection of radiolabelled proteins separated by SDS-PAGE the gels were first 
prepared and run as described above. The gels were stopped once sufficient separation of 
the pre-stained protein markers had occurred and the gels were removed from the gel 
running apparatus. The gels were then rinsed in water before incubation in Coomassie 
brilliant blue stain for 30 minutes at room temperature with gentle agitation. Following 
coomassie blue treatment the gel was washed in destain solution at room temperature 
with gentle agitation with frequent changes of the destain solution until protein bands 
within the gel became distinct. The gel was then rinsed several times with water and 
subsequently incubated with 1M salicylic acid for 30 minutes. The gel was then 
transferred onto a piece of card, covered in saran wrap and placed in a gel drier for 1 
hour. The radiolabelled proteins in the dried gel were then visualised by exposing the gel 
to either photographic film for 48 hours of by exposing to a phosphorimaging plate 
overnight. 
2.5.3 - Pulse labelling 
Sample preparation 
INS 1e cells were grown in 6-well plates in INS 1e cell culture media (as defined in 3.2.2) 
at 37°C in an atmosphere of 5% CO2 / air until - 80 % confluency. The medium was 
removed and replaced with sufficient prewarmed cysteine / methionine deficient media 
and the cells were incubated for 30 min at 37°C. The medium was then removed and 
replaced with 1 ml of cysteine / methionine deficient media supplemented with 200 µCi 
of Tran-35S-label radiolabelled methionine (ICN biomedicals) and incubated at 37°C. 
Following the desired period of incubation in the presence of 35S labelled methionine (the 
pulse period) radiolabel incorporation was halted by the addition of 10 mM cysteine and 
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4 mM methionine. Medium was then removed and the cells were lysed on ice by 
addition of 1 ml of RIPA buffer (20 mM Tris-HCl, 150 mM NaCl, 2 mM EDTA, 1% 
Nonidet-P40,1 % Na-deoxycholate, 0.1 % SDS) supplemented with protease inhibitor 
cocktail (Sigma drugs company). Debris was removed from the cell lysates by high 
speed centrifugation at 4°C for 30 minutes. 
Isolation of KATP channel subunits by immunoprecipitation 
Cell lysates were pre-cleared by incubation with fresh protein-G-sepharose for 1 hr at 4°C 
with rotation, and then separated by centrifugation. The pre-cleared supernatant was 
removed and added to protein-G-sepharose which had previously been bound with rabbit 
anti-SUR1 antibodies and incubated for 16 hr at 4°C with rotation. The beads were then 
washed twice with ice-cold RIPA buffer then twice in ice cold high salt buffer (0.5 M 
LiCl, 0.1 M Tris-HCl in RIPA buffer). The washed beads were then resuspended in 
alkaline SDS-sample buffer (as described in 2.2.5) supplemented with 10 mM 1,4-Dithio- 
DL-threitol (DTT) and boiled for 5 minutes. 
Separation and visualisation of radiolabelled proteins 
Immunoprecipitated protein samples were separated by SDS-PAGE on a5- 15 % 
gradient gel prepared as described in chapter 2.2.3.20 µl of each sample were loaded 
into individual wells alongside 10 gl of marker protein samples. The marker proteins 
used were Biorad precision plus protein standards [(Size in KDa): 250,150,100,75,50, 
37,25,20,15,10] and New England Biolabs prestained protein marker [(size in KDa): 
175,83,62,47,32,25,16,6]. Once the gels had run they were rinsed in water and 
incubated in 1M sodium salicylate solution before being dried. Once dry the gels were 
exposed either to photographic film or to a phosphorimaging plate overnight to visualise 
the separated radiolabelled proteins. 
2.5.4 - Insulin assays 
Sample preparation 
INS1e or RIN-m cells were plated into wells of a 24 well plate and cultured until 
reaching 60-70 % confluency. Cells were then incubated in KRB-HEPES supplemented 
with either 3 mM or 25 mM glucose for 1 hour at 37°C. Following 1 hour supernatants 
were removed for insulin assay. The cells were retained for protein assay. 
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Insulin assay 
Insulin content of supernatants was determined using an insulin radio immunoassay kit 
(ICN-biomedicals) as per manufacturer's instructions. Insulin content of the samples was 
normalized to total protein of the corresponding cells. Insulin secretion was expressed as 
insulin units per gg cellular protein per hour (IU/µg protein/hr). 
Protein content determination 
Following removal of supernatants for insulin assay, cells were solubilised in lysis buffer 
(0.5 % Triton-X100 / 0.1 % SDS) and assayed for protein by bicinchoninic acid (BCA) 
assay. Several dilutions of cell lysate samples were added to individual wells of a flat- 
bottomed 96-well plate and made up to a final volume of 10 µl with sterile water. To 
each sample 200 µl of BCA reagent was added and incubated at 37°C for 20-30 min. 
BCA reagent was prepared by mixing bicinchoninic acid solution and 4% CuSO4 (50: 1 
ratio). Concurrently, several samples containing a known amount of BSA (ranging 
between 0-10 µg) were also subjected to BCA assay in order to construct a standard 
curve. Following the 37°C incubation the absorbance at 550 nm of each sample and 
standard was read and protein content of each sample was calculated from the standard 
curve. 
2.6 - Electrophysiological methods 
2.6.1 - Two electrode-voltage clamp 
Removal and preparation ofXenopus laevis oocytes 
Female Xenopus laevis frogs were anaesthetised by immersion in 2% 3-aminobenzoic 
acid (pH 7.2 with TRIS and HCl) for 45 min. The frogs were then killed by cervical 
dislocation and pithing, in full accordance to Home-office schedule I guidelines. 
Ovarian lobes were then removed via a mid-line incision (Stuhmer & Parekh 1995). 
The ovarian lobes were torn into small clumps and further fragmented by two 45 minute 
incubations with type-I-collagenase (1 mg m1"') dissolved in OR-Mg solution (m1VI: NaCl 
82, MgC12 2, HEPES 0.5, KC10.2; pH 7.4). The cell suspension was thoroughly washed 
between and following collagenase treatments with OR-Mg solution with the resultant 
single cell suspension finally transferred into ND-96 solution (mM: NaCl 9.6, MgC12 0.1, 
HEPES 0.5, CaCl2 0.18, KC1 0.2; pH 7.4) from where Dumont stage V and VI oocytes 
were selected for injection. 
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cRNA microinjection ofXenopus laevis oocytes 
Prior to injection, glass capillaries were sterilised by baking at 200°C for at least 4 hours. 
Sterile glass capillaries were pulled into very fine tipped pipettes and then broken to the 
correct diameter with a pair of flame-sterilised forceps. 50 nI of cRNA was injected into 
the light hemisphere of each oocyte using a Pneumatic PicoPump pressure injection 
system (WPI). The oocytes were returned to ND-96 solution and incubated at 18°C for 2- 
4 days. 
Electrophysiological recordings from Xenopus laevis oocytes 
A schematic representation of the two-electrode voltage clamp setup is shown in figure 
2.5. 
The GeneClamp 500 amplifier (Axon Instruments) was used for electrophysiological 
recordings. Both current and voltage outputs from the voltage clamp amplifier were 
shown on a Takronix 5113 dual beam storage oscilloscope (using D. C. coupled 5A22N 
and 5A21N amplifiers). The signals were fed via a CED 1401 analogue interface to a 
computer running the CED on-line analysis software (version 6). The current signal was 
low pass filtered at 1 kHz by the amplifier and sampled at 4 kHz. 
The oocytes to be examined were placed in an oocyte chamber which was perfused with 
bath solution as described below at a rate of- 2 ml min 1. The solution was continuously 
removed from the oocyte chamber by a suction tube connected to a peristaltic pump. The 
electrode holders containing the current and voltage electrodes were mounted onto 
headstages and were placed at either side of the oocyte chamber. The bath electrode was 
placed so that it was submerged in the bath solution. Finally, to minimize the 
interference between the current and voltage electrodes a copper shield was placed 
between the two electrodes once the oocyte had been impaled. To further minimize 
interference from external sources the whole apparatus were assembled inside a Faraday 
cabinet which was placed on an anti-vibration table, both of which were earthed to the 
circuit ground. 
Before the electrodes were used to impale the oocyte the resistances were checked and if 
necessary adjusted by gently touching the tip with a pair of fine forceps. The current 
electrode resistance was adjusted between 0.3 and 1 MS2 and the voltage electrode 
between 0.3 and 2 M52. Both electrodes were then offset to 0 mV and the electrodes 
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advanced so that they bareley impaled the oocyte. Healthy oocytes typically had 
membrane potentials of -- 30 to - 70 mV. Following impalement of both electrodes, the 
oocyte was left until the membrane potential had stabilised, normally between 1 and 10 
min. The amplifier was then set to clamp and the gain and stability controls on the 
amplifier were adjusted to maximise the clamp. An ideal clamp results in a square pulse 
for the voltage trace with small capacitance transients for the current trace. Once set, the 
clamp stability was monitored using the online display on the computer screen during 
recordings. 
TEVC protocol 
Whole-cell currents were recorded in high potassium Ringers solution containing: (mlvi) 
90 KCI, 1 MgCl2,1.8 CaC12,5 HEPES (pH 7.4) at room temperature. A ramp voltage 
protocol from -150 to +50 mV was used with the cells being held at -30 mV. Currents 
were elicited by perfusion of the oocyte in Ringers solution supplemented with 3mM 
sodium azide, a metabolic inhibitor and 200 µM diazoxide, a selective KATP channel 
opener. Currents elicited in this manner were then inhibited by perfusion in Ringers 
solution supplemented with 1 µM glibenclamide. 
Data analysis 
The current / voltage relationships obtained from the TEVC protocol were analysed using 
EPC version 6.42 software (Cambridge electronic design). The current passing at -120 
mV was recorded from sequential ramp protocols and plotted against time to allow the 
construction of current versus time plots. 
2.6.2 - Whole-cell patch clamp recordings 
Whole cell patch clamp recordings were performed by Dr M. Hunter (University of 
Leeds) 
The pipette solution for whole cell recordings comprised (MM): 140 KCI, 0.6 MgC12, 
1.03 CaC12,10 EGTA, 10 HEPES, 0.1 MgATP, and 0.1 ADP (adjusted to pH 7.2). The 
bath solution for whole cell recording comprised (mM): 122.5 NaCl, 5.0 KCI, 1.0 MgC12, 
1.0 CaC12,10 HEPES (adjusted to pH 7.4). This bath solution was supplemented with 25 
mM D-glucose or 3 mM D-glucose + 22mM D-sorbitol as required. 
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Currents were recorded in the whole cell configuration. The currents were measured 
during a voltage ramp (-100 mV to +100 mV) from a holding potential of 0 mV and 
normalised to the membrane capacitance. Diazoxide (200 µM) was perfused to activate 
the channel, and tolbutamide (100 µM) to block the activated currents. 
2.7 - Data and statistical analysis 
When relating to immunocytochemistry, pulse labelling, two-electrode voltage clamp or 
insulin assay based experiments, `n' numbers relate to the number of separate occasions 
on which the experiment was performed. For fluorescence quantification experiments the 
`n' numbers relate to the number of individual cells examined for fluorescence intensity. 
Where required the statistical significance of data was determined by performing the 
student t-test. 
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Figure 2.5 - Schematic of the main components of the two-electrode voltage clamp 
configuration. All electrophysiological recordings were made on Xenopus oocytes using 
conventional two-electrode voltage clamp. This technique allows the membrane 
potential to be clamped at a specified value while simultaneously recording whole cell 
currents. By comparing the voltages measured by the bath electrode (VB) and the voltage 
sensing electrode (VSE) a measure of membrane potential is calculated. The desired 
membrane potential (VcoýM) is maintained by an injection of current by the current- 
passing electrode (Vc) through a negative feedback loop. The whole cell current being 
passed is equivalent to the ionic flow across the membrane at the clamped membrane 
potential. 
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Chapter 3 
Regulation of KATP channel expression 
by glucose in pancreatic f3-cells 
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3.1 - Introduction 
It has been established that the overall activity of KATP channels in a pancreatic ß-cell 
membrane correlates very closely with the overall level of insulin secretion. The 
overall activity of a given ion channel at the cell surface is determined by its open 
probability (Po) and the number of channels (N) present (Hille 2001). Although a 
great deal of research has focused on the regulation of the Po of these channels by 
changes in glucose concentrations (See Aguilar-Bryan & Bryan 1999 for review), the 
effect of these same changes in glucose on the number of channels (N) has not yet 
been extensively investigated. The importance of understanding exactly how channel 
numbers are regulated and how this may impact on the overall level of KATP channel 
currents and thus regulation of insulin secretion should not be underestimated. This 
importance has been reinforced in recent times by the discovery of a number of KATP 
channel mutants which have been shown to cause hyperinsulinaemia by disrupting 
normal channel trafficking and thus cell surface density of the channels (Cartier et al. 
2001, Partridge et al. 2001, Taschenberger et al. 2002, Reimann et al. 2003). 
Nutrient regulation of gene expression has long been known to be a very important 
adaptation allowing survival of an organism on intermittent food supplies (Johnston et 
al. 1999). Since glucose is the most abundant and commonly used fuel by almost all 
organisms it is hardly surprising that mechanisms exist whereby changing glucose 
availability cause changes in the expression of certain genes. In yeast, these 
mechanisms are fairly well understood (see Johnston et al. 1999 for review). An 
increase in glucose availability will cause an increase in the expression of a number of 
metabolic genes and the suppression of many genes involved in the utilisation of 
alternative energy sources. The role of glucose in the regulation of gene expression in 
mammalian cells is less clear. This is largely due to the added complication of 
hormonal control of systemic glucose concentrations in addition to any cell specific 
responses to fluctuations in local glucose levels. Despite this, the importance of 
glucose regulated gene expression has begun to be revealed in numerous tissues, 
particularly the pancreas and liver. In the pancreas elevated glucose has been shown 
to induce the expression of the pre-proinsulin gene (Permutt et al. 1972) as well as a 
number of glycolytic enzymes (Marie et al. 1993, Roche et al. 1997) and suppress the 
expression of other genes, e. g. peroxisome proliferator-activated receptor-a (PPARa) 
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(Roduit et al. 2000). In the liver, elevated glucose has been shown to induce the 
expression of the glucose transporter GLUT2 (Asano et al. 1992, Rencurel et al. 
1996) and a number of glycolytic enzymes, e. g. L-type pyruvate kinase (Vaulont et al. 
1986, Thompson et al. 1991) and acetyl-CoA carboxylase (Pape et al. 1988) as well 
as some lipogenic enzymes such as fatty acid synthase (Paulauskis & Sul 1989, 
Katsurada et al. 1990). It is perhaps worth noting however, that although glucose has 
been shown to regulate the expression of a number of genes, these reports describe 
changes in the level of expression only at the transcriptional level, and to my 
knowledge, no report has yet described an associated change in protein levels. 
More recently it has begun to become apparent that specific protein kinases play 
important roles in the regulation of the expression of these glucose responsive genes. 
One of the most important and currently best understood of these protein kinases is 
AMP-activated protein kinase (AMPK). AMPK is a serine / threonine kinase which 
has been described to act as a metabolic "master switch" by phosphorylating target 
proteins involved in carbohydrate and fat metabolism in response to changes in 
cellular energy charge (see Leclerc et al. 2002, Rutter et al. 2003 for reviews). It has 
been shown that in pancreatic 0-cells, glucose concentrations above -8 mM inhibit 
the activity of AMPK (Salt et al. 1998, da Silva Xavier et al. 2000b). This inhibition 
of AMPK by high glucose, or pharmacological activation of the protein kinase by the 
addition of 5-amino-4-imidazolecarboxamide riboside (AICAR) have been shown to 
be sufficient to alter the expression level of most of the more common glucose 
responsive genes (da Silva Xavier et al. 2000a, b, Woods et al. 2000, da Silva Xavier 
et al. 2003). Since the activity of AMPK in pancreatic ß-cells has been recently 
shown (Leclerc et al. 2004) to also be very closely linked to overall level of insulin 
secretion, this may implicate a possible link between blood glucose levels, AMPK 
activity and overall KATP channel activity. 
Since all of the genes identified to date which display glucose regulated expression 
are involved in some way with glucose homeostasis, it is conceivable that any gene 
involved with the regulation of glucose levels might be similarly regulated. Since the 
function of KATP channels in the pancreatic ß-cell is to sense changes in blood glucose 
concentrations and to regulate the secretion of insulin accordingly, the possibility that 
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expression of these channels might be regulated by glucose warrants further 
examination. 
INS 1e cells were used for the majority of this study as a model for the pancreatic (- 
cell in preference to a number of other similar cell lines such as MIN6, RIN-m and 
HIT-15. Whereas most other pancreatic ß-cell lines have a tendency to lose their 
ability to secrete insulin correctly following prolonged culture, INS1e cells have 
previously been shown to be able to maintain this ability for much longer periods of 
time (Poitout et al. 1996, Salt et al. 1998). In addition, INSle cells have also been 
shown to respond to glucose in the normal physiological range and the combination of 
these properties means that they represent the best available model cell line for this 
type of study. Since these cells do resemble native ß-cells so closely it is hoped that 
any findings will have direct implications with respect to physiological regulation of 
KATp channel regulation and ultimately insulin secretion. 
Using both INSle and pancreatic ß-cells isolated from mouse islets the effect of acute 
changes in glucose concentrations on the expression levels of KATP channels were 
investigated. 
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3.2 - Results 
3.2.1 - Anti-SUR1 and anti-Kir6.2 antibodies are specific 
Labelling proteins using specific antibodies coupled with fluorescent conjugates 
provides a quick and easy way of visualizing proteins in cells. In addition, by 
examining the intensity of fluorescent staining it is possible to compare the amounts 
protein of interest present within two or more populations of labelled cells. This 
approach has been used here to examine the effect of varying glucose concentrations 
on the expression of both Kir6.2 and SUR1 in the INS1e pancreatic ß-cell derived cell 
line and also in primary cultures of ß-cells freshly isolated from pancreas. The 
validity of data obtained from such experiments however relies on the antibodies to 
have a high specificity for the target protein. It has previously been shown (Hough 
2000, Partridge et al. 2001) that the antibodies used in this study show a very high 
degree of specificity for the intended target proteins as demonstrated by clear 
fluorescence in cells transfected with both Kir6.2 and SUR1 and an absence of 
staining in cells which had not been transfected. 
3.2.2 - Glucose regulates the expression of Kir6.2 and SUR1 in INS1e cells 
The effect of glucose concentration of the extracellular medium on the expression 
level of KATP channels was investigated using INSle cells as a pancreatic ß-cell 
model. INS le cells grown on poly-L-lysine coated coverslips were incubated for 2 hr 
in glucose free media supplemented with varying concentrations of glucose, ranging 
from 0 mM to 25 mM. Following this incubation Kir6.2 or SUR1 protein within 
these cells were labelled using either anti-Kir6.2 or anti-SUR1 antibodies, followed 
by FITC-conjugated secondary antibodies. The intensity of fluorescent staining of the 
cells was then examined by confocal microscopy, during which all microscope 
settings were kept identical to allow direct comparison between each set of images. It 
was observed that cells incubated in low glucose concentrations showed significantly 
greater levels of fluorescence than cells incubated in higher glucose concentrations, 
indicating greater levels of protein in cells incubated low glucose (figure 3.1). Indeed, 
measurement of the mean pixel intensity of each cell showed that the fluorescence 
observed in cells incubated in 0.5 mM glucose was 2-2.5 fold higher than in cells 
incubated in 25 mM glucose (figure 3.2). This was true of cells stained for both Kir6.2 
and SUR1. Interestingly the distribution of KATP channel subunits was not uniform 
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throughout the cell, and this was particularly true of cells incubated in high glucose 
and stained with anti-SUR1 antibodies. As the overall intensity of fluorescence 
decreased within cells with the increase in glucose concentration, the staining towards 
the periphery of the cell appeared to be more prominent whereas the staining in the 
peri-nuclear regions appeared to be much more greatly reduced by comparison. Cells 
incubated in low glucose conditions showed much more even staining throughout the 
cytoplasm often in vesicular structures. For the purposes of further experimentation 
two glucose concentrations were chosen, 3 mM and 25 mM, with which to proceed. 
These two glucose concentrations have been widely used previously and represent the 
lower limits of normal blood glucose and a profoundly hyperglycemic blood glucose 
level respectively. The possibility that altered osmolarity of the incubation medium 
was responsible for the effect was also tested. INS1e cells incubated in media 
supplemented with 3 mM glucose and 22 mM mannitol, a non-metabolisable glucose 
derivative, showed a comparable difference in fluorescence intensity relative to cells 
incubated in 25 mM glucose to cells incubated with 3 mM glucose alone (figure 3.3). 
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Figure 3.2 - Mean pixel intensities of INSl e cells incubated in either 0.5 mM or 25 
mM glucose for 2 hours. Mean pixel intensities of cells were measured using Image) 
software (NIH) as described in the methods. (n =number of cells analysed). *=P< 
0.01 (unpaired students t-test) - fluorescence intensity of cells incubated in 25 mM 
compared to those incubated in 3 mM. 
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Figure 3.3 - Altered osmolarity of the medium does not affect K, 411, channel 
expression. INS Ie cells were incubated for 2 hours in media containing either 3 mM 
glucose of 3mM glucose + 22 mM mannitol. Cells were then stained using anti- 
SURI antibodies followed by FITC-conjugated secondary antibodies. Labelled cells 
were then examined by LSCM using identical settings for each image. (n = 3) 
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3.2.3 - Altered KATp channel expression is specific to glucose responsive 
pancreatic ß-cells 
The possibility that glucose regulation of KATp channel expression is specific to 
pancreatic ß-cells was next investigated. HEK293 cells stably expressing both Kir6.2 
and SUR1 which were similarly treated with 3 mM or 25 mM glucose did not show 
the difference in the intensity of staining seen with INS1e cells (figure 3.4). Also 
investigated was the possibility that in order to show the differences in KATP channel 
expression in response to glucose, the ß-cell must also show a responsiveness to 
glucose with respect to correct glucose stimulated insulin secretion (GSIS). This was 
made possible by the fact that many, if not all pancreatic ß-cell derived cell lines such 
as RINm, MIN6 and indeed INSle lose the ability for normal GSIS with prolonged 
culture and passage (Poitout et al. 1996). The glucose responsiveness, measured by 
the ability for GSIS, of late passage RINm cells were compared to early passage 
INSle and the effect of varied glucose concentrations on the expression of KATP 
channels examined. Early passage INS 1e cells showed robust insulin secretion in 
response to high glucose. Cells exposed 25 mM glucose secreted -11 fold more 
insulin compared to cells exposed 3 mM glucose (p < 0.01) (figure 3.5A). Staining of 
corresponding INS 1e cells confirmed that levels of SUR1 were greater in cells 
incubated with 3 mM glucose compared to those incubated in 25 mM glucose. In 
contrast, late passage RINm cells showed no significant difference in the levels of 
insulin secreted between cells incubated in 3 mM and 25 mM glucose (p > 0.05). 
Examination of KATP channel expression in these RINm cells lacking normal GSIS 
showed that there appeared to be no difference in the levels of staining when cells 
incubated in 3 mM glucose were compared to those incubated with 25 mM glucose 
(figure 3.5). 
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Figure 3.4 - Expression of K4 p channels in HEK293 cells stably expressing Kir6.2 
and SURI is not glucose dependent. Stably expressing HEK293 cells were incubated 
for 2 hours in media containing either 3 mM glucose or 25 mM glucose. Cells were 
then stained using anti-SURI antibodies followed by FITC-conjugated secondary 
antibodies. Labelled cells were then examined by LSCM using identical settings for 
each image. (n = 3) 
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Figure 3.5 - Glucose mediated regulation of the density of IK477' channels is dependent 
on the ability of ß-cells for GSIS. (A) INS-le and Rin-m cells were incubated in low 
(0.5 mM) and high (25 mM) glucose for 2 hrs before immunostaining for SURI. 
Representative images are shown. (B) Glucose induced insulin secretion from INS-l 
and Rin-m cells. Cells were incubated in 3 mM or 25 mM glucose for 2 hr and the 
amount of insulin secreted into the medium was assayed. The data represent the mean 
f s. e. m of three independent experiments. (n = 3). 
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3.2.4 - Time-course of KATp appearance and disappearance in response to 
changes in ambient glucose concentration 
Next to be investigated was whether the increased levels of KATP channels in cells 
incubated in low glucose was due to either an increase in the rate of channel synthesis 
or due to a decrease in the rate of channel degradation. To achieve this INS 1e cells 
were first cultured overnight in either 3 mM or 25 mM glucose in order to achieve a 
steady state level of channel expression. The culture medium bathing the cells was 
then switched for media containing the opposite glucose concentration, i. e. cells 
previously incubated in 25 mM glucose were switched to media containing 3 mM 
glucose, and vice-versa. Following incubations of the desired duration in media 
containing the second glucose concentration the cells were fixed and stained as 
described previously. Cells incubated in 25 mM glucose overnight showed very low 
levels of expression prior to incubation with 3 mM glucose (figure 3.6). Following 
switch to 3 mM glucose levels of fluorescence increased very rapidly, with cells 
incubated for only 15 minutes showing noticeably increased fluorescence. The 
intensity of fluorescence continued to increase for the duration of the experiment. 
Cells incubated in 3 mM glucose overnight showed high levels of fluorescence. 
Following the switch to 25 mM glucose however the levels of fluorescence decreased, 
albeit relatively slowly (figure 3.7). 
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The data presented above suggest that the elevated intensity of fluorescence in cells 
incubated in low glucose concentrations may be due to an increase in the rate of 
channel synthesis. It is also apparent that the rate of channel synthesis is very rapidly 
increased following the switch from high to low glucose. The initial rate of channel 
synthesis following the initiation of low glucose incubation was therefore tested using 
a biochemical method. Briefly, INS1e cells were incubated in either high or low 
glucose conditions before switching to media containing either the same glucose 
concentration or to the opposite glucose concentration. The media used was deficient 
in cysteine and methionine and for the second incubation was supplemented with [35S] 
methionine to label newly synthesized proteins. The labelled channel subunits were 
then isolated by immuno-precipitation with anti-SURI antibodies, separated by SDS- 
PAGE and examined by fluorography. Samples from cells incubated in 25 mM 
glucose overnight (0/N) followed by incubation with 3 mM glucose showed a very 
rapid increase in the amount of radiolabelled protein, with detectable bands apparent 
as early as 2 minutes following the switch to low glucose. Three major bands are 
evident with predicted sizes of (KDa) - 220, -170, - 47. The bands of - 220 and 
170 KDa are thought to correspond to the mature glycosylated and immature non- 
glycosylated forms of SUR1 respectively, whereas the band at - 47 KDa is thought to 
represent Kir6.2 since SUR1 is predicted to be 177 KDa and Kir6.2 to be 44 KDa in 
size. However, from the literature, the sizes of bands corresponding to either the 
mature and immature forms of SURI and Kir6.2 vary quite considerably (Conti et al. 
2002, Crane & Aguilar-Bryan 2004). In this case, since the sizes of the observed 
bands are so close to the predicted sizes and that they are only observed in samples 
where increased protein synthesis might be expected it has been assumed that these 
bands do indeed correspond to SUR1 and Kir6.2. Generally, the intensity of all bands 
increased with time but the comparative intensity of the two SUR1 bands changed 
from more immature-SUR1 at the earliest time points (< 5 minutes) to more mature- 
SUR1 at the later time points (> 5 minutes) as might be expected due to protein 
maturation. The intensities of the Kir6.2 and mature-SURI bands also appear to 
increase in parallel throughout, suggesting that the expression of both SUR1 and 
Kir6.2 may be very closely linked via a common mechanism. In addition to this, that 
both SUR1 and Kir6.2 are retrieved by immunoprecipitation with anti-SUR1 
antibodies suggests that these newly formed subunits are rapidly assembled into 
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hetero-oligomeric channels, even as rapidly as two minutes following glucose 
depletion (figure 3.8 top left panel). 
In contrast to the above results, no significant stimulation of the radiolabel 
incorporation into the channel subunits occurred during other conditions, that is when 
cells were shifted from 3 to 25 mM or from 25 to 25 mM, or even from 3 to 3 mM 
glucose. These data suggest that the channel synthesis is stimulated only in response 
to a sudden decline in glucose concentration; under other conditions channel synthesis 
is either switched off or occurs very slowly (figure 3.8 other panels). Synthesis of 
channel subunits over a longer time course has not been investigated using this 
approach. 
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Figure 3.8 - Pulse labelling of INSl e cells demonstrates a rapid increase in K171 
channel synthesis stimulated by low glucose. INS-le cells were incubated overnight 
(16 hrs) in media containing the indicated pre-incubation glucose concentration (25 or 
3 mM; corresponds to the first number at the bottom of each panel) before switching 
to cysteine/methionine deficient media containing the same glucose concentration for 
30 min. The cells were then switched to media containing the test glucose 
concentration (3 or 25 mM, as indicated by the second number at the bottom of each 
panel) plus 200 µCi of [35S]methionine. At the indicated time points, incorporation of 
[35S]methionine into newly synthesised proteins was terminated, the radiolabelled 
KA 1p channels were immunoprecipiated from the cell lysates with anti-SLl Rl 
antibodies, and subjected to SDS-PAGE (5-15% gradient gel) and lluorography. 
Representative phosphorimages are shown (n = 3). 
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3.2.5 - The rapid increase in KATP channel expression is due to an increase in the 
rate of translation and not transcription 
An increase in protein synthesis can be brought about in two ways; either by 
producing more mRNA encoding the protein of interest by increasing the rate of 
transcription, or by increasing the rate of translation by utilising the existing mRNA 
more efficiently. Whether the increase in KATP channel expression in response to low 
glucose observed here is due to an increase in transcription or translation was 
therefore investigated using pharmacological agents to selectively inhibit either 
transcription or translation. Briefly, INS1e cells were incubated in media containing 
either 3 mM or 25 mM glucose overnight before being switched to media containing 
the opposite glucose concentration supplemented with various inhibitors of 
transcription or translation. 
INS1e cells treated with either a-amanitin (5 pg ml') or actinomycin D (1 µg ml-1), 
both inhibitors of transcription, displayed a response to glucose comparable to that of 
untreated cells, with greater levels of fluorescence in the cells incubated in 3 mM 
glucose compared to those incubated in 25 mM glucose (figure 3.9). By contrast, 
cells treated with the translational inhibitor cycloheximide (25 µg ml') showed much 
lower levels of fluorescence in the cells incubated with 3 mM glucose compared to 
the untreated cells. Indeed, the level of fluorescence in these cells was comparable to 
that observed in cells incubated with 25 mM glucose, suggesting that addition of 
cycloheximide had impaired the normal response to low glucose. In these cells, 
whilst the level of staining near the periphery of the cell remained relatively high, the 
intensity of the staining throughout the majority of the cytoplasm was clearly reduced 
in a similar fashion to the cells incubated in high glucose in figure 3.1. These data 
therefore suggest that the increase in KATp channel expression is due to an increase in 
the rate of translation and not transcription. If this is indeed true an examination of 
the levels of mRNA encoding either of the KATP channel subunits should show no 
difference in cells incubated in either 3 mM or 25 mM glucose. In order to 
investigate this, probes were designed against SUR1 to be used in northern blot 
analysis. As shown in figure 3.10, northern blot analysis of lysates of INS1e cells 
showed no difference in the levels of SUR1 mRNA isolated from cells treated with 3 
mM or 25 mM glucose using two separate sets of probes. Densitometric analysis of 
the data showed no significant difference (p > 0.05) in the SUR1 mRNA content 
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(expressed as mean ± s. e. m. of SURl/actin ratio) of cells treated with 3 mM glucose 
(3.00 ± 0.27) from that of 25 mM glucose (3.14 ± 0.4). 
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Figure 3.10 - Northern blot unult'. sis of SURI mRNA reveals no change in response to 
glucose. A- Northern blots of total RNA isolated from INS-le cells incubated in 3 
mM (lanes 1,2) or 25 mM (lanes 3.4) glucose, showing the SURI and actin bands; 
data generated from RNA isolated two separate flasks of cells are shown for each 
glucose concentration. B- shows mean f s. e. m (n =4) of SURI mRNA, normalised to 
actin mRNA band intensity; P>0.05 (Student two-tailed t-test). Northern blotting 
was performed by Dr A. Asipu (Si . lames' University Hospital, Leeds) 
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3.2.6 - Cell surface channel density is unaffected by glucose 
An important question to address is whether the apparent increase in KATP channel 
expression in INS1e cells is translated into a concomitant increase in the density of 
channels at the cell surface. Since the vast majority of the fluorescent staining 
appeared to be cytoplasmic it was impossible to determine if such a difference 
existed. The cell surface density of KATP channels was therefore determined by 
electrophysiological means by functionally assaying whole cell currents using the 
patch-clamp technique. Recordings were taken from cells, which had previously 
been pre-incubated in media containing either 3 or 25 mM glucose, perfused with bath 
solution containing the same glucose concentration. Maximal KATP channel currents 
were elicited by the addition of diazoxide and were subsequently inhibited by addition 
of tolbutamide (figure 3.11 A+ B). The maximal amplitude of the diazoxide- 
stimulated tolbutamide-sensitive currents, corresponding to KATP channel specific 
currents, were normalised to the capacitance of the cell (which provides a measure of 
cell surface area) to obtain an estimate of cell surface channel density. Whilst cells 
incubated in 3 mM glucose showed a higher mean density of channels at the cell 
surface (636 ± 125 pA/pF; n= 7) compared to those incubated with 25 mM glucose 
(428 ± 70 pA/pF; n= 8), the difference was not deemed to be statistically significant 
(P > 0.1) (figure 3.11 Q. 
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Figure 3.11 - The cell surface density of KATP channels is unaffected by changes in 
glucose. A-B, KATP channel currents measured from INS-1 cells cultured in 3 mM 
glucose. Currents were measured in the whole cell patch clamp configuration. Data 
points represent currents measured at 0 mV during perfusion of bath solution alone or 
bath solution supplemented with diazoxide (D) or tolbutamide (T), as indicated by 
horizontal bars. B shows current-voltage relationships measured during the 
application of diazoxide or tolbutamide, corresponding to time points (gray filled 
circles) labelled I and 2 in A. C. Histogram of mean ± s. e. m of currents from cells 
incubated in 3 and 25 mM glucose as indicated. Whole cell patch-clamp º+was 
performed by Dr M. Hunter (School of Biomedical Sciences, University of'Leeds) 
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3.2.7 - The increase in KATP channel expression in low glucose may involve the 
activation of AMPK 
For the expression of KATp channels to be affected by changing glucose 
concentrations, a metabolic sensor must be involved to sense the changes in glucose 
and then to translate this into a signal that the cell can recognize to initiate the 
increase in expression. Studies into the glucose regulated expression of a number of 
other proteins, for example pre-proinsulin and L-type pyruvate kinase (de Silva 
Xavier et al. 2000a) have lead to the identification of AMP-activated protein kinase 
(AMPK) as a possible candidate for this role (de Silva Xavier et al. 2000b). AMPK is 
a serine / threonine protein kinase which is activated by depletion of ATP and 
increase of AMP. It has recently been described as a "metabolic master-switch" 
responsible for down-regulating high energy demand processes within cells when 
metabolism is slowed. Whether this role extends to protecting the cell from low 
glucose by stimulating pathways which will actively act to protect from the effects of 
low glucose, like upregulating the expression of KATp channels in the pancreatic (- 
cell has yet to be shown. 
The activity of AMPK in INS 1e cells was stimulated by the addition of either 5- 
Aminoimidazole-4-carboxamide 1-b-D-ribofuranoside (AICAR) or the anti-diabetic 
drug metformin, both potent and selective activators of AMPK, but with varying 
mechanisms of action (Henin et al. 1996, Zhou et al. 2001). Addition of either agent 
to cells incubated in 3 mM glucose produced no effects on the level of observed 
fluorescence compared to untreated cells. However, when cells incubated in 25 mM 
glucose were exposed to either AICAR or metformin the levels of fluorescence were 
comparable to those observed in cells incubated in low glucose and noticeably higher 
than those cells incubated in 25 mM glucose alone (figure 3.12). These data suggest 
that activation of AMPK by low glucose may be central to the increase in KATP 
channel expression observed in INS 1e cells. 
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Figure 3.12 - Pharmacological activation of AMPK mimics the effect of low glucose 
on the expression of KArp channels in INSI e cells. INS Ie cells were incubated for 2 
hours in media containing either 3 mM glucose or 25 mM glucose supplemented with 
AICAR (0.5 mM) or metformin (0.5 mM) as required. Cells were then stained using 
anti-SURI antibodies followed by FITC-conjugated secondary antibodies. Labelled 
cells were then examined by LSCM using identical settings for each image. (n = 3) 
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3.2.8 - KATp channel expression is regulated by glucose in isolated mouse 
pancreatic ß-cells 
As a model system for pancreatic (3-cells, INS1e cells are largely suitable for most 
purposes. However, during the establishment and subsequent long-term culture of 
these immortal model cell lines some aspects of normal (3-cell function may be 
distorted or lost altogether, and some new traits not representative of native ß-cells 
may arise (Minami et al. 2000, Rustenbeck 2002). In order to confirm that the data 
obtained in INS1e cells are indeed representative of native cells it was decided to 
repeat the key findings in R--cells freshly isolated from mouse pancreas. Following 
removal of the whole pancreas from freshly killed mice and subsequent collagenase 
digestion, whole islets were isolated from the surrounding exocrine tissue. These 
intact islets were further disrupted by gentle trypsin treatment to yield a suspension of 
islet cells including ß-cells, but also a-cells and S-cells. For the purposes of the 
experiments, the 0-cells were counterstained with anti-insulin antibodies and in this 
way were easily distinguishable from the other cell types. It was also apparent that (3- 
cells always appeared as more spherical in shape compared to other cell types which 
appeared flatter with more pronounced projections (figure 3.13). 
Two strains of mice were used for the islet isolations. The first strain, BALB/c, is a 
popular, inbred mouse strain which has been used extensively for all areas of 
biomedical research. The second strain, C57bl/6J, is perhaps the most popular mouse 
model used in biomedical research. Recent research has shown that islets from the 
C57bl/6J mice show impaired insulin secretion in response to glucose which becomes 
more pronounced when fed on a high fat diet (Kaku et al. 1988, Surwit et al. 1988, 
Kooptiwut et al. 2002). Because of this, isolated ß-cells from each strain were used to 
investigate the effect of low glucose on KATP channel expression. 
Pancreatic ß-cells isolated from BALB/c mice showed much higher levels of anti- 
SUR1 fluorescence in cells incubated in 3 mM glucose compared to those incubated 
in 25 mM glucose. This difference was comparable to that observed in INSle cells. 
By contrast, ß-cells isolated from C57b1/6J mice showed a difference in fluorescence 
which was far less pronounced than that observed with either INS 1e cells or ß-cells 
isolated from BALB/c mice (figure 3.14). 
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Figure 3.13 - Pancreatic fl-cells from isolated mouse islets can he easilt" 
distinguished from surrounding cells. Isolated cells from pancreatic islets were 
stained using rabbit anti-SURI antibodies followed by FITC-conjugated anti-rabbit 
secondary antibodies and with mouse anti-insulin antibodies followed by Cy3- 
conjugated anti-mouse secondary antibodies. (A) - Non ß-cell type cells not stained 
with anti-insulin antibodies. (B) - ß-cells stained by anti-insulin antibodies. Cells 
were viewed by LSCM. (n = 2). 
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Figure 3.14 - Glucose regulates the expression of'K, 4T, > channels in /3-cells OI'BALB/c 
mice, but not in C57b1/6J mice. Cells from pancreatic islets isolated from either 
C57B16/J or Balb/C mice were incubated for 2 hours in media supplemented with 
either 3 mM or 25 mM glucose. They were then stained using rabbit anti-SUR] 
antibodies followed by FITC-conjugated anti-rabbit secondary antibodies and with 
mouse anti-insulin antibodies followed by Cy3-conjugated anti-mouse secondary 
antibodies. Cells were viewed by LSCM using identical settings for each image. (n = 
1). 
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3.3 - Discussion 
3.3.1 - Overview 
Described here is evidence to suggest that the expression of the pancreatic KATP 
channel is regulated by glucose. When incubated in low glucose, pancreatic ß-cells 
are shown to increase the overall level of KATP channel subunits rapidly, not by 
increasing the rate of transcription, but by increasing the rate of translation of pre- 
existing mRNA (figures 3.1 - 3.10). It is also apparent that this regulation of KATP 
channel expression by glucose is specific for pancreatic ß-cells which exhibit normal 
insulin secretory responses to elevated glucose levels, since the characteristic increase 
in expression was not observed in either HEK293 cells stably expressing KATP 
channels or more importantly pancreatic ß-cells which have lost their ability to secrete 
insulin correctly (figure 3.5 and figure 3.14). Further to this it appears that this effect 
may be regulated by modulation of the activity of AMPK. 
3.3.2 - Glucose regulation of expression 
A number of groups, whose work is described below, have investigated the possibility 
that glucose may affect the expression of KATP channels in pancreatic ß-cells. These 
studies however were limited to investigating the effect of glucose on the level of 
mRNA encoding Kir6.2 and SUR1 within cells which were chronically exposed to 
varying concentrations of glucose. Due to a wide range of cell types used, ranging 
from different model ß-cell lines (e. g. INS, MIN6) to intact islets form different 
species (mouse, human), and the diverse range of culture conditions and durations of 
treatment, it is difficult to draw many conclusions as to the role which glucose may be 
playing in regulating KATP channel expression. For example, Shalev et al. (2002) 
suggested that incubation of intact isolated human islets in high glucose for 24 hours 
had no effect on SUR1 mRNA levels compared to those islets incubated in low 
glucose, as assayed by RT-PCR. In contrast, Moritz et al. (2001) reported that INS1 
cells showed a -70 % decrease in the levels of both Kir6.2 and SURI mRNA when 
incubated for 72 hours in high glucose compared to those cells incubated in low 
glucose, using northern blot analysis. Another study by Wang et al. (2002) 
demonstrated that mRNA levels in INS1e cells for either Kir6.2 of SURI were not 
affected by brief (8 hour) exposure to elevated glucose content of the culture medium. 
The findings of this third study support the findings of the present study, where brief 
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(2 hour) exposure to 25 mM glucose had no effect on the level of SUR1 mRNA as 
shown in figure 3.10. This may suggest that acute changes in glucose concentrations 
have no effect on the level of KATP channel mRNAs, whereas more prolonged 
exposure to elevated glucose may cause a reduction in these mRNA levels. This is 
supported by the observation that induced diabetes in mice, with associated long-term 
hyperglycaemia, leads to a marked reduction in KATP mRNAs (Jonas et al. 1999). 
To my knowledge this is the first report describing glucose regulated expression of a 
protein by modulation of the rate of translation in preference to transcription. All 
other examples of glucose responsive genes from the literature describe changes in the 
rate of mRNA synthesis by the transcription of the gene of interest (Permutt et al. 
1972, Vaulont et al. 1986, Asano et al. 1992, Marie et al. 1993, Roche et al. 1997). 
In this way, it would appear that the mode of regulation of pancreatic KATP channel 
expression in response to acute changes in glucose is at the present time unique. 
Similar mechanisms have, however, been previously described in other systems where 
nutrient supply must be tightly regulated (Eisenstein 2000). The expression of both 
ferritin and transferrin are regulated by changes in iron availability, and this has been 
shown to be via regulation at the translational level. When iron is particularly 
abundant the cell responds to an increase in cytosolic iron concentrations by 
increasing the synthesis of the iron binding protein ferritin and a parallel decrease in 
the synthesis of the plasma membrane iron transporter, transferrin receptor. When 
iron availability is low the opposite is true, with synthesis of ferritin slowed and 
transferrin receptor synthesis greatly increased in order to import more iron into the 
cell. It has been shown that these two responses are mediated by the action of a single 
iron-responsive regulatory protein, aconitase, which recognises and binds to common 
features in the mRNA structure of both ferritin and transferrin receptor. When iron 
availability is limited, aconitase is bound to the mRNA of both transferrin receptor 
and ferritin. Binding of aconitase to the 3'-UTR of transferrin receptor mRNA blocks 
an endonuclease cleavage site thus stabilising the mRNA allowing increased 
translation. Binding of aconitase to the 5'-UTR of ferritin mRNA blocks translational 
initiation thus preventing protein synthesis. When iron becomes abundant it binds to 
aconitase causing dissociation from the mRNA allowing translation of ferritin and 
destabilising transferrin receptor mRNA (Hentze et al. 1987, Casey et al. 1988). The 
existence of such a mechanism for the regulation of KATP channel expression is 
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currently not known but may warrant further examination on the strength of the 
presented data. 
3.3.3 - The role of AMPK in regulating KAB channel expression 
The data presented in figure 3.12 suggests that the increase in KATP channel synthesis 
following a switch to low glucose may be mediated by the activation of AMP- 
activated protein kinase. The lowering of glucose availability to the cells would lead 
to a lowering of glucose uptake and thus lead to a lowering in the rate of metabolism 
with a resulting decrease in the ATP / ADP ratio. As well as stimulating the activity 
of KATp channels within these cells, the lowering of the ATP / ADP ratio leads to an 
increase in the levels of AMP because of the action of the enzyme adenylate kinase 
which attempts to maintain the ATP / ADP ratio by the reaction [2ADP H ATP + 
AMP] in equilibrium (Hardie & Hawley 2001). The increase in AMP within the cells 
due to the decrease in glucose availability would be sufficient to stimulate AMPK 
activity. Indeed several sources report a stimulation of AMPK activity by lowered 
glucose in pancreatic ß-cells over the same concentration range in which insulin 
release is inhibited (Salt et al. 1998, da Silva Xavier et al. 2000b). Once active, 
AMPK has been shown to adapt the cell for short-term survival during periods of low 
ATP via a number of different mechanisms (see Kemp et al. 2003 for review). As a 
consequence of increased AMPK activity, both gene transcription (Kawaguchi et al. 
2001, Leclerc et al. 2001, Yang et al. 2001) and protein synthesis are affected (Bolster 
et al. 2002, Horman et al. 2002). Interestingly, since the activation of AMPK tends to 
halt processes with high ATP demands, processes such as protein synthesis would be 
expected to be inhibited. It has been shown that an increase in AMPK activity leads 
to an increase in the activity of protein kinase elongation factor-2 kinase. This in turn 
leads to increased phosphorylation of elongation factor-2 leading to a decrease in 
translation (Horman et al. 2002, McLeod & Proud 2002). This is contrary to the 
findings reported in the current study where it appears that AMPK activation mediates 
an increase in the synthesis of KATP channel subunits. This could perhaps be 
attributed to the fact that an increase in KATP channel density might provide an 
additional protective mechanism by suppressing insulin secretion following a rapid 
decrease in glucose concentration and is therefore in some way exempt from the 
normal mechanisms which serve to prevent processes with high energy demands. A 
recent report suggests that the activation of AMPK may indeed lead to an increase in 
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the rate of vascular epithelial growth factor (VEGF) protein synthesis in vascular 
smooth muscle in response to metabolic stress (Ouchi et al. 2005) perhaps supporting 
the role of AMPK in protecting against metabolic injury. As described earlier (1.3.2) 
KATP channels have been proposed to play an important role in protecting against 
injury during ischemia and it is possible that AMPK may also play a part in this 
protective mechanism in these tissues. As well as being stimulated by the application 
of AICAR, the action of AMPK in regulation of glucose stimulated expression of 
KATP channels was stimulated by the action of metformin (figure 3.12). Metformin 
has been used to treat type-2 diabetes for many years and has recently been shown to 
activate AMPK by an as yet poorly understood mechanism (Zhou et al. 2001, Hawley 
et al. 2002, Fryer et al. 2002). Many of the actions of metformin in the treatment of 
type-2 diabetes were attributed to its actions on peripheral tissues (liver and skeletal 
muscle). However, it became evident that many of the actions of metformin may be 
mediated by directly acting on the insulin secreting pancreatic ß-cell. It has been 
reported that treatment with metformin is able to restore correct insulin secretory 
capacity to ß-cells which had previously lost this ability due to prolonged exposure to 
elevated levels of either glucose or fatty acids (Lupi et al. 1999, Patane et al. 2000). 
From these studies it is unclear whether these effects are mediated by the stimulation 
of AMPK or whether the drug may be acting in some other fashion. This does 
however propose a possible link between metformin stimulated AMPK activity and 
the onset of type-2 diabetes which becomes all the more prominent when considered 
alongside the data presented in figure 3.5. These data show that the ability for 
glucose regulation of KATP channel expression is very closely linked to the ability of 
the cell for GSIS. If the anti-diabetic action of metformin is mediated via AMPK 
activation, this suggests a possible link between the ability of a cell for GSIS, the 
activation of AMPK and the correct regulation of KATP channel expression. Taken 
together this may reinforce the importance of both the ability of the cell to regulate 
the expression of KATp channels and the role of AMPK in this mechanism for correct 
functioning of the pancreatic ß-cell and maintenance of correct GSIS. 
3.3.4 - Physiological significance of the findings 
Immunofluorescence experiments showed that the expression of KATP channels 
decreased sharply when INS1e cells were bathed in medium containing > 5mM 
glucose (figure 3.1). Since the normal physiological range of glucose concentrations 
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is between 3-6 mM, this may imply that this response is a physiologically significant 
phenomenon and not merely due to adaptations of INS1e cells as a consequence of 
prolonged culture. Since this phenomenon is also apparent in mouse pancreatic ß- 
cells freshly isolated from BALB/c mice (figure 3.14), it is likely that this is indeed an 
important regulatory mechanism possessed by ß-cells to aid in the correct regulation 
of insulin secretion. This is further reinforced by the observation that ß-cells lacking 
the ability to secrete insulin correctly in response to glucose, both glucose 
unresponsive RIN-m cells and isolated islets from the GSIS impaired C57b16/J mouse 
strain, lack the same level of glucose regulated expression observed in INS Ie cells. 
These observations may therefore have important implications for the understanding 
of the onset of type-2 diabetes, where often the normal glucose stimulated insulin 
secretion is disrupted. Whether the dysregulation of KATP channel expression by 
glucose is a cause or is caused by a loss of normal glucose stimulated insulin secretion 
remains to be shown. 
Following the shift from high glucose to low glucose the onset of KAIp channel 
synthesis has been shown to be very rapid as demonstrated using both 
immunostaining (figure 3.6) and pulse-labelling techniques (figure 3.8). Evidence 
from pulse-labelling suggests that detectable amounts of both SUR1 and Kir6.2 are 
produced within only 2 minutes of the change in glucose concentration from high to 
low. Also, since the presence of bands thought to correspond to Kir6.2 are present in 
samples immunoprecipitated using anti-SUR1 antibodies it would appear that these 
newly synthesised channel subunits are being very rapidly assembled to form 
complete channels under these particular conditions. In all other conditions tested (a 
switch from low glucose to high glucose as well as maintaining low or high glucose) 
synthesis of KATP channel subunits was absent. Thus it would appear that a rapid 
decline of glucose concentrations is sufficient to stimulate a rapid accumulation of 
newly synthesised and assembled channels rather than a steady rate of synthesis of 
channels in low glucose conditions. It is likely that the rapid nature of this response is 
due in part to the induction of increased expression by an increase in translation, 
rather than having to wait to produce more mRNA by transcription prior to protein 
expression. The physiological significance of such a mechanism becomes apparent if 
the need to prevent a severe hypoglycaemic episode is considered. If the blood 
glucose levels of an organism decrease sharply, the secretion of insulin will be 
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required to be halted to prevent any further residual lowering of systemic glucose 
levels. It is therefore preferable that the secretion of insulin would be halted rapidly 
rather than a gradual decrease. One way to do this would be through inducing a large 
current through KATP channels resident at the plasma membrane. It may be that the 
newly synthesised channels are intended to augment such a KATP current thus rapidly 
halting and maintaining the block of insulin secretion. When glucose levels are more 
stable, such tight control of insulin secretion may not be required. 
If such a mechanism were true it might be expected that the cell surface density of 
KATP channels would increase sharply following challenge with low glucose. Patch- 
clamp recordings of whole-cell currents demonstrated that this was not the case, 
although a small increase in channel density was observed in cells incubated with low 
glucose compared to those incubated in high glucose, this was not significant (figure 
3.11). In addition, this small observed difference in channel density was much 
smaller than the difference observed using immunocytochemistry, where a -2.5 fold 
increase in fluorescence was observed between cells treated similarly (figures 3.1 and 
3.2). The discrepancy between the two estimates (fluorescence intensity vs. 
electrophysiology) may be attributed to membrane trafficking of the channels. Under 
the experimental conditions, channels made in the cell might have either failed to 
traffic to the cell surface, or may be rapidly removed out of the cell surface. 
Consistent with this notion, we found that most of the channel density was seen in 
structures distributed throughout the cytoplasm, which might represent trafficking 
vesicles or storage compartments. Regulated insertion and removal has been 
described as being a major determinant of membrane density of a number of cell 
surface proteins including a number of ion channels, e. g. AMPA receptors (Ehlers 
2000) and the possible existence of such mechanisms for KATP channels warrants 
further examination. 
3.3.5 - Summary of findings 
In conclusion, it would appear that the expression of the pancreatic KATP channel is 
regulated by glucose via a mechanism which modulates the rate of translation of pre- 
existing mRNA rather than increasing the rate of gene transcription to produce more 
mRNA. Because of this, the increase in KATP channel synthesis triggered by a sudden 
decrease in glucose levels is very rapid, eventually leading to an increase of - 2.5 fold 
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in channel numbers. The exact mechanisms controlling this has not been 
characterised, but some evident for involvement of AMPK was presented in this 
study. Despite the large increase in channel numbers, a similar increase in cell 
surface channel density is not observed and the majority of the channels appear to be 
confined to cytoplasmic compartments, suggesting a possible role for regulated 
trafficking of the channel which is addressed in chapter 5. 
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Chapter 4 
Production and characterisation of 
Kir6.2HA+11 aaHMKFLAG 
constructs 
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4.1 - Introduction 
If the factors affecting the surface expression of KATP channels are to be fully 
investigated it is necessary to be able to label channels that have been inserted into 
the plasma membrane selectively. By labelling surface bound channels in this way, 
the internalisation and trafficking of channels through endocytic pathways can be 
investigated. Selective labelling of plasma membrane bound channels in intact cells 
can be achieved either through the use of antibodies targeted against extracellular 
epitopes or by the use of fluorescent membrane impermeable ligands to the channel. 
Since no suitable membrane impermeable ligands exist for KATP channels, it was 
decided to attempt the antibody labelling method. Unfortunately, the predicted 
topology of the channel subunit SUR1 (Raab-Graham et al. 1999, Conti et al. 2001) 
along with the crystal structure of bacterial Kir channel homologues (Doyle et al. 
1998, Kuo et al. 2003) suggests that very little of the KATP channel complex would 
exist extracellularly, with only very short loops in both Kir6.2 and SUR1 accessible 
from outside of the cell. The size of these loops makes them unsuitable to be used as 
epitope targets for raising antibodies, thus making selective labelling of the 
membrane bound channel difficult. However, a number of groups (Sharma et al. 
1999, Zerangue et al. 1999, Reimann et al. 2003) have shown that the insertion of 
antibody epitopes into various extracellular domains of either Kir6.2 or SUR1 can 
allow selective staining of cell surface channels without apparent alteration in 
regulation of normal channel function or trafficking. An approach similar to that 
described by Zerangue et al. (1999) has been used to insert a haemaglutinin A (HA) 
antibody epitope into the extracellular loop preceding the pore region of Kir6.2 
(figure 4.1). The HA-epitope was inserted into the Kir6.2 sequence following residue 
102 and in addition to this a second short sequence will also be inserted at position 98 
of the Kir6.2 sequence. This 11 amino acid linker sequence (+11aa) is homologous 
to the corresponding region of Kir6.1 and has previously been shown to improve the 
accessibility of the HA-epitope following insertion into Kir6.2 (Zerangue et al. 1999). 
The insertions will be achieved using an approach based around insertion PCR 
methodology, as summarised in figure 4.2. 
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Figure 4.1 - Schematic showing the location of both the HA and +1Iaa insertions in 
Kir6.2. Inset shows an expansion of the predicted first extracellular loop with 
inserted sequences (+11 as - yellow, HA - blue). Numbering corresponds to the 
residue positions of wild-type Kir6.2. 
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4.2 - Results 
4.2.1 - Production of the Kir6.2-HA+llaa-HMKFLAG construct 
In order to selectively label plasma membrane bound channels a haemaglutanin-A 
(HA) antibody epitope was to be inserted into the first extracellular loop of Kir6.2. In 
addition to this an additional 11 amino acid (+11 aa) linker sequence was to be 
inserted upstream of the HA epitope in order to improve antibody accessibility. 
Shown in figure 2.2 is a schematic diagram of the strategy used to produce the 
Kir6.2-HA+1laa construct. Following the initial insertion of the HA epitope into 
pKS-Kir6.2-HMKFLAG a major PCR product of - 3.9 Kb was observed (figure 4.3 
A) corresponding to the predicted size of pKS-Kir6.2-HA-HMKFLAG. Correct 
insertion of the HA epitope was confirmed by DNA sequencing (figure 4.3 B). For 
expression of the Kir6.2-HA-HMKFLAG construct in mammalian expression 
systems it was necessary to subclone the construct into the pcDNA3 plasmid vector. 
Since no suitable restriction sites were present in both the donor (pKS) and the 
recipient plasmid (pcDNA3), it became necessary to first subclone the construct into 
another plasmid vector, pSportll (figure 2.1). A BamHI / Sall restriction of pKS- 
Kir6.2-HA-HMKFLAG gave a-1.6 Kb fragment which was ligated into BamHI / 
Sall restricted pSportlI. This now enabled a BamHI / EcoR1 fragment of pSportlI- 
Kir6.2-HA-HMKFLAG to be subcloned into the BamHI / EcoRI sites of pcDNA3. 
Correct insertion was confirmed by restriction digestion and DNA sequencing. In 
order to improve the accessibility of the HA epitope to antibodies we also inserted an 
11 amino acid linker sequence (+l laa) downstream of the HA insertion site. These 
11 amino acids correspond to those found in the sequence of Kir6.1, but do not 
correspond to residues found in Kir6.2. As such they are not expected to impact on 
either the function or trafficking of the channels. The +1 laa sequence was inserted 
into pcDNA3-Kir6.2-HA-HMKFLAG using a similar approach to that employed for 
insertion of the HA epitope. However, due to much higher levels of non-specific 
products being produced, a touch-down PCR protocol was utilised in an attempt to 
improve the final yield of the correct product. Following the PCR reaction, a major 
band of - 7.3 Kb was seen, corresponding to the predicted size of the construct. The 
PCR product was transformed into XL-blue competent cells and colonies were then 
subjected to plasmid mini-preparation protocol. Correct insertion of the +llaa 
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sequence was confirmed by DNA sequencing (figure 4.4). For expression of this 
construct in the Xenopus oocyte expression system, it was necessary to subclone the 
Kir6.2-HA+11 aa-HMKFLAG construct into the pKSglobin plasmid vector. In order 
to achieve this, a BamHI / EcoRI fragment of pcDNA3-Kir6.2-HA+l Iaa-HMKFLAG 
was ligated into the BamHI / EcoRI sites of the pKSglobin vector. 
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GCC CAC GGT GAC CTG GCC CCC TAC CCA TAC GAC GTA CCA GAT TAC GCT 
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Kir6.2 (continued) 
............................................ 
EGTNV 
GAG GGC ACC ATT GTG 
Figure 4.3 - Production and sequencing of the pKS-Kir6.2-HA-HMKFLAG 
construct. 
A) PCR product analysed by electrophoresis on aI% agarose gel. Thick arrow 
denotes main PCR product. M= X-HindllI markers (marker sizes (bp) are 
shown on the left); I= pKS-Kir6.2-HA-H MKFLAG PCR product. 
B) Sequencing of PCR product. Both single letter amino acid code and 
nucleotide sequences are shown. Numbering refers to residue positions of 
wild-type Kir6.2. 
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FAHGDIYAYMEKGITD 
TTC GCC CAC GGT GAC ATC TAT GCT TAC ATG GAG AAA GGC ATC ACG GAC 
Kir6.2 HA-epitope 
.................... --------- LAPYPY 
CTG GCC CCC TAC CCA TAC .. 
Figure 4.4 - Production and sequencing of the pcDNA3-Kir6.2-HA+IIaa- 
HMKFLAG construct. 
A) PCR product analysed by electrophoresis on aI% agarose gel. Thick arrow 
denotes main PCR product. M=a, -Hindlll markers (marker sizes (bp) are 
shown on the left); I= pcDNA3-Kir6.2-HA+ ll aa-HMKFLAG PC R product. 
B) Sequencing of PCR product. Both single letter amino acid code and 
nucleotide sequences are shown. Numbering refers to residue positions of 
wild-type Kir6.2. 
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4.2.2 - Functional expression of Kir6.2-HA+llaa-HMKFLAG in Xenopus 
oocytes 
The function of ion channels can be easily tested by expression and 
electrophysiological examination in oocytes from Xenopus laevis frogs. For this, 
cRNA encoding both the Kir6.2 and SUR1 subunits are microinjected into each 
individual oocyte and currents from the resultant channels can be examined using the 
two electrode voltage clamp method. cRNA encoding SUR1 and Kir6.2 constructs 
were in vitro transcribed using T7-Megascript kit (Ambion) followed by examination 
of the resultant cRNA by agarose gel electrophoresis (figure 4.5). 
In order to examine the effect of the HA+11 as insertions on the function of KATP 
channels, Xenopus oocytes were injected with cRNA for SUR1 along with either 
wild-type (wt) Kir6.2-HMKFLAG or Kir6.2-HA+llaa-HMKFLAG and currents 
were examined using the two electrode voltage clamp method. In both cases large 
currents were observed when injected oocytes were treated with 200 gM diazoxide (a 
selective KATp channel opener) and 3 mM sodium azide (a metabolic inhibitor). 
These currents were rapidly and completely inhibited by addition of 1 µM 
glibenclamide (selective KATP channel inhibitor), confirming that the observed 
currents were due to KATP channels (figure 4.6 A). No such currents were observed 
in water injected oocytes suggesting that the currents were due to introduced channels 
and not channels native to the cells. Consistent with this, fluorescent labelling of 
oocyte sections showed clear labelling in both the plasma membrane and cytoplasm 
in oocytes expressing either Kir6.2-wt or Kir6.2-HA-1 laa containing channels. 
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Figure 4.5 - In vitro produced cRNA analysed by 1% agarose gel electrophoresis. 
M=A. -HindIIl markers (marker sizes (bp) are shown on the left); I= Kir6.2- 
HA+I laa-HMKFLAG cRNA; 2= His6-SURI cRNA. 
139 
M12 
A 
Q 
c 
1) 
1 -1 
0 
B 
-13 
wt-Kir6.2 + SUR1 
Time (min) 
5 10 15 20 25 
0 
b 
5 10 
O 
4. 
Diazoxide Glib 
Azide 
Kir6.2-HA+11 as + SUR 
Time (min) 
5 10 15 20 25 30 
0. 
0.5 
o 
-1.5 Diazoxide Glib 
Azide 
Figure 4.6 - Comparison of wild-type Kir6.2 and Kir6.2HA+Ilaa in Xenopus 
oocytes. (A) - Plot of current at -120 mV against time from an oocyte injected with 
cRNA encoding either wt-Kir6.2 or Kir6.2-HA+1 l as both alongside His6-SUR 1. 
Drugs were applied for the duration indicated by the horizontal bars at the following 
concentrations; diazoxide - 200 µM, sodium azide -3 mM, glibenclamide -I µM. 
Currents were recorded using a ramp protocol from -150 mV to + 50 mV (0.22 V. s-1) 
and a holding potential of -30 mV. (B) - Oocytes injected as above were sectioned at 
20 µm and labelled with anti-Kir6.2 antibodies and appropriate FITC conjugated 
secondary antibodies before viewing by confocal microscopy. 
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4.2.3 - Expression of Kir6.2-HA+llaa containing channels in mammalian cells 
It was next necessary to assess whether the HA+llaa insertions were affecting 
normal membrane trafficking of the channels in mammalian cells. This also provided 
an opportunity to assess the suitability of the HA epitope for surface labelling studies. 
Normal trafficking of wild-type KATP channels requires that both Kir6.2 and SUR1 
subunits are present, and that complete channel assembly has occurred. Otherwise 
ER retention motifs (-RKR-) contained in each subunit prevents the export of channel 
subunits into the later biosynthetic pathway. To ensure that addition of the HA+1 laa 
insertions have not interfered with this quality control mechanism, surface expression 
of Kir6.2-HA+llaa containing channels in HEK-293 and COST cells was 
investigated. 
Expression of Kir6.2-HA+1 laa-HMKFLAG along with SUR1 in either HEK-293 or 
COST cells showed strong surface staining in unpermeabilised cells when labelled 
with anti-HA antibodies coupled with complementary fluorescently labelled 
secondary antibodies (figure 4.8 upper panels). However, no surface labelling was 
observed in unpermeabilised cells when Kir6.2-HA+l laa-HMKFLAG was expressed 
in the absence of SUR1 (figure 4.8 lower panels). Immunofluorescence labelling of 
permeabilised cells revealed that in the absence of SUR1, anti-HA staining was 
largely limited to perinuclear regions, most probably the endoplasmic reticulum 
(figure 4.9). In untransfected cells, no labelling was observed in either permeabilised 
or unpermeabilised cells with the anti-HA and complementary secondary antibodies 
(figure 4.7). 
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Figure 4.7 - Anti-HA antibodies do not label untransfected cells. HEK-293 cells 
were fixed, permeabilised where necessary and labelled with rat anti-HA primary 
antibodies followed by anti-rat Cy3 conjugated secondary antibodies prior to viewing 
by confocal microscopy. Insets show phase DIC phase contrast images of the cells 
within the fluorescent images. 
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Figure 4.8 - Kir6.2-HA+llaa-HMKFLAG requires SURI to traffic to flit' cell 
surface. Both HEK-293 and COST cells were transiently transfected using 
Fugene6TM with pcDNA3-Kir6.2-HA+I laa-HMKFLAG with or without pcDNA6- 
His6-SURI. Cells were fixed, left unpermeabilised and stained with rat anti-HA 
antibodies and complementary secondary antibodies. Where no fluorescently- 
labelled cells are evident the entire coverslip has been examined but no fluorescent 
cells were seen. 
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Figure 4.9 - Kir6.2-HA+11 aa-HMKFLAG is confined to perinuclear compartment in 
the absence of SUR]. Both HEK-293 and COST cells were transiently transfected 
using Fugene6TM with pcDNA3-Kir6.2-HA+I l aa-HMKFLAG with or without 
pcDNA6-His6-SURI. Cells were fixed, permeabilised and stained with rat anti-HA 
antibodies and complementary secondary antibodies. 
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4.3 - Discussion 
The successful insertion of both the HA-epitope and the 11 amino acid linker 
sequence into an extracellular domain of Kir6.2 will allow the examination of many 
aspects of KATP trafficking. Despite recent advances in the understanding of the 
mechanisms responsible for controlling KATP channel trafficking to the plasma 
membrane, little is known concerning the fate of the channels once they have reached 
the cell surface. Hu et al. (2003) recently reported a possible role for protein kinase 
C (PKC) in the regulation of KATP channel internalisation from the plasma membrane, 
but this study did not investigate the fate of the internalised channels very 
comprehensively. As such, it is still unclear what happens to the channels once they 
have been removed from the cell surface. Studies of the fates of numerous other 
proteins internalised from the cell surface have revealed a number of diverse 
trafficking pathways, all of which influence the normal physiological functioning of 
the protein. For example, the transferrin receptor is known to be very rapidly 
recycled back to the cell membrane via specialised early-endosomes following 
internalisation whereas the GLUT4 glucose transporter has been shown to be 
recruited into a highly specialised, TGN-associated storage compartment. EGF 
receptors however are targeted through late-endosomes ultimately ending with the 
degradation of the protein in the lysosome (see Maxfield & McGraw 2004 for 
review). To understand fully how the cell surface density of KATP channels is 
regulated the route by which the channels traverse the endosomal system must be 
elucidated. 
An indication suggesting that regulated trafficking pathways may play a role in the 
normal function of KATP channels has already been shown in chapter 3. The 
investigation into the effects of glucose on KATP channel expression showed that 
although a large increase in KATP channels is observed in low glucose, the density of 
channels at the cell surface is not similarly increased. Indeed, much of the 
fluorescence associated with this increase in channel density is confined to structures 
in the cytoplasmic regions of the cell. Taken together these findings could indicate 
the existence of a KATP channel storage compartment within the cell or the existence 
of tightly controlled insertion / removal regulatory mechanisms governing the density 
of channels at the cell surface. The production of the Kir6.2-HA+l laa construct will 
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allow the investigation of these hypotheses as well as examining the pathways taken 
by KATP channels following internalisation from the cell surface. From these data it 
appears that the Kir6.2-HA+l laa construct behaves in the same fashion as the wild- 
type channel. The construct forms functional channels which are activated by azide 
and diazoxide treatment and inhibited by glibenclamide application when co- 
expressed alongside SUR1 in a similar manner as wild-type channels (figure 4.6). 
channels containing the HA-tagged Kir6.2 are also only able to traffic to the cell 
surface in mammalian cells when co-expressed with SUR1 (figure 4.8). Because the 
HA-tagged Kir6.2 does behave like the wild-type Kir6.2, this makes it a suitable tool 
for use in investigating the endocytic trafficking of KATP channels. 
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Chapter 5 
Elucidation and regulation of the 
endocytic trafficking pathways of KATP 
channels 
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5.1 - Introduction 
It has recently become apparent that regulated trafficking pathways play an important 
role in the regulation of the overall activity of a number of cell surface ion channels, 
transporters and receptors (Kleizen et al. 2000, Robinson 2002, Muth & Caplan 2003, 
Tan et al. 2004, Watson et al. 2004 - see for reviews). Since trafficking pathways of 
this kind have the potential to impact greatly on the physiological roles of these 
proteins it is important to understand the mechanisms which are responsible for 
regulating them as well as how proteins traverse through them. A diverse range of 
pathways which both upregulate and downregulate the density of a wide range of 
target proteins at the cell surface are already known, some of which are outlined 
below. 
One of the best characterised of these mechanisms is that which regulates the 
desensitization of certain members of the G-protein coupled receptor (GPCR) family, 
as exemplified by the ß-adrenoceptor. In this case, receptor activation by ligand 
binding results in phosphorylation of the receptor, allowing binding of the adaptor 
protein ß-arrestin leading to the formation of clathrin coated pits (see Fergusson 2001 
for review). Once endocytosed into the cytoplasm, the receptors are 
dephosphorylated, which results in receptor resensitization and allows reinsertion 
back into the plasma membrane. Another well characterised trafficking pathway is 
that which regulates the cell surface density of the GLUT4 glucose transporter in 
adipocytes and smooth muscle. The activity of GLUT4 was shown to be greatly 
increased in the presence of insulin, and it was later discovered that this was due to a 
massive, rapid, recruitment of GLUT4 to the cell surface (James et al. 1988). It 
became apparent that under normal conditions GLUT4 is retained in an insulin- 
responsive compartment which consists of TGN-derived endosomal compartments 
along with a number of specialised transport vesicles, collectively termed the peri- 
centriolar reticular-GLUT4 storage compartment (PR GSC). Stimulation of GLUT4 
expressing cells with insulin results in the release of GLUT4 from the PR-GSC and a 
rapid translocation to the cell surface (Kanai et al. 1993, Lund et al. 1995). It is 
becoming more apparent that the mechanisms governing cell surface density of many, 
if not all, channels are tightly regulated and physiologically significant processes. A 
wide range of channels have so far been identified as having their surface density 
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controlled in some manner. Examples include, members of the Kv channel family - 
Kv4.2 for example (Wang et al. 2004), the ENaC sodium channel (Carattino et al. 
2003), the cystic fibrosis transmembrane regulator chloride channel (see Bertrand & 
Frizzell 2003 for review), the aquaporin-2 water channel (see Brown 2003 for review) 
and the AMPA receptor (Ehlers 2000) to name a few. 
The mechanisms regulating KATp channel trafficking are poorly understood. As 
described earlier (section 1.1.4) the presence of an endoplasmic retention motif in 
both Kir6.2 and SUR1 is known to regulate the biosynthetic export of the channel. 
However, once the channel has reached the cell surface very little is known of its fate. 
A study by Hu et al. (2003) showed that activation of PKC resulted in a reduction in 
KATp channel surface density which they attributed to an increase in the rate of 
internalisation. They also showed that the kinase sites responsible for this effect were 
not present of the Kir6.2 subunit although a dileucine motif in Kir6.2 may have been 
involved in the initial internalisation. The fate of the channels following 
internalisation was not studied in any detail, and as such it is not clear whether the 
internalised channels are able to recycle back to the cell surface or indeed to which 
organelles they are targeted. 
The data presented in chapter 3 showed that a decrease in glucose concentration led to 
an increase in the expression of KATp channel subunits. This rise in the number of 
KATp channels subunits appeared to translate into an increase in fully assembled 
mature channels but the density of channels at the cell surface did not appear to 
similarly change. This has led to the idea that perhaps the surface density of KATp 
channels is tightly regulated through trafficking of channels to and from the plasma 
membrane. If this were found to be true it could have significant implications for the 
understanding of the actions of KATp channels in relation to all of its physiological 
roles including the regulation of insulin secretion. Therefore the endocytic trafficking 
of KATp channels has been investigated, including elucidation of the trafficking 
pathway and the involvement of channel recycling. In addition, such studies are 
important for understanding the cellular basis of diseases associated with defective 
trafficking of KATp channels such as CHI and PNDM. 
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5.2 - Results 
5.2.1 - Suitability of stably transfected cells for the examination of KATP channel 
internalisation 
The HEK293 cells stably expressing HA-tagged KATP channels (KATP-HA) have been 
shown to be suitable for surface labelling studies (see chapter 4). It is however not 
clear from these experiments whether these cells are suitable for use for studies 
requiring the internalisation of labelled channels from the cell surface. It is possible 
that antibodies may internalise into cells via fluid phase uptake in a non-specific 
manner and not because of being bound to epitope-tagged channels. Figure 5.1 shows 
that this is not the case, and proves that uptake of the anti-HA antibodies requires the 
presence of KATP-HA channels (figure 5.1A) and that the fluorophore conjugated 
secondary antibodies require the prior application of anti-HA antibodies in order to 
bind (figure 5.1 B). 
5.2.2 - KATP channels are constitutively internalised from the plasma membrane 
in HEK293 cells into a perinuclear compartment 
The internalisation of KATP-HA from the cell surface was investigated in the stably 
transfected HEK293 cells. Briefly, cells were incubated in the presence of anti-HA 
antibodies at 4°C for 1 hour to label channels present at the cell surface, before 
incubation for varying lengths of time at 37°C to allow internalisation. Labelled 
channels were then visualised using fluorophore-conjugated secondary antibodies in 
cells which were either unpermeabilised (to examine surface expression) or 
permeabilised (to examine distribution throughout the cell). 
In cells which were unpermeabilised (figure 5.2) fluorescence at the cell membrane is 
clearly defined immediately following the 4°C incubation (t =0 min). Following the 
subsequent incubations at 37°C the fluorescence can be seen to become less uniform 
before lessening in intensity. This lessening in the intensity of fluorescence 
presumably occurs due to the internalisation of anti-HA bound channels from the cell 
surface making then unavailable for subsequent binding with fluorescently-conjugated 
secondary antibodies. The intensity of the cell surface fluorescence decreases very 
rapidly, suggesting a very rapid rate internalisation. However, from 10 minutes 
onwards the level of fluorescence remains relatively unchanged, albeit at a 
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significantly lower level than at t=0. It should be noted that at no point does the 
fluorescence disappear completely; indeed at the later time points the level of 
fluorescence appears to fluctuate slightly, perhaps indicating that some sort of 
recycling is occurring. 
In cells which were permeabilised (figure 5.3), endocytosed material can be seen in 
vesicular structures close to the plasma membrane as early as 5 minutes of incubation 
at 37°C, supporting the observations of rapid internalisation from figure 5.2 above. At 
this time however the majority of the fluorescence still appears to be at, or very near 
to, the cell surface. From 10 minutes onwards, the fluorescence appears to move from 
the cell surface towards the centre of the cell, first in the form of smaller punctate 
structures, later accumulating in larger structures in the peri-nuclear region which 
begin to become apparent after 15 minutes. 
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Figure 5.1 - Stably transfected HEK293 cells are suitable for internalisation studies. 
(A) Stably transfected and untransfected HEK293 cells were labelled with mouse 
anti-HA Alexafluor594-conjugated antibodies (2 tg ml-1) and subsequently viewed by 
fluorescence microscopy using the live cell imaging protocol. Each image is a single 
frame taken from the movies included as supplementary material. (n = 3) (B) Stably 
transfected HEK293 cells were labelled using the internalisation protocol in the 
presence or absence of rat anti-HA antibodies (0.2 µg ml-1) followed by fixation, 
permeabilisation and staining with anti-rat Cy3-conjugated secondary antibodies (n = 
4). Labelled cells were subsequently viewed by LSCM. 
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Figure 5.2 - K, 1TJ'-HA channels are rapidly removed from the surface of 
unpermeabilised cells. Stably transfected HEK293 cells were incubated at 4°C for 2 
hours in the presence of rat anti-HA antibodies (0.2 µg ml-1). The cells were then 
washed with chilled media before incubation at 37°C for the indicated duration. 
Following this incubation the cells were fixed and labelled channels at the cell surface 
were stained with anti-rat Cy3 conjugated secondary antibodies. The cells were 
subsequently viewed by LSCM using identical settings for each image (n = 3). 
Representative images are shown. 
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Figure 5.3 - KATp-HA channels are rapidly internalised into perinuclear 
compartments. Stably transfected HEK293 cells were incubated at 4°C for 2 hours in 
the presence of rat anti-HA antibodies (0.2 µg ml"'). The cells were then washed with 
chilled media before incubation at 37°C for the indicated duration. Following this 
incubation the cells were fixed, permeabilised and labelled channels were stained with 
anti-rat Cy3 conjugated secondary antibodies. The cells were subsequently viewed by 
LSCM using identical settings for each image (n = 4). Representative images are 
shown. 
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5.2.3 - Effect of PKC activity on the internalisation of KAB channels 
It was recently reported (Hu et al. 2003) that rapid KATP channel internalisation from 
the cell surface required the activation of protein kinase C (PKC). From the data 
presented above (figures 5.2 & 5.3) it would appear that in these stably transfected 
cells activation of PKC by pharmacological means was not required for rapid channel 
internalisation to occur. In an attempt to reconcile the differences between these two 
sets of data the effect of both activation and inhibition of PKC on the internalisation 
of KATP channels was investigated. Following 2 hours of antibody-labelled channel 
internalisation, cells which were untreated showed the majority of fluorescence in the 
fairly large punctate perinuclear structures as described earlier (figure 5.4 - upper left 
panel) and no fluorescence was seen at the cell surface. These structures were also 
present in cells which had been treated with PMA, an activator of PKC, and no 
significant fluorescence was observed at the cell surface (figure 5.4 - upper right 
panel). In cells treated with chelerythrine, an inhibitor of PKC, the majority of 
fluorescence was observed at the periphery of the cells, most likely at the cell surface 
(figure 5.4 - lower left panel). The perinuclear punctate structures were absent in 
these cells, and the only punctate structures in these cells were very small and located 
near the cell membrane. In cells treated with both PMA and chelerythrine staining 
was observed in both the perinuclear compartments and at the cell surface (figure 5.4 
- lower right panel). One possible explanation for the difference in the PKC 
regulation of channel internalisation between the data presented here and the data 
reported in Hu et al. (2003) could be due to the constructs used in each study. The 
Kir6.2-HA construct that has been used here to establish the stably transfected cell 
line has an HMKFLAG tag attached to the C-terminus, whereas the construct used by 
Hu and colleagues does not and it possible that the presence this tag has in some way 
affected the characteristics of the internalisation event. In order to test this, a Kir6.2- 
HA construct lacking the HMKFLAG moiety was produced, as described in 2.3.9, 
(Kir6.2-HA-iHMKFLAG) (figure 5.5) and its internalisation characteristics were 
examined. When cells expressing Kir6.2-HA-OHMKFLAG and SUR1 were stained 
with anti-HA antibodies using the internalisation protocol the pattern of staining was 
very similar to that observed in the stably transfected cell line (figure 5.6). Untreated 
cells showed the majority of fluorescence in the large punctate perinuclear 
compartments and little near the cell surface (upper left panel). Cells treated with 
PMA showed a similar distribution of staining (upper right panel), whereas cells 
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treated with chelerythrine showed the majority of the staining at the periphery of the 
cell (lower left panel). As with the stably transfected cell line, the cells treated with 
both PMA and chelerythrine showed both the perinuclear staining as well as some 
staining at the cell surface (lower right panel). From these data it would appear that 
the presence of HMKFLAG tag at the C-terminus of Kir6.2 is not responsible for the 
differences observed between the present data and the previously published results. 
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Figure 5.4 - Effect of modulation of PKC activity on KATp-HA channel internalisation. 
Stably transfected HEK293 cells were treated with drugs as described for 30 minutes 
prior to and throughout the labelling protocol. Cells were labelled with rat anti-HA 
antibodies (0.2 . xg ml-1) using the internalisation staining protocol. Cells were then 
fixed, permeabilised and labelled with anti-rat Cy3-conjugated antibodies (n = 3). 
The cells were subsequently viewed by LSCM. Representative images are shown. 
The drugs used were PMA (phorbol-l2-myristate- 13-acetate) - 100 nM, CHE 
(chelerythrine) - 10 sM . 
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Figure 5.5 - Confirmation of the correct insertion of a stop codon to produce Kir6.2- 
HA+llaa-AHMKFLAG. A stop codon was introduced into pcDNA3-Kir6.2- 
HA+11 aa-HMKFLAG to replace the first residue of the HMKFLAG epitope as 
described in 2.3.9. Correct insertion was confirmed by DNA sequencing. When 
expressed the produced protein will not have the C-terminal HMKFLAG attached 
(Kir6.2-HA+11 aa-AHMKFLAG). 
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Figure 5.6 - Removal of HMKFLAG from the C-terminus of Kir6.2-HA does not 
affect internalisation of KATp-HA channels. HEK293MSRII cells were transiently 
transfected with SURI and Kir6.2-HA+llaa-AHMKFLAG. 48 hours post 
transfection the cells were stained with rat anti-HA antibodies (0.2 µg ml-1) using the 
internalisation protocol before fixation and permeabilisation. The cells were then 
labelled with anti-rat Cy3-conjugated antibodies and were subsequently examined by 
LSCM. Representative images are shown (n = 3). The drugs used were PMA 
(phorbol-l2-myristate-l3-acetate) - 100 nM, CHE (chelerythrine) - 10 pM . 
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5.2.4 - Elucidation of the KATp channel endocytic trafficking pathway 
Figures 5.2 and 5.3 suggest that in the stably transfected HEK293 cell line, KATP 
channels are constitutively internalised from the cell surface into numerous punctate 
structures in the perinuclear region of the cell. By identifying the identity of these 
structures it should be possible to elucidate the endocytic trafficking pathways 
through which KATP channels are translocated following internalisation from the cell 
surface. Cells were incubated at 37°C for two hours in the constant presence of anti- 
HA antibodies, so that all channels internalised channels from the cell surface during 
the duration of the incubation would be antibody bound. It was hoped that this would 
lead to labelled antibody being present in each compartment along the endocytic 
pathway of KATP channels and allow subsequent identification using fluorescent 
markers specific for each organelle. 
The distribution of internalised channels was first compared to that of internalised 
fluorescent probes with well characterised trafficking pathways (figure 5.7). The first 
marker used was FITC-conjugated wheatgerm agglutinin (WGA) which is known to 
bind to glycoproteins at the cell surface before being internalised into the cell where it 
is eventually concentrated at the TGN. A fairly high degree of co-localisation was 
observed when the distribution of internalised KATp channels and WGA are 
compared; this is hardly surprising since most compartments will contain 
glycoproteins to some extent. The highest degree of co-localisation was apparent in 
the perinuclear regions of the cells where the WGA staining was at its most intense, 
perhaps suggesting the presence of KATP channels in the TGN or a TGN associated 
compartment. The second marker used was FITC-conjugated transferrin (TI). Tf is 
known to bind to the transferrin receptor (TfR) at the cell surface leading to 
internalisation of the ligand-receptor complex. Following internalisation the ligand- 
receptor complex is rapidly recycled via a well characterised pathway involving the 
sorting endosome (SE) and the endocytic recycling compartment (ERC). Co- 
localisation between Tf staining and KATP channel staining was rather limited 
suggesting that KATP channels and Tf may not share a common trafficking itinerary to 
a significant extent. 
Although these data give some indications as to the pathways which might be 
involved in KATP channel trafficking, further investigations are needed to confirm 
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what has been shown. In a similar series of experiments the distribution of 
internalised KATP channels was compared to the distribution of a number of organelle 
specific marker proteins. One way in which this was achieved was to transiently 
express GFP-tagged organelle marker proteins in the stably transfected HEK293 cells. 
A number of GFP-tagged markers were obtained including EEA1 (SE), Rab4 (SE & 
ERC), Rme-1 (ERC), Rab7 (LE & lysosome), Lampl (Lysosome) and TGN46 
(TGN). As can be seen in figure 5.8 the most prominent co-localisation of 
fluorescence was observed between internalised KATP channels and EEA1 and 
TGN46. Slight co-localisation was observed with Rab7 and Rab4 and no co- 
localisation was observed with Rme-1 and Lamp 1. Thus although a large amount of 
the internalised KATP channel fluorescence was co-localised with that of TGN46-GFP, 
the regions showing overlap accounted for only a small portion of the total TGN46- 
GFP fluorescence. This may imply that internalised KATp-HA channels are targeted 
only to specific regions of the TGN. Although the majority of internalised KATP 
channels did not co-localise with EEAl-GFP, the majority of EEA1-GFP positive 
structures did co-localise with internalised KATP channels. So whilst the majority of 
internalised KATP channels are not present in EEA1 containing compartments, it is 
likely that they do pass through these compartments at some point during the 
trafficking pathway. The slight co-localisation observed between internalised KATP 
channels and Rab4-GFP or Rab7-GFP suggests that these compartments may be 
involved at some point during the trafficking of the channels, albeit to a lesser extent. 
The lack of co-localisation between internalised KATP channels and Rmel-GFP or 
Lampl-GFP would suggest that the compartments containing these markers are not 
involved in the trafficking pathways. 
A second approach was used in order to confirm the previous co-localisation data 
using antibodies targeted against specific markers of the endocytic organelles (figure 
5.9). The antibodies used were anti-CI-M6PR, anti-EEA1, anti-cathepsin-D, anti- 
TGN46 and anti-clathrin light chain. A very high degree of co-localisation was 
observed between internalised KATP channels and anti-CI-M6PR staining. At steady- 
state distribution, the majority of CI-M6PR is thought to reside in a recycling loop 
between the TGN and the late endosomes, although it is also supposed to be present at 
much lower levels at the cell surface and in the early endosomal system. The extent 
of co-localisation between internalised KATP channels and CI-M6PR suggests that 
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both the TGN and late endosomal compartments may be involved in the trafficking 
pathway. A high degree of co-localisation was also observed between internalised 
KAT? channels and anti-clathrin light chain staining. Whilst a large proportion of this 
co-localisation was evident near the periphery of the cell, some co-localisation was 
also observed in larger structures in the perinuclear regions of the cell. The extent of 
co-localisation between anti-EEA1 and the internalised KATP channels was much 
lower by comparison but was still significant. Slight co-localisation was observed 
between internalised KATP channels and anti-cathepsin-D staining, but only in 
occasional isolated spots. No co-localisation was observed between internalised KATP 
channels and anti-TGN46. 
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Figure 5.7 - Co-localisation of internalised KATZ'-HA channels with internalised 
FITC-conjugated ligands. Stably transfected HEK293 cells were stained with rat 
anti-HA antibodies (0.2 µg ml-1) using the internalisation protocol. Media was 
supplemented with FITC-wheat germ agglutinin (WGA) (5 µg ml-1) or FITC- 
transferrin (TF) (25 µg ml-') for the final 15 minutes of the incubation. Following this 
the cells were fixed, permeabilised and stained with anti-rat Cy3-conjugated 
antibodies. The cells were then viewed by LSCM. Representative images are shown 
(n = 3). 
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Figure 5.8 - Co-localisation of internalised K4rp-HA channels with EGFP-tagged 
organelle markers. Stably transfected HEK293 cells were transfected with various 
EGFP-tagged organelle markers. 48 hours post-transfection cells were stained with 
rat anti-HA antibodies (0.2 µg ml-) using the internalisation protocol. Following this 
the cells were fixed, permeabilised and stained with anti-rat Cy3-conjugated 
antibodies (n = 4). The cells were then viewed by LSCM. Representative images are 
shown. 
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Figure 5.9 - Co-localisation of internalised KATF-HA with antibody labelled 
organelles. Stably transfected cells were labelled with rat anti-HA antibodies (0.2 µg 
m1) using the internalisation staining protocol. Cells were then fixed, permeabilised 
and labelled with antibodies targeted against various endocytic organelles. The 
antibodies used were mouse anti-cation independent mannose-6-receptor (CI-M6PR) 
antibody (10 µg m1'), mouse anti-cathepsin-D antibody (1 gg ml-1), mouse anti-early 
endosome 1 (EEA1) antibody (2.5 µg mr ), sheep anti-TGN46 antibody (2.5 µg ml") 
and mouse anti-clathrin light chain antibodies (0.5 µg ml-1). Following this all cells 
were labelled with anti-rat Cy3-conjugated antibodies along with either anti-mouse 
FITC conjugated antibodies or anti-sheep FITC-conjugated antibodies as required (n 
= 3). Cells were subsequently examined by LSCM. Images of the cells stained with 
anti-clathrin light chain antibodies were taken in an optical plane near the coverslip 
attached membrane. Shown are the merged images along with the staining associated 
with each individual fluorophore (HA - red, organelle - green). 
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5.2.5 - Internalised KATP channels are recycled back to the cell surface 
Many channels and transporters which are internalised from the cell surface enter into 
rapidly recycling pathways, leading to their reinsertion into the plasma membrane. 
The possibility that KATP channels are also similarly recycled was investigated. KATP- 
HA channels were labelled with anti-HA antibodies for 2 hours at 37°C so that HA- 
labelled internalised channels saturate the endocytic trafficking pathways. The cells 
were then incubated in acidic buffer at 4°C to strip any bound anti-HA antibodies 
from the cell surface whilst halting any other channel movement. Following the acid 
wash, cells were returned to media at 37°C containing FITC-conjugated secondary 
antibodies. Any channels bound with anti-HA antibodies which had previously been 
internalised which then recycled back to the cell surface would therefore be labelled 
with FITC. The remainder of the anti-HA-labelled channels which had remained 
within the cell throughout the FITC-labelling step were subsequently labelled with 
Cy3-conjugated antibodies. For the recycling assay to be effective it is vital that the 
acid strip step removes all bound anti-HA antibodies from the cell surface. The data 
presented in figure 5.10 shows that this is indeed the case. Cells were labelled with 
anti-HA antibodies using the internalisation protocol. Following internalisation, the 
cells were rapidly chilled to 4°C to halt trafficking, before incubation with either 
chilled acidic strip buffer or chilled phosphate buffered saline (PBS). The cells were 
subsequently fixed and surface fluorescence examined by LSCM. Those cells which 
had been treated with acidic strip buffer showed no surface fluorescence. This is in 
contrast with the cells treated with chilled PBS which displayed prominent 
fluorescence at the cell surface. 
Shown in figure 5.11 is representative data depicting apparent KATP channel 
recycling. When the cells were allowed to recycle for 0 minutes no FITC staining is 
observed, suggesting that the acidic stripping buffer is removing all of the anti-HA 
antibodies from channels at the cell surface. FITC-staining begins to become 
apparent after only 5 minutes, with faint fluorescence at the cell surface. After a 
further 10 minutes (t = 15 min) the faint staining at the cell surface is still apparent at 
as well as some fluorescence in punctate structures within the cytoplasm of the cell. 
For the remainder of the first hour the staining is seen at both the cell surface and in 
the cell interior but the intensity of the FITC-fluorescence (recycled channels) 
increases whilst the intensity of the Cy3-fluorescence (non-recycled channels) 
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decreases. At later time points (t =2 hr and t=3 hr) the intensity of fluorescence at 
the cell surface becomes less intense and the vast majority of fluorescence is apparent 
in the perinuclear compartments. These data suggest that KATP channels are recycled 
back to the cell surface following internalisation. 
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Figure 5.10 - Treatment with acidic stripping buffer removes surface bound anti-HA 
antibodies. Cells were labelled with rat anti-HA antibodies (0.2 µg ml-) for 2 hours 
at 37°C. The cells were then rapidly chilled to 4°C and incubated in either chilled 
acidic stripping buffer (+ acid strip buffer) or in chilled PBS (- acid strip buffer) for 
30 minutes at 4°C. The cells were then fixed and labelled with anti-rat FITC 
conjugated secondary antibodies (n = 3). The labelled cells were subsequently 
viewed by LSCM. 
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Figure 5.11 - KATP-HA channels recycle following internalisation from the cell 
surface. HEK293 cells stably expressing KATP-HA channels were labelled with rat 
anti-HA antibodies (0.2 µg ml-1) using the recycling protocol. Recycled channels 
were labelled with anti-rat FITC-conjugated antibodies and non-recycled channels 
were recycled with anti-rat Cy3-conjugated antibodies. Cells were then viewed by 
LSCM using identical settings for each image. Representative images are shown (n = 
2). 
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5.2.6 - Channel recycling is PKC dependent 
The data reported in chapter 5.3.3 supports the observations of Hu et al. (2003) that 
the internalisation of KATP channels appears to be dependent on PKC activation. It is 
shown in figure 5.3 that PKC activation leads to a redistribution of channels from the 
cell surface into a perinuclear compartment. When PKC activity is inhibited the 
channels remain at the cell surface. This effect may be achieved in two ways; either 
by preventing internalisation of channels when PKC is inhibited or by increasing the 
recycling of internalised channels. The effect of PKC activity on the recycling of 
KATP channels was investigated using the recycling assay as described in chapter 2.4.5 
with cells treated with either PMA or chelerythrine. 
Cells treated with PMA behaved very similarly to those cells which were untreated 
(figure 5.12). In cells where recycling had not been allowed (t = 0) the majority of 
Cy3-fluorescence, corresponding to non-recycled channels, was located in the 
perinuclear compartments with some also present at the periphery of the cell, possibly 
in vesicles near the cell surface. No FITC-fluorescence was observed in these cells, 
confirming that no recycling had occurred. At later time points the amount of FITC- 
fluorescence increases and is apparent at both the cell surface and in the perinuclear 
compartment following 30 minutes of recycling whilst the Cy3 fluorescence is 
confined to the perinuclear compartment. From 60 minutes of recycling and onwards 
all of the fluorescence is seen only in the perinuclear compartment and not at the cell 
surface. At this stage the FITC-labelled channels co-localise fairly well with those 
channels labelled with Cy3, suggesting that those channels which have initially 
recycled (green) were later sequestered to the same compartment as those channels 
which where never recycled (red) to the cell surface during the recycling step. 
By contrast, cells treated with chelerythrine showed a marked difference between the 
distribution of recycled channels to that observed in cells which were either untreated 
or treated with PMA (figure 5.13). In cells where recycling had not been allowed (t = 
0) no FITC-fluorescence was observed, consistent with no channel recycling, and the 
majority of the Cy3-fluorescence was observed towards the periphery of the cell with 
very little visible in the perinuclear compartments. After 30,60 and 120 minutes of 
recycling, both the FITC and Cy3-fluorescence remains near at the periphery of the 
cell and little is observed in the perinuclear compartments. 
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Figure 5.12 -Effect of PKC activation on recycling of KATP-HA channels. Stably 
transfected cells were treated with PMA (100 nM) for 30 minutes prior to and for the 
duration of labelling with rat anti-HA antibodies (0.2 µg ml-1) using the recycling 
protocol. Recycled channels were labelled with anti-rat FITC-conjugated antibodies 
and non-recycled channels were labelled with anti-rat Cy3-conjugated antibodies. 
Cells were then viewed by LSCM using identical settings for each image. 
Representative images are shown (n = 1). 
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Figure 5.13 - Effect of PKC inhibition on recycling of KArp-HA channels. Stably 
transfected cells were treated with chelerythrine (10 µM) for 30 minutes prior to and 
for the duration of labelling with rat anti-HA antibodies (0.2 µg ml-1) using the 
recycling protocol. Recycled channels were labelled with anti-rat FITC-conjugated 
antibodies and non-recycled channels were labelled with anti-rat Cy3-conjugated 
antibodies. Cells were then viewed by LSCM using identical settings for each image. 
Representative images are shown (n = I). 
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5.2.7 - Live cell imaging reveals two potential pools of trafficking vesicles 
The previous data suggest that both the internalisation and recycling of KATP channels 
is very rapid and that the channels may be present in two pools of vesicles; those that 
rapidly recycle and those which are trafficked to the perinuclear compartment and 
appear to not to recycle. In an attempt to confirm these observations and to gain a 
further understanding of the properties of these vesicles, the movement of labelled 
channels was investigated in live cells. 
For the purposes of viewing the movements of KATP-HA laden vesicles within live 
cells, Alexafluor594-conjugated anti-HA antibodies were used to label channels at the 
cell surface and then to follow any subsequent internalisation and trafficking events. 
The uptake of the anti-HA antibodies relies on the presence of the HA epitope and is 
not due to uptake of fluorophore by fluid phase uptake as shown in figure 5.2A. The 
resulting movies are included as supplementary material. Figures 5.14 and 5.15 show 
several still images taken from sequential frames of one of these movies and 
demonstrate two of the most common types of trafficking vesicles observed in these 
cells. 
Figure 5.14 shows an example of a vesicle which is trafficked from near the periphery 
of the cell into the perinuclear compartment. This vesicle is fairly large compared to a 
number of other vesicles in the cell and may possibly represent part of an endosomal 
compartment. The vesicle is first located in the cytoplasm approximately one-third of 
the way between the cell surface and the mass of fluorescence in the perinuclear 
compartment and appears to be spherical in shape (upper left and right panels). The 
vesicle then begins to move rapidly towards the perinuclear compartment. As it does 
so the vesicle can be seen to elongate, possibly as it translocates along microtubules 
(lower left and right panels). This vesicle and others like it may represent a 
population of vesicles which are translocated away from the plasma membrane into 
the perinuclear compartments. 
Figure 5.15 shows an example of a vesicle which appears to recycle directly back to 
the cell surface following internalisation. This vesicle is much smaller than those 
described above and may represent an endocytic vesicle of some description. 
Throughout the duration of the time course shown the vesicle never moves very 
far 
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from the plasma membrane. The highlighted vesicle appears to be very short lived, 
rejoining the plasma membrane only - 10 seconds after appearing in the cytoplasm. 
The size and shape of this vesicle appears to remain unchanged throughout this 
trafficking in contrast to the vesicle shown in figure 5.14. This vesicle and others 
which behaves in a similar fashion may represent vesicles which rapidly recycle to the 
plasma membrane following internalisation. 
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Figure 5.14 - Live cell imaging of KArp-HA channel internalisation reveals a 
population of rapidly moving vesicles. Stably transfected HEK293 cells were labelled 
with mouse anti-HA Alexafluor594-conjugated antibodies (2 tg ml- ') using the live 
cell imaging protocol. Each frame was captured at 2 second intervals. Shown are 
four sequential frames corresponding to frames 170 - 173 of the movie included in the 
supplementary material (see animation I on the attached CD). Inset images 
correspond to expanded versions of the outlined area shown in the main image. The 
arrows highlight a vesicle of interest as it traverses the cell. The positions of the 
vesicle in the previous frames are denoted by * in the final image. The experiment 
was repeated three times and similar results were obtained each time. 
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Figure 5.15 - Live cell imaging of KArP-HA channel internalisation reveals a 
population of rapidly recycling vesicles. Stably transfected HEK293 cells were 
labelled with mouse anti-HA Alexafluor594-conjugated antibodies (2 µg ml-1) using 
the live cell imaging protocol. Each frame was captured at 2 second intervals. Shown 
are eight sequential frames corresponding to frames 40 - 45 of the movie included in 
the supplementary material (see animation I on the attached CD). The arrows 
highlight a vesicle of interest as it enters the cell and recycles back to the cell 
membrane. The experiment was repeated three times and similar results were obtained 
each time. 
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5.3 - Discussion 
5.3.1 - Overview 
Shown in the results section is evidence in support of the endocytic trafficking 
pathways of KATP channels. Also presented are data suggesting that this trafficking is 
regulated by the activity of protein kinase C (PKC). HA-tagged KATP channels are 
shown to internalise constitutively and rapidly into HEK293 cells. Internalised 
channels have been demonstrated to be present in a number of perinuclear 
compartments including the sorting endosome, late endosomes and the trans-Golgi 
network (TGN) or a TGN associated compartment. A proportion of internalised 
channels are rapidly recycled back to the cell surface, a process which is enhanced 
when PKC activity is suppressed. The final fate of the channels internalised into the 
perinuclear compartments is still not clear. 
Shown in figure 5.16 are the likely endocytic trafficking pathways for KATP channels 
as suggested by the current data. It is suggested that the channels are first rapidly 
internalised from the cell surface and enter the sorting endosome. At this stage the 
channels are either recycled directly back to the cell surface in a pathway which does 
not appear to involve the endocytic recycling compartment or they are directed 
towards the late endosomal compartment. It would appear that this sorting step is 
regulated by PKC. From the late endosome the vast majority of the internalised 
channels are directed towards the TGN or a TGN-associated compartment although it 
appears possible that a small fraction of internalised channels may be targeted to 
lysosomes for degradation. The fate of the channels once at this destination is not 
known, although many possibilities exist, including recycling and storage, as will be 
discussed in more detail below. 
5.3.2 - Residency at the membrane and mechanisms of endocytosis 
These data suggest that the residence time of KATP channels at the cell membrane is 
fairly short. Two lines of evidence point toward this. Firstly, internalisation of 
channels from the cell surface is very rapid, with almost complete removal of labelled 
channels from the surface within 10 minutes (figure 5.4). Secondly, labelling of 
recycled channels reveals that newly recycled channels can be seen to move rapidly 
from the cell membrane into cytoplasmic vesicular structures (compare figure 5.11, at 
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5 minutes and 15 minutes). This suggests that channels which are recycled back to 
the cell surface from the cell interior may remain in the cell membrane for as short a 
time as 5-10 minutes before re-internalisation. 
The exact mechanisms of channel internalisation are not clear. The rapid nature of 
internalisation, almost all surface labelled channels internalised within 10 minutes 
(figure 5.4), suggests that clathrin mediated endocytosis is the most likely mechanism, 
since internalisation via other means is thought to be much slower (Conner & Schmidt 
2003). Indeed, internalised channels show a very high degree of co-localisation with 
anti-clathrin light chain antibodies near the periphery of the cell (figure 5.9). If 
clathrin mediated endocytosis were responsible for the removal of channels from the 
cell surface it would be expected that this process would be inhibited by 
overexpression of dominant negative forms of dynamin (Damke et al. 1994). An 
examination of the role of dynamin in the internalisation of KATP channels by Hu et 
al. (2003) suggested that dominant-negative forms of dynamin did indeed slow the 
rate of endocytosis further reinforcing its potential role in this initial internalisation 
step. However, a large proportion of the anti-clathrin light chain co-localisation is 
located near the centre of the cell. These structures could represent endosomal or 
TGN-associated compartments through which KATp-HA channels are trafficked, since 
clathrin has been shown to be present on these compartments where it is thought to 
regulate movement to and from one compartment and the next (Nicoziani et al. 2000). 
If the exact mechanisms which mediate KATP channel endocytosis are to be 
elucidated, further investigation must be undertaken. Should channel endocytosis not 
be clathrin mediated it is possible that the process might be mediated by caveolin, 
with internalisation of channels via caveolae. For internalisation by this mechanism 
to occur the channels must first be present in lipid-rafts in the plasma membrane of 
the cell. It has been reported that KATP channels consisting of SUR1 and Kir6.2 (the 
same composition as the channels examined in the present study) are excluded from 
lipid rafts in pancreatic ß-cell membranes (Xia et al. 2004). However, a more recent 
study has isolated KATP channels containing Kir6.1 from lipid rafts in aortic smooth 
muscle (Sampson et al. 2004) raising the possibility that pancreatic-like KATP 
channels (Kir6.2 + SURI) might also be present in lipid rafts, even if only in a 
transient manner. The rapid nature of internalisation suggests that uptake via 
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caveolae is not very likely as this form of uptake is thought to be fairly slow (t'/z > 20 
minutes) (Conner & Schmidt 2003) although the involvement of caveolin and lipid 
rafts in the internalisation process may warrant further investigation. Other areas on 
which to focus further research could involve the role of the adaptor-proteins, such as 
AP-2, on channel internalisation. Dominant negative forms of AP-2 should 
selectively inhibit clathrin coated vesicle formation at the cell membrane whilst not 
affecting clathrin dependent intracellular trafficking mechanisms which are thought to 
rely on AP-1, AP-3 and AP-4 (Dell'Angelica et al. 1997, Simpson et al. 1997, Meyer 
et al. 2000, Ihrke et al. 2004, Peden et al. 2004). One approach which could prove 
particularly useful in further elucidating these processes is electron microscopy, 
which might provide a much higher resolution view of the processes occurring. 
5.3.3 - Trafficking through early endosomes 
For all material internalised from the cell surface which is destined for the endosomal 
system the point of entry is the sorting endosome. The entry of endocytosed material 
relies on the fusion of endocytic vesicles with the sorting endosome, a process which 
is regulated by Rab5 and EEA1 (Rubino et al. 2000). Once in the sorting endosome 
some material, such as the transferrin receptor, is targeted to the endocytic recycling 
compartment (ERC) from where they are returned to the cell surface in a process 
dependent on the action of Rab4, RablI and Rmel (Ward et al. 2005). The 
trafficking of internalised KATP channels through the early endosomal compartments 
was investigated by several approaches. Internalised KATP channels co-localised 
fairly well with both GFP-tagged EEA1 (figure 5.8) and anti-EEA1 antibody 
associated fluorescent staining (figure 5.9). This suggests that KATp channels are 
indeed present in the sorting endosome following internalisation from the cell surface. 
Limited co-localisation was evident when the distribution of internalised KAI,,, 
channels was examined alongside that of GFP-tagged Rab4 (figure 5.8), which is 
known to be present in both the sorting endosome and ERC (Sonnichsen et al. 2000). 
Limited staining was also observed when the distribution of internalised channels was 
compared to that of internalised FITC-conjugated transferrin (figure 5.7) which would 
also be expected to be present in both the sorting endosomes and ERC. No co- 
localisation of staining was observed when comparing internalised channels along 
with GFP-tagged dominant negative form of Rmel (figure 5.8), which is known to 
accumulate ERC cargo proteins (Lin et al. 2001). Taken together it appears likely 
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that KATP channels are present in sorting endosomes following internalisation from 
the cell surface as indicated by co-localisation between the channels and EEA1 and to 
a smaller extent Rab4. Since residency time in the sorting endosome is thought to be 
very short (t1/2 -2-4 minutes) (Conner & Schmid 2003) the extent of co-localisation 
observed may not be as robust as that observed in other organelles where cargo 
accumulation may have more opportunity to occur. It does not appear likely that the 
internalised channels are present in the ERC, since no co-localisation was observed 
with Rmel-DN-GFP (figure 5.8). It could be argued that the limited co-localisation 
observed with FITC-conjugated transferrin (figure 5.7) could imply that the 
internalised channels are indeed present in the ERC since transferrin will only be 
present in either the sorting endosome or the ERC. However, if the internalised 
channels were present in the ERC, a higher degree of co-localisation might be 
expected, with all FITC-transferrin staining overlapping to some degree with staining 
associated with internalised channels. Since this is not the case it is likely that the 
overlap of staining observed with FITC-transferrin is due to the proportion of 
transferrin which is still contained within the sorting endosome. In conclusion, it 
appears that internalised KATp channels enter the endocytic system via the sorting 
endosome but are excluded from the ERC. Any rapid recycling which occurs must be 
occurring directly from the sorting endosome, and will be discussed in more detail 
below. These findings are supported by the observations of Hu et al. (2003) who 
described only very slight co-localisation with Rmel-GFP following PKC stimulated 
KATP internalisation in COS1 cells. 
5.3.4 - Trafficking through late endosomes and lysosomes 
Since it does not appear that the internalised channels are targeted into the ERC from 
the sorting endosome, it is likely that they are translocated towards the late endosomal 
compartments. Evidence for this comes from extensive co-localisation of internalised 
channels with fluorescence associated with anti-cation-independent mannose-6- 
phosphate receptor (CI-M6PR) antibodies (figure 5.9). CI-M6PR has been shown to 
be enriched in the late endosomal compartment as well as the TGN of most cell types 
and has been used extensively as a marker for these compartments (Dintzis et al. 
1994). Another marker for late endosomes, albeit less selective, is Rab7 which is 
involved in late endosomal maturation as part of lysosome biogenesis (Bucci et al. 
2000). Internalised KATP channels do show some co-localisation with Rab7-GFP, 
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although only to a lesser extent (figure 5.8). This may be because the compartments 
enriched in Rab7 are already undergoing the maturation necessary for its conversion 
into lysosomes, and that internalised channels have been excluded for traffic to 
different compartment. Consistent with this, lysosomal markers such as Lamp1-GFP 
or anti-cathepsin-D antibody associated fluorescence (both proteolytic enzymes 
enriched in the lysosome) (Dean & Barrett 1976, Diment et al. 1988) display very 
little, if any, co-localisation with internalised KATP channels. This could suggest that 
the majority of internalised channels are diverted away from the lysosome mediated 
protein degradation pathways and to another destination. Another possibility for the 
lack of co-localisation of internalised channels with markers for lysosomes could be 
that the low luminal pH of these compartments, coupled with the enrichment of 
proteolytic enzymes, could interfere with anti-HA antibody binding to the channel. 
The targeting of internalised KATP channels to a degradative pathway, is however, 
unlikely, since the half life of mature channels has been reported to be as long as 7.3 
hours (Crane & Aguilar-Bryan 2004). If internalised channels were targeted towards 
lysosomes the rapid nature of channel endocytosis would surely mean that channel 
turnover would be much more rapid than that reported, but labelling remains intense 
for a number of hours following the internalisation into the perinuclear compartments 
(figure 5.11). In conclusion, it would appear that internalised KATP channels are 
targeted from the sorting endosome to the late endosome where further sorting occurs 
to divert the bulk of the channels away from entering the lysosome. These findings 
are supported by the observations of Hu et al. (2003) who described a fairly high 
degree of co-localisation between internalised KATP channels and Rab7-GFP in COS1 
cells. 
5.3.5 - Trafficking to the trans-Golgi network (TGN) 
The direct trafficking pathways between the late endosome and TGN have been fairly 
well characterised and it is possible that the internalised KATP channels could utilise 
one of these routes following sorting in the late endosome. As with the investigation 
of earlier compartments, a number of markers were used in an attempt to evaluate the 
role of the TGN in KATP channel endocytic trafficking. Firstly, FITC-conjugated 
wheat-germ agglutinin (WGA) accumulation in the TGN was used as a crude marker. 
WGA binds to glycoproteins and so will label any region of the cell where 
glycoproteins are found. Apart from the cell membrane the main concentration of 
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glycoproteins in cells is found at the TGN, so any regions of strong intracellular 
perinuclear fluorescence would most likely be associated with the TGN. A fair 
degree of co-localisation was observed between internalised KATP channels and FITC- 
conjugated WGA suggesting the possibility that the TGN may play a role in the 
endocytic trafficking pathways (figure 5.7). These findings are supported by the 
observations of Hu et al. (2003) who described a very high degree of co-localisation 
between internalised KATP channels and fluorescent-WGA in COST cells. However, 
WGA is not selective enough for the TGN to be sure that the co-localisation observed 
is due to internalised channels in this compartment. To confirm the above data the 
distribution of internalised channels was compared to that of the TGN resident protein 
TGN46, visualised by both TGN46-GFP and anti-TGN46 antibodies. Significant co- 
localisation was observed between internalised KATP channels and TGN46-GFP 
(figure 5.8) suggesting that the channels are indeed targeted to the TGN. In contrast, 
no co-localisation was observed when the distribution of internalised channels was 
compared to that of anti-TGN46 antibodies (figure 5.9). It is possible that this 
discrepancy has arisen because the TGN46-GFP has become overexpressed and so 
has `over-flowed' into other compartments which are peripheral to the TGN. It is also 
possible that internalised KATP channels are directed to areas of the TGN in which 
TGN46 is not normally found at steady state, since it has been reported that many 
TGN resident proteins are segregated from cargo proteins (Hirschberg et al. 1998) 
especially in the more peripheral regions of the TGN. In conclusion, it appears 
possible that internalised KATP-HA channels are directed to the TGN or to a TGN- 
derived endosomal compartment following passage through the late endosome. This 
is suggested by the high degree of co-localisation observed between internalised KATP 
channels with both WGA in the perinuclear region and TGN46-GFP. These findings 
are also supported by the very good co-localisation observed between internalised 
KATP channels and CI-M6PR which at steady state is found to some extent in the TGN 
as well as the late endosome. 
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Figure 5.16 - Schematic of the suggested endocytic trafficking pathways Of K4TP 
channels. Where strong evidence for KATP channel residency of a compartment is 
shown solid symbols are shown. Where evidence for KATP channel residency is less 
convincingly shown symbols are semi-transparent. The suggested trafficking 
pathways are shown by the thick red arrows. Other trafficking pathways which are 
not thought to be involved are shown by dashed arrows. SE - sorting endosome, ERC 
- endocytic recycling compartment, MVB - multi-vesicular body, LE - Late 
endosome, TGN - trans-Golgi network, Lys - lysosome. 
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5.3.6 - Recycling of internalised KATP channels 
KATP channels have the ability to recycle back to the cell surface following 
internalisation (figure 5.13). An antibody-capture assay was devised allowing 
examination of recycling dynamics of KATP channels as described earlier (2.4.5). As a 
result of the antibody-capture assay, anti-HA bound channels which had previously 
been internalised, and so were protected from the acid stripping step, and had then 
subsequently been recycled back to the cell surface were labelled with FITC- 
conjugated secondary antibodies. The remaining HA-bound antibodies which had not 
recycled would be labelled with Cy3-conjugated secondary antibodies. The absence 
of FITC fluorescence at the beginning of the experiment (t = 0) where no recycling 
has been allowed suggests that the acid-stripping has successfully removed all bound- 
HA from the cell surface. This means that any FITC fluorescence observed at later 
time points will be as a result of recycled channels and not due to contamination from 
labelled channels already at the cell surface. Recycled channels, i. e. those which have 
bound FITC-conjugated antibodies, begin appearing at 5 minutes of recycling at the 
surface of the cell. This is hardly surprising since the entire endocytic pathways of 
these cells will have HA-labelled antibodies within them following the 2 hours of 
antibody internalisation. As such, the rapid appearance of recycled channels gives no 
indication as to the actual rates of channels recycling. This will have to be examined 
by other means. Following 15 minutes of recycling, FITC-labelled channels are more 
prominent at the cell surface and are beginning to become apparent in vesicular 
structures in the perinuclear region of the cell. The appearance of these vesicles at 
this location suggests that recycled KATP channels do not reside for very long at the 
cell surface, < 10 minutes, possibly even less since they have already been returned to 
the cell surface and re-internalised and translocated to these compartments in a very 
short space of time. As the duration of the recycling step increases, FITC labelling in 
the intracellular structures becomes more pronounced whilst the staining at the 
surface becomes more indistinct. This suggests that whilst channels may pass through 
multiple recycling cycles, a proportion of these channels may be removed from the 
recycling pool at each pass diminishing the numbers of HA-labelled channels 
competent to recycle (compare t= 15 minutes with t=1 hour in figure 5.11). It also 
appears that those FITC-labelled channels which enter the perinuclear compartments 
are entering the same compartment as the population of channels which have not 
recycled back to the cell surface (the Cy3-labelled channels). Indeed, the existence of 
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this population of channels suggests that residency in this compartment may be fairly 
long lived since a large proportion of channels always appears to be resident here. 
The dynamics of channels recycling were also investigated by live cell imaging which 
revealed two populations of trafficking vesicles. The first type of vesicle were fairly 
large in nature and appeared to move rapidly from near the periphery of the cell 
towards the perinuclear compartments, possibly along microtubules (figure 5.14). 
Vesicles similar to these are likely to represent the trafficking pathways of the 
perinuclear targeted channels. The second type of trafficking vesicles were small and 
were located near to the plasma membrane (figure 5.15). They were seen budding 
away from the plasma membrane before rapidly recombining again and may represent 
a mechanism for rapid recycling of KATP channels, although further research into this 
area is required to substantiate these hypotheses. 
5.3.7 - Regulation of KATp channel recycling by PKC 
It was recently reported by Hu et al. (2003) that the endocytosis of KATP channels was 
regulated by the activity of PKC. They described that PKC activation was required 
for rapid channel internalisation and that in the absence of PKC activity channels 
were internalised only very slowly from the cell surface. Analysis of the current data 
would suggest that this is not strictly the case in the system used here. The 
internalisation which is observed with the HEK293 cells which are stably expressing 
KATP shown in figure 5.1 and 5.2 is constitutive, although this effect could possibly 
be due to an elevated basal level of PKC in the HEK293 cells compared to the COS 1 
cells used by Hu et al. (2003). Indeed, initial studies using an inhibitor 
(chelerythrine) and an activator (PMA) of PKC validated the observations of Hu et al. 
(2003), with internalised channels present in a perinuclear region following PKC 
activation but apparently confined to the cell membrane following PKC inactivation 
(figure 5.4). It is worth noting that although the vast majority of channels were 
present in the cell membrane there were also some small vesicular structures present 
in the cytoplasm near the cell surface of these cells, indicating that internalisation was 
continuing under these conditions. Indeed, the presence of these vesicles in the 
cytoplasm suggests that the apparent retention of labelled channels at the cell surface 
could be due to an increased rate of recycling as opposed to a decrease in the rate of 
internalisation per se. The effect of PKC activation and inhibition on channel 
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recycling was therefore investigated. It was discovered that whilst in the presence of 
PKC activation channels are internalised and a small proportion of these will indeed 
rapidly recycle back to the cell surface for a short time, although recycled channels at 
the cell surface are only apparent at early time points (< 1 hour) (figure 5.12). It is 
likely that during each cycle of internalisation and recycling a proportion of the 
recycling channels are sequestered into the perinuclear compartments thus reducing 
the overall population of recycling HA-labelled channels. In the presence of reduced 
PKC activity very few channels appear able to enter the perinuclear compartment and 
the vast majority of channels appear to be present at or near the cell surface (figure 
5.13). A large proportion of channels are labelled with FITC-conjugated antibodies, 
suggesting that they have been recycled, and are present in punctate regions of the cell 
membrane. The fact that these channels are labelled with FITC-conjugated antibodies 
suggests that they were internalised into the cell and so were protected from the acid- 
stripping of anti-HA antibodies prior to the commencement of the recycling assay. 
This suggests that internalisation of KATp channels is indeed constitutive even in the 
absence of PKC activity. That the recycled channels remain at or near the cell surface 
rather than being sequestered into the perinuclear compartment suggests that it is the 
recycling of KATP channels which is regulated by PKC and not the initial endocytic 
event as has been proposed by Hu et al. (2003) 
In summary, the data suggest that it is not the endocytosis as such which is regulated 
by PKC, but rather the ability of the channels to traffic to the perinuclear 
compartments in preference to recycling back to the cell surface. With reference to 
the current data it is proposed that PKC is responsible for regulating an intracellular 
trafficking step which in the presence of elevated PKC activity causes a redistribution 
of internalised channels to the perinuclear compartments and out of a rapid recycling 
pathway. Inhibition of PKC activity allows all of the internalised channels to rapidly 
recycle back to the cell surface avoiding the perinuclear compartments. These two 
pathways are summarised in figure 5.17. 
The sorting of a number of other membrane proteins including many channels and 
transporters have been shown to be regulated in some manner by PKC as described 
below. A number of different effects on protein trafficking and sorting are associated 
with PKC activation with a number of channels and transporters being upregulated 
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and a number downregulated in response to increased PKC activity. The cell surface 
density of the glutamate transporter EEAC1 is greatly increased when PKC activity is 
elevated (Dowd & Robinson 1996, Davis et al. 1998). Under basal conditions 
EEAC1 cycles between the cell surface and an intracellular pool but when PKC is 
activated the rate of endocytosis is slowed and a massive recruitment of transporters 
to the cell surface is stimulated (Fournier et al. 2004). Two other proteins whose cell 
surface density is increased by PKC activation are NMDA receptors (Lan et al. 2001) 
and the glucose transporter GLUT2 in intestinal brush borders (Helliwell et al. 2000). 
An example of a protein whose recycling to the cell surface is PKC dependent is the 
EGF receptor, which is diverted away from a degradative pathway into a recycling 
compartment following PKC stimulation (Bao et al. 2000). The activation of PKC 
has also been implicated in the downregulation of a number of proteins at the cell 
surface, a phenomenon which is perhaps more applicable to the current study. 
Activation of PKC is associated with the down regulation of the neurotransmitter 
transporters GAT1 - GABA transporter (Beckman et al. 1999), SERT - serotonin 
transporter (Qian et al. 1997) and GLT1 - glutamate transporter (Kalandadze et al. 
2002) by mechanisms which are still poorly understood. In the case of GAT1 a 
parallel inhibition of activity by the direct association of syntaxinlA is seen, a 
phenomenon which is also observed with KATP channels (Pasyk et al. 2003, Kang et 
al. 2004, Cui et al. 2004). Increases in the rate of endocytosis associated with an 
increase in PKC activity have been observed with the dopamine receptor DAT 
(Pristupa et al. 1998) and E-cadherin (Le et al. 2002), a component of adherens 
junctions in epithelial cells. In both cases the increase of internalisation is associated 
with an accumulation of protein in the endocytic recycling compartment (Melikian & 
Buckley 1999, Le et al. 2002, Lodler & Melikian 2003). In the case of DAT 
internalisation it appears that direct phosphorylation by PKC of DAT itself is not 
required for internalisation (Torres et al. 2001). The retention in the endocytic 
recycling compartment observed with both DAT and E-cadherin results in a reduced 
rate of recycling back to the cell surface. A similar reduction in the rate of recycling 
as a result of increased PKC activity has been observed with the hepatocyte growth 
factor receptor, c-Met (Kermorgant et al. 2003) and the chloride channel, GABAA 
(Connolly et al. 1999). In both cases endocytosed proteins were seen to traffic to 
perinuclear endosomal compartments which in the case of c-Met includes the TGN 
(Kermorgant et al. 2003). In the case of GABAA channels, PKC was shown not to 
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affect the rate of endocytosis, affecting only the rate of recycling (Connolly et al. 
1999), characteristics which are apparently shared by KATP channels. 
5.3.8 - Summary of findings 
It has been shown that following internalisation into cells, KATP channels move along 
a trafficking pathway which most likely includes the early sorting endosome, the late 
endosome and a compartment which is associated with the trans-Golgi network 
(TGN). Both the mechanism of endocytosis and the fate of the channels once they 
reach the TGN-associated compartment remain unclear. It is also apparent that 
following endocytosis KATP channels are able to recycle back to the cell surface 
rapidly and that this process is dependent on the activity of protein kinase C (PKC). 
An elevation in PKC activity results in the sequestration of channels in the trafficking 
pathway outlined above, whereas inhibition of PKC activity results in the majority of 
internalised KATP channels returning rapidly back to the cell surface. The exact 
mechanisms responsible for this phenomenon are yet to be understood. 
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Figure 5.17 - Effect of PKC on the endocytic trafficking of KATP-HA channels. The 
suggested trafficking pathways when PKC activity is elevated are shown by the thick 
red arrows. The suggested trafficking pathways when PKC activity is attenuated are 
shown by the thick blue arrows. Other trafficking pathways which are not thought to 
be involved are shown by dashed arrows. SE - sorting endosome, ERC - endocytic 
recycling compartment, MVB - multi-vesicular body, LE - late endosome, TGN - 
trans-Golgi network, Lys - lysosome. 
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Chapter 6 
Characterisation of two mutations of 
Kir6.2 known to cause congenital 
hyperinsulinism 
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6.1 - Introduction 
Congenital hyperinsulinism (CHI), also known as persistent hyperinsulinaemic 
hyperglycaemia of infancy (PHHI) and familial hyperinsulinism is an insulin secretory 
disorder characterised by an inappropriately high level of insulin secretion for the level 
of blood glucose (see Dunne et al. 2004 for a comprehensive review). 
Cases of CHI are not common, with an incidence of -1: 50000 live births in Finland 
and 1: 27000 in Ireland, although in some isolated communities the incidence is 
significantly higher, for example in a central region of Finland (1 : 3200) or in the 
Arabian peninsular (1 : 2500) (Glaser et al. 2000). CHI can not currently be diagnosed 
in utero and only becomes apparent following birth. The majority of sufferers are born 
with inappropriately high birth weight due to the anabolic effects of prolonged 
hyperinsulinaemia in utero leading to increased muscle, adipose tissue and liver mass 
(Aynsley-Green et al. 2000) although this is not always the case. The first symptoms of 
CHI usually become apparent soon after birth and may include cyanosis, respiratory 
distress, sweating, hypothermia, irritability, poor feeding, hunger, jitteriness, lethargy, 
and apnea, which can progress to vomiting, seizures, tachycardia, and neonatal death. In 
older children and adults symptoms tend to be typical of those of hypoglycemia 
including confusion, headaches, dizziness, syncope, and, when severe, loss of 
consciousness. Clinical diagnosis of CHI relies on several features; 1) blood glucose 
levels of < 2.6 mM, 2) a glucose requirement of >6-8 mg glucose kg'' min' to 
maintain euglycaemia, 3) detectable levels of insulin and elevated C-peptide levels in 
the blood during hypoglycaemia, 4) inappropriately low free-fatty acids and ketone 
bodies during hypoglycaemia, 5) the absence of ketonuria, 6) and a glycaemic response 
to glucagon during hypoglycaemia (Aynsley-Green et al. 2000). 
Following diagnosis several strategies may be employed in an attempt to treat the 
disorder, and these are ultimately targeted at either lowering insulin secretion or 
increasing glucose availability. Glucose availability is most commonly increased by a 
simple infusion of glucose into the blood, although this may not be practical for long- 
term management of the disorder. In some cases glucagon has been used to treat CI II 
by mobilizing glucose from hepatic glycogen stores, although this mode of treatment is 
far from ideal as glucagon also has actions as an insulin secretagogue and prolonged 
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administration may contribute to the tendency for insulin hypersecretion. Many other 
therapies are targeted at preventing insulin secretion, such as administration of 
somatostatin or its analogues octreotide and sandostatin which act to hyperpolarize the 
ß-cell membrane preventing the opening of voltage dependent calcium channels 
(VDCC). Other drugs such as nifedipine block the VDCC directly, preventing the Ca2+ 
influx required for insulin release. Another possible therapy is the use of diazoxide to 
open the pancreatic KATP channel directly, meaning that the resultant membrane 
hyperpolarization blocks insulin release. Unfortunately, a large proportion of CHI cases 
do not respond to pharmacological intervention, leaving a partial pancreatectomy as the 
last resort in treatment, often with up to 95 % of the pancreatic mass being removed to 
limit the insulin secretory capabilities (Aynsley-Green et al. 2000). 
CHI has been shown to occur in two main types, namely diffuse and focal CHI. Diffuse 
CHI is so called because all pancreatic islets are affected and arises predominantly 
because of autosomal recessive inheritance of KATP channel subunit mutations (Glaser 
et al. 2000). The focal form of the disorder is characterised by a number of so-called 
focal lesions, areas of the pancreas where hyperplasia of the ß-cells has occurred. Focal 
lesions appear histologically as small regions of islet adenomatosis measuring 2-5 mm 
in size and appear to develop through imbalanced expression of maternally imprinted 
tumor suppressor genes H19 and p57kip2, and the paternally derived insulin-like growth 
factor II gene (see Dunne et al. 2004 for review). 
The cause of CHI has been discovered in only about half of those cases diagnosed. To 
date mutations in five genes have been implicated. These genes are ABCC8 (SUR1), 
KCNJJI (Kir6.2) (see Dunne et al. 2004 for review), GLUDI (glutamate 
dehydrogenase) (see Kelly et al. 2001 for review), HADHSC (short-chain L-3- 
hydroxyacyl-CoA dehydrogenase) (Clayton et al. 2001) and the glucokinase gene 
(Glaser et al. 1998, Christesen et al. 2002). Over 100 mutations of either ABCC8 or 
KCNJI1 have been described as causing CHI (Fournet & Junien 2003), although the 
vast majority of these mutations are associated with ABCC8. Mutations of these genes 
have been shown to cause CHI by disrupting the normal function of the pancreatic [1- 
cell KATP channel. This may occur by several processes such as by reducing the rate of 
channel synthesis, by reducing the stability, thus increasing the rate of channel 
degradation, by interfering with channel trafficking, or by interfering with the function 
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of the channel. Many of these scenarios have been shown to occur, for example several 
ABCC8 mutations have been shown to prevent trafficking of the channel to the cell 
surface (Cartier et al. 2001, Partridge et al. 2001, Taschenberger et al. 2002). Other 
mutations associated with ABCC8, for example the mutation resulting in the V 1479R 
mutation of SUR1, have been shown to interfere with function of the channels by 
interfering with normal nucleotide binding (Nichols et al. 1996). Several mutations 
have also been described in KCNJII. These mutations have not been very well 
characterized, and the aim of the current study is to investigate the effect of two of these 
Kir6.2 mutations on KATP channel trafficking and function. 
The first Kir6.2 mutation to be investigated in the current study involves the substitution 
of the tryptophan residue at position 91 for an arginine (W91R). This mutation was first 
described by Aguilar-Bryan & Bryan (1999) and was identified in a neonate suffering 
from severe hyperinsulinaemia which was unresponsive to treatment with either 
diazoxide or somatostatin. Treatment of this individual required a partial 
pancreatectomy at an age of two weeks, followed by a second resection four weeks 
later. This tryptophan residue is one of a pair of tryptophan residues which are thought 
to be located at the top (extracellular) side of TM1 of Kir6.2 (figure 6.1). The model 
shown in figure 6.3, constructed by threading the amino-acid sequence of Kir6.2 onto 
the crystal structure coordinates of Kirbacl. 1 (Kuo et al. 2003), supports this idea, 
clearly showing that W91 is likely to be found near the top of TM1, facing outwardly at 
the periphery of the channel complex. Some aspects of channels containing this 
mutation have previously been investigated. Aguilar-Bryan & Bryan (1999) have 
suggested that channels containing this mutation are non-functional. Further to this it 
has been reported that channels containing the W9IR mutation are much less stable than 
those containing wild-type Kir6.2 subunits as demonstrated by an apparent increase in 
the turnover of mutant Kir6.2 subunits compared to that of wild-type (Crane & Aguilar- 
Bryan 2004). However, the same study showed that W91R mutant Kir6.2 subunits 
were able to associate with SUR1 subunits raising the possibility that ER exit and 
further trafficking of fully assembled channels may occur. 
The second Kir6.2 mutation to be investigated in the current study involves the 
substitution of a leucine residue at position 147 for a proline (L147P). This mutation 
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was first described by Thomas et al. (1996) and was the first mutation to be discovered 
in Kir6.2 which was shown to be associated with CHI. The affected individual 
presented with profound hyperinsulinaemia soon after birth, which was unresponsive to 
treatment with diazoxide, somatostatin or glucagon. Final treatment required a 95 % 
pancreatectomy, and histopathological analysis of the excised tissue revealed a diffuse 
nesidioblastosis. The leucine residue in question is thought to reside near the top of 
TM2 of Kir6.2 (figure 6.2). The model shown in figure 6.3 again supports this idea, 
clearly showing that L147 is likely to be found near the top of TMI, facing outwardly at 
the periphery of the channel complex. Very little is known about the effect that the 
L147P mutation has on KATP channels other than that the channels appear to be non- 
functional (Aguilar-Bryan & Bryan 1999). 
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Figure 6.1 - The proposed location of the W91R mutation in Kir6.2. W91 is thought to 
reside near the top of the first transmembrane domain of Kir6.2. The inset shows an 
expansion of the predicted first extracellular loop showing the proposed location of 
W91 (red circle) and both the 11 as (yellow) and HA (blue) insertions. Numbering 
corresponds to the residue positions of wild-type Kir6.2. 
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Figure 6.2 -The proposed location of the L147P mutation in Kir6.2. L147 is thought to 
reside near the top of the second transmembrane domain of Kir6.2. The predicted 
location of L147 is depicted by the red circle. Also shown are the locations of the 
+llaa (yellow) and HA (blue) insertions. The inset shows an expansion of the 
predicted second extracellular loop and also shows the proposed location of L147. 
Numbering corresponds to the residue positions of wild-type Kir6.2. 
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Figure 6.3 - Both W91 R and L147P are predicted to be found at the periphery of the 
Kir6.2 letramer. The amino acid sequence of Kir6.2 was aligned to that of the bacterial 
Kir channel homologue Kirbacl. l. A model of Kir6.2 was then constructed using the 
coordinates I P713 (obtained from the protein data bank) using Deepview / Swiss- 
PdbViewer software. The individual subunits are coloured alternately light and dark for 
clarity. The predicted positions of W91 (blue) and L147 (red) are shown. 
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WT 5'-TTT GCC ATG GTC TGG TGG CTC ATC GCC TTC GCC- 
W91R 5'-TTT GCC ATG GTC TGG CGT CTC ATC GCC TTC GCC-3' 
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Figure 6.4 - Sequence of Kir6.2 surrounding W91 in both wild-type and W91 R mutant 
subunits. The sequence of W91 R-Kir6.2-HA+1 laa-HMKFLAG was confirmed by 
DNA sequencing. Shown is a comparison of the DNA and protein sequences of the 
area surrounding W91 of both wild-type (WT) and W91 R mutant Kir6.2 constructs. 
The mutated codon and the resultant amino-acid change are highlighted in grey. The 
numbering corresponds to that of wild-type Kir6.2. 
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WT 5'-TGT CCC CTG GCC ATC CTC ATT CTC ATT GTG CAG-3' 
L147P 5' - TGT CCC ATG GCC ATC CCC ATT CTC ATT GTG CAG - 
3' 
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Figure 6.5 - Sequence of Kir6.2 surrounding L147 in both wild-type and L147P mutant 
subunits. The sequence of L147P-Kir6.2-HA+llaa-HMKFLAG was confirmed by 
DNA sequencing. Shown is a comparison of the DNA and protein sequences of the 
area surrounding L147 of both wild-type (WT) and L147P mutant Kir6.2 constructs. 
The mutated codon and the resultant amino-acid change are highlighted in grey. The 
numbering corresponds to that of wild-type Kir6.2. 
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6.2 - Results 
6.2.1 - Both W91R and L147P mutant containing channels are non-functional in 
Xenopus oocytes 
Point mutations were inserted into pcDNA3-Kir6.2-HA+1laa-HMKFLAG using the 
QuikChangeTM mutagenesis protocol (2.3.9) and correct insertion of the point mutation 
was confirmed by DNA sequenceing (figure 6.4 & 6.5). The function of KATp channels 
containing either the W91R or L147P mutations were examined in Xenopus oocytes 
using the two-electrode voltage clamp (TEVC) method. Oocytes from Xenopus laevis 
frogs were injected with cRNA encoding His6-SUR1 and Kir6.2-HA+l laa-HMKFLAG 
containing one of the two mutations. Neither mutant Kir6.2 subunit formed channels 
which elicited currents upon channel stimulation by metabolic poisoning with azide and 
the channel opener diazoxide (figure 6.6A). This is in contrast to Xenopus oocytes 
expressing wild-type channels in which robust currents were elicited in response to the 
same stimuli (see figure 4.7A for comparison). 
6.2.2 - KATP channels containing the L147P mutation traffic to the cell surface 
whereas those containing W91R do not 
The lack of functional channels observed in Xenopus oocytes expressing the mutant 
channels could be due to two reasons; either the channels have been rendered non- 
functional by the mutations or that the mutations have in someway prevented the normal 
trafficking of the channels to the cell surface. These possibilities were investigated by 
sectioning the Xenopus oocytes and antibody labelling the channels present in the 
sections to examine their cellular distribution. It was discovered that whilst channels 
containing the L147P mutation were present largely in the cell membrane, channels 
containing the W91 R mutation were not present at the cell surface and were confined to 
the cytoplasm of the oocytes (figure 6.6B). It was confirmed that these findings also 
applied in mammalian cells by expressing mutant channels in both COST and HEK293- 
MSRII cells, where channels containing the L147P mutation were observed at the cell 
surface whereas those containing W91R were not (figure 6.7). 
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Figure 6.6 - Channels containing either the W91R or L147P mutant Kir6.2 subunit are 
non-functional. (A) - Xenopus oocytes co-injected with SURI and either W91 R or 
L147P-Kir6.2HA cRNA were examined by two electrode voltage clamp (TEVC). K, ý ii, 
channels currents were elicited by perfusion in 90 mM K' Ringers supplemented with 
azide (3 mM) and diazoxide (200 µM) and were inhibited by glibenclamide (I µM) for 
the duration of the time indicated by the horizontal bars. Currents were recorded using 
a ramp protocol from -150 mV to + 50 mV (0.22 V. s-1) and a holding potential of-30 
mV. Data points correspond to currents recorded at -120 mV. (B) - Oocytes injected in 
parallel with those used for TEVC were sectioned and stained with rabbit anti-SUR I 
and anti-rabbit FITC-conjugated antibodies. The sections were then examined by 
+ LSCM. Representative images are shown. Oocytes injected with wild-type Kir6.211A 
SURI are shown in figure 4.7 for comparison. (n = 3). 
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Figure 6.7 - Channels containing the L147P mutation traffic to the cell sm. - izce ºrhercas 
those containing the W91R mutation do not. Cells were transiently transfected with 
His6-SURI and either W91R or L147P mutant Kir6.2-HA+llaa-HMKFLAG. They 
were then fixed and stained without permeabilisation of the cell membranes using rat 
anti-HA antibodies followed by anti-rat FITC-conjugated secondary antibodies. The 
cells were subsequently viewed by LSCM. Representative images are shown. (n = 4). 
Where no fluorescently-labeled cells are evident the entire coverslip has been examined 
but no fluorescent cells were seen. 
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6.2.3 - Intracellular distribution of channels containing the W91R mutation 
Since channels containing the W91R mutation do not traffic to the cell surface it was 
necessary to investigate the fate of the channels within the cell. In order to accomplish 
this, channels were stained in permeabilised cells which had previously been treated 
with the translational inhibitor cycloheximide. The purpose of the cycloheximide 
treatment was to prevent synthesis of new channel subunits for a brief period prior to 
the commencement of staining so that any channels in the cells which had been 
synthesised before the cycloheximide treatment would achieve a steady-state 
distribution. It was hoped that staining in this manner would give a better indication of 
the exact site of channels' retention. The stained channels were seen to be concentrated 
in an often spherical perinuclear structure, with staining absent in the remainder of the 
cytoplasm (figure 6.8 upper left panel). The nature of this compartment was 
investigated by comparing the distribution of channel associated staining with that of a 
number of organelle markers. No co-localisation was observed with anti-EEA1 
antibodies (sorting endosome marker). However, a moderate degree of co-localisation 
was observed between the labelled channels and anti-mannose-6-phosphate receptor 
antibodies (late endosome / TGN marker) and a very high degree of co-localisation with 
anti-syntaxin6 antibodies (TGN marker) (figure 6.8). 
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Figure 6.8 - Co-localisation of W91 R mutant containing channels with antihodº' 
labelled organelles. HEK293-MSRII cells were transiently transfected with His6-SURI 
and W91 R-Kir6.2-HA+11 aa-HMKFLAG. Prior to staining the cells were treated 
cycloheximide (25 µg ml-1) for 4 hours at 37°C in order to remove channels from the 
biosynthetic pathway and allow channels already produced to achieve a steady-state 
distribution. The cells were then fixed, permeabilised and the channels stained using rat 
anti-HA antibodies followed by anti-rat Cy3 conjugated secondary antibodies. 
Intracellular organelles were then stained using appropriate primary and secondary 
antibodies. Antibodies used were mouse anti-EEAI, mouse anti-M6PR and mouse anti- 
syntaxin6 primary antibodies and anti-mouse FITC-conjugated secondary antibodies. 
Cells were subsequently viewed by LSCM. Shown are the merged images along with 
the staining associated with each individual fluorophore (HA - red, organelle - `erred). 
Representative images are shown. (n = 3). 
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6.2.4 - The trafficking defect associated with the W91R mutation 
is not reversed by 
pharmacological intervention 
Recent reports suggest that trafficking defects of KATP channels associated with PHHI 
may be reversed by pharmacological intervention by treatment with either the KATP 
channel opening drug diazoxide or inhibitor glibenclamide (Partridge et al. 2001, Yan et 
al. 2004). Several reports have also suggested that cell surface trafficking of certain 
mutant forms of CFTR may be rescued by lowering the incubation temperature to 27°C 
(Denning et al. 1992). The possibility that some or all of these treatments might rescue 
the surface expression of channels containing the W91R mutation was investigated. 
Cells expressing W91R containing channels were incubated in media supplemented 
with either glibenclamide or diazoxide or in normal media at 27°C for 24 hours prior to 
the commencement of staining. None of the treatments appeared to induce trafficking 
of the mutant channels to the cell surface as illustrated by a lack of staining at the cell 
surface in unpermeabilised cells (Figure 6.9). 
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Figure 6.9 - Neither drug treatments nor lowered temperature incubations are able to 
reverse the trafficking defect associated with W91R-Kir6.2. HEK293-MSRII cells were 
transiently transfected with HA-tagged W91 R-Kir6.2 + SUR 1. For the final 24 hours of 
culture prior to staining cells were incubated at 27°C or in media supplemented with 
either glibenclamide (10 µM) or diazoxide (200 µM). Cells were stained using rat anti- 
HA antibodies followed by anti-rat Cy3 conjugated antibodies (tipper panels). The 
lower panels show phase contrast images corresponding to those shown above each one. 
Wild-type channels (containing wt-Kir6.2 + SURI) were stained in parallel and 
displayed strong fluorescence in all cases (data not shown). 
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6.3 - Discussion 
Described in this chapter is an examination of the functional and cell biological 
consequences of two mutations of the Kir6.2 subunit of KATP channels known to cause 
the disorder CHI. The first mutation, W91R, has been shown to cause retention of KATP 
channels in an intracellular compartment which has been identified as likely being the 
trans-Golgi network (TGN). Retention of the channels in this compartment could not 
be reversed by any intervention attempted. The second mutation, L147P, was shown to 
traffic to the cell surface in both Xenopus oocytes and in mammalian cells, but was not 
able to pass currents when stimulated with diazoxide and azide. Figure 6.10 
summarizes these findings. 
6.3.1 - The W91R mutation 
Of the characterised mutations known to cause CHI, two broad mechanisms have been 
demonstrated whereby the channel defects arise. The first type of channel defect is 
those which result from impairments to the function of the channel. The second 
mechanism results from a disruption of the correct trafficking of channels leading to a 
reduction or complete abolition of currents. The W91R mutation of Kir6.2 has been 
shown to cause a trafficking defect of KATP channels in both Xenopus oocytes and in 
mammalian cells (figures 6.6 and 6.7). In addition to this, it has also been demonstrated 
that these W91R mutantion containing channels are retained in a post-ER cytoplasmic 
compartment which stains positive for syntaxin 6, which implies that this compartment 
is most likely part of a TGN / endosomal population of structures. That the channels are 
capable of exiting the ER and to move into TGN-associated structures implies that 
Kir6.2 subunits harbouring the W91R mutation are capable of assembling with SUR1. 
These observations are supported by the findings of Crane and Aguilar-Bryan (2004) 
who showed association between SURI and W91R mutant containing Kir6.2. 
A number of KATP channel mutations known to cause CHI have been described as 
causing a trafficking defect. Indeed, the vast majority of characterised channel 
mutations display some degree of change in cell surface numbers, even those mutations 
which are known to primarily cause functional defects (for example the L1551V 
mutation of SUR1 which displays both impaired function and a small decrease in 
channel density (Reimann et al. 2003)). Other than the mutations which have been 
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shown to reduce cell surface density, several mutations, in both Kir6.2 and SUR1, have 
been shown to totally abolish channel trafficking to the cell surface in a similar manner 
to that reported here for the W91R mutation. The Kir6.2 mutation P254L is thought to 
cause KATP channels to be retained within the endoplasmic reticulum (Tornovsky et al. 
2004) perhaps due to incorrect shielding of the -RKR- retention motifs in either of the 
two subunits. The same is also true of a number of SUR1 mutations including AF1388 
(Cartier et al. 2001), A1457T, V 1550D (both Reimann et al. 2003), A116P and V 187D 
(both Yan et al. 2004) which all lead to retention in the ER. In contrast, the R1394H 
mutation of SUR1 has been shown to lead to retention of the channel in the TGN 
(Partridge et al. 2001) in a similar manner to that described here for the W91R Kir6.2 
mutation. Partridge et al. (2001) also reported that the TGN retention of the R1394H 
mutation containing channel could be overcome by treatment of the cells with the KATP 
channel activator diazoxide, however, this type of treatment was not effective in 
restoring the trafficking of W91 R mutation containing channels (figure 6.9). It has also 
been reported that treatment with sulphonylureas can reverse the ER retention of certain 
SUR1 mutant channels (Al 16P and V 187D (Yan et al. 2004)) but such treatments were 
again not effective in restoring the membrane trafficking of W91R containing channels 
(figure 6.9). 
The exact mechanisms which have led to TGN retention of channels containing the 
W91R mutation remain unclear. The tryptophan residue at this position is the second of 
a pair of tryptophan residues which are fairly well conserved throughout the Kir channel 
family suggesting the potential for an important role (figure 6.11). Aromatic residues 
are commonly found at the membrane / water interfaces of membrane spanning regions 
of integral membrane proteins (Killian & Von Heijne 2000, Ulmscheider & Sansom 
2001). It is thought that they stabilize transmembrane a-helices by anchoring proteins 
into the membrane via interactions with lipid head-groups. These interactions were first 
proposed to exist in the photoreaction center (Deisenhofer & Michel 1989) and were 
subsequently proposed to play a role in maintaining the structure of bacterial porins 
(Cowan et al. 1992). More recently, bioinformatical studies using crystal structures of a 
number of integral proteins have confirmed the tendency for aromatic residues to be 
present at the membrane boundary (Landolt-Marticorena et al. 1993, Ulmscheider & 
Sansom 2001). It may be that the tryptophan residues located at the top of TM1 of 
Kir6.2 are acting in a similar fashion, and that substitution of one of the tryptophan 
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residues with arginine is destabilizing the structure of the channel. Further evidence for 
this is demonstrated by the crystal structure of the KcsA archetypal bacterial K+ ion 
channel, where two rings of tryptophan residues appear to form a `collar' at the 
periphery of the membrane embedded portions of the channel (Doyle et al. 1998). 
Another contributing factor behind the defect cause by the mutation may be due to the 
nature of the amino acid change. The tryptophan to arginine change has substituted a 
very hydrophobic amino acid with a hydrophilic charged amino acid and it is 
conceivable that this drastic change may affect the stability of the protein in this region. 
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Figure 6.10 -A schematic summarizing the different effects of the W91 R and L 147P 
mutations of Kir6.2. Channels containing either the W91 R or L147P mutation are able 
to exit the endoplasmic reticulum (ER) and traffic to the Golgi apparatus. The channels 
containing the W91 R mutation are retained (X) in elements of the Irans-Golgi network 
whereas channels containing the L147P mutation are able to traffic to the cell surface. 
Once at the cell surface the L147P containing channels are unable to pass current, 
suggesting a functional defect (®). 
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82 T I F I T A FL G SW F FFG L LW A V; A YIHKDL PE Kirl. 1 
86 V I F C L A FV L SW L FFG C VF L I; A LLHGDL DA Kir2.1 
85 F I F I L T YT V AW L FMA S MW V I; A YTRGDL NK Kir3.1 
69 L L F S A T FA G TW F LFG V VW L V; A VAHGDL LE Kir4.1 
75 V I F S L S YI L SW L IFG S VF L I; A FHHGDL LN Kir5.1 
74 V I F T M S FL C SW L LFA I MW L V; A FAHGDI YA Kir6.1 
73 L I F T M S FL C SW L LFA M AW LIAFAHGDL AP Kir6.2 
58 L V F S A S FV V HW L VFA V LW V L: A EMNGD- LE Kir7.1 
Transmembrane helix 1 (TM1) Extracellular 
Figure 6.11 - Sequence alignment of the Kir channel members surrounding the location 
of the W91 R mutation. The sequences of human KirX. 1 family members are shown. 
The full length protein sequences of each subunit were aligned using the ClustalW 
function of DNA star - Megalign programme. The sequence of Kir6.2 is shown in bold 
and the location of W91 is denoted in italics. The corresponding residues in alignments 
are highlighted red if identical or _ «"n 
if similar. The predicted boundaries of the first 
transmembrane helix (TMI) are shown. Numbering down the left hand side 
corresponds to the position of the first amino acid of the sequence shown. 
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6.3.2 - The L147P mutation 
The basis of the functional defect which affects L147P containing channels is unclear. 
Several possibilities exist, however, which could explain this functional defect. Firstly, 
the introduction of a proline residue at this position may cause a deformation in TM2 
which may interfere with the movements of this transmembrane helix thought to be 
important for gating of the channel. The introduction of the proline residue could cause 
a `kink' in the helix which might cause an occlusion of the channel gate located at the 
bundle crossing at the cytoplasmic end of TM2 thus preventing the passage of ions into 
the K+ conduction pathway. It seems unlikely that this is responsible for the functional 
defect purely because of the distance between the site of the mutation and the 
cytoplasmic gate. It is possible however that a mutation in this region could interfere 
with the channel pore, where a second gate has been postulated to reside (Claydon et al. 
2003) Secondly, the introduction of the proline residue into TM2 of Kir6.2 might 
interfere with its assembly with SUR1. It seems unlikely that such interference would 
totally disrupt the interactions between the two subunits since the channels are able to 
traffic to the cell surface suggesting that assembly has occurred sufficiently to allow 
ER export. However, the overall structure of the channel might be sufficiently 
disrupted so that normal functional coupling between the Kir6.2 tetramer and SUR1 
might not be able to occur. A third possibility is that the introduction of the proline 
residue into the top of TM2 could in some way affect the packing of the pore region of 
the channel. The location of the mutation lies very close to both the pore and pore 
helices and it is conceivable that misfolding of the transmembrane domain may interfere 
with the architecture of either the pore or may interfere with the orientation of the pore 
helices. All of the above possibilities are purely speculative however, and the exact 
reason for the functional defect remains unknown. 
Examples of functional defects have previously been reported in both Kir6.2 and SUR1. 
The K67N mutation of Kir6.2 has been shown to lead to no loss of cell surface density 
of the channel but Xenopus oocytes expressing the mutant channels yielded currents 
reduced by about a half compared to wild-type channels, although the exact impact of 
this mutation remains unknown (Reimann et al. 2003). Several SUR1 mutations have 
been described where channel function has been shown to be defective. These include 
the R1420C mutation (Matsuo et al. 2000) in which it has been shown that nucleotide 
binding to NBF2 is disrupted and the L1551V mutation (Reimann et al. 2003) which 
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showed a loss of sensitivity to both MgADP and diazoxide stimulation as well as a mild 
reduction in cell surface expression. 
6.3.3 - Summary of findings 
Described in the current chapter is characterization of two mutations of the Kir6.2 
subunit of KATP channels which are known to cause CHI. Functional analysis of the 
mutant channels reveals that neither the W91R- nor L147P-containing channels are 
functional in Xenopus oocytes. It has been demonstrated that in the case of the W91 R 
mutation containing channels the lack of currents results from a trafficking defect which 
prevents channels from reaching the cell surface. The channels have been found to be 
retained within a compartment which is enriched in syntaxin 6 and is therefore thought 
to be associated with the TGN or a TGN derived endosomal population. The lack of 
currents observed with L147P mutation containing channels is thought to result from a 
loss of channel function since membrane trafficking of these channels appears normal. 
Taken together these findings demonstrate two ways in which mutations associated with 
Kir6.2 can adversely affect the function of the pancreatic-type KATP channel. 
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7.1 - Overview 
The aim of the current study was to investigate the possible mechanisms by which the 
cell surface density of KATP channels could be regulated. It has been shown that: 
(i) The expression of KATP channel subunits is increased - 2.5 fold in response to a 
sudden lowering of glucose in the bathing medium in both INS-le cells and freshly 
isolated mouse pancreatic ß-cells. These findings are discussed in more detail in 
chapter 3. (ii) It has been demonstrated that regulated trafficking pathways play some 
part in regulating the cell surface density of KATP channels. Under basal conditions, 
channels are rapidly internalised into the cell and accumulate in a perinuclear 
compartment which includes elements of the early endosome, late endosome and 
trans-Golgi network (TGN) / TGN derived endosomal compartments. In the presence 
of PKC inhibitors these internalised channels are redirected into a pathway which 
allows rapid recycling back to the cell surface. These data are discussed in more 
detail in chapter 5. (iii) It has also been demonstrated that mutations of the Kir6.2 
subunit known to cause the disorder congenital hyperinsulinism can affect both 
channel function and channel trafficking. These findings are discussed in more detail 
in chapter 6. 
7.2 - Physiological relevance of the findings & future perspectives 
Glucose regulation of KATp channel expression 
A sudden decrease in glucose availability results in a rapid upregulation of KATP 
channel numbers. It seems most likely that the purpose of this increase in channel 
numbers would be to enable the cell to respond to the lowering of glucose by 
increasing the numbers of channels available to be inserted into the cell membrane. 
Together with decreased [ATP], this may prevent insulin secretion from the ß-cell, 
and it is likely that this mechanism has evolved to protect the body from the effects of 
a sudden hypoglycaemic shock. A corresponding difference was not however 
observed in the cell surface density of KATP channels when examined by the patch 
clamp analysis. This prompted the investigation of the possibility that channel 
turnover at the cell surface might also be tightly regulated, that is, in low glucose 
conditions the rate of both channel insertion and removal at the membrane might be 
greatly increased, a process which might only be possible with a larger population of 
channels within the cells (see endocytic trafficking of KATP channels below). The 
precise role that AMP-activated protein kinase plays in mediating the glucose 
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stimulated upregulation of the pancreatic KATP channel following glucose withdrawal 
remains unclear. However, there is mounting evidence to suggest that AMPK is one 
of the most important sensors of cellular energy status and it is becoming increasingly 
evident that a multitude of processes which depend on the energetic state of the cell 
are regulated by the action of this kinase. The role that AMPK activation plays in 
mediating the upregulation of KATP channels in pancreatic ß-cells requires further 
examination. The potential roles that AMPK may play in this process are further 
discussed in chapter 3 (3.4.3). These data also do not rule out another role for KATP 
channels within these cells, for example a role for KATp channels has been proposed at 
the level of the insulin secreting granule (Geng et al. 2003). The physiological 
significance of these findings is discussed in more detail in chapter 3. 
Endocytic trafficking of KATP channels 
The pathway through which KATP channels are internalised appears to involve the 
early sorting endosomes, late endosomes, eventually leading to accumulation in a 
TGN / TGN-derived endosomal compartment in the perinuclear region of the cell. In 
the presence of PKC inhibitors, internalised channels appear to bypass this trafficking 
pathway in favour of an alternative pathway which allows rapid recycling of the 
channels back to the cell surface. This pathway outlined for the endocytic trafficking 
of KATp channels will hopefully lead to a better understanding of how the density, and 
hence the overall activity, of these channels is regulated by the cell, although a great 
deal of further research is required to answer a number of questions raised. 
Firstly, the fate of the channels once they have been internalised into the perinuclear 
(TGN / TGN-derived endosomal) compartment remains unclear. It is possible that 
the channels could traffic back to the cell surface, be targeted for degradation by the 
either the proteasome or lysosome or that they will remain in the peri-nuclear region 
in some sort of storage compartment. The most likely outcome from the data 
presented (the presence of internalised channels in long-lived perinuclear structures) 
is that the channels are internalised into the TGN-associated perinuclear compartment 
where they accumulate. No significant loss of internalised channels is observed in 
cells where channels have been allowed to internalise for >3 hours, suggesting that 
significant degradation of channels is not occurring. The live cell imaging of KATP 
movement showed many vesicles moving towards the centre of the cell but very few 
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moving back towards the periphery, supporting the idea that KATP channels 
internalised into the perinuclear compartment were largely retained for some purpose. 
If there is a TGN-associated KATP storage compartment within the cell this may 
provide an explanation as to why certain CHI causing mutations are retained in TGN- 
like / derived structures. It is conceivable that channels harbouring either of the two 
mutations currently known to lead to TGN retention (W91R - current study and 
R1394H - Partridge et aL 2001) may be unable to interact correctly with whatever 
machinery which might be required for entry to or export from this compartment. 
This is however highly speculative. The purpose of such a mechanism is unclear; 
however, parallels do exist with other proteins, for example the GLUT4 glucose 
transporter, which is retained in a TGN-derived endosomal storage compartment until 
stimulated by the presence of insulin (Kanai et al. 1993, Lund et al. 1995). It is not 
clear if such a mechanism is at play with KATP channels, but a further characterisation 
of this compartment may provide clues as to its exact function with respect to KATP 
channel trafficking. 
A very clear difference in the endocytic trafficking of the channels can be seen when 
PKC activity is impaired. With the activity of PKC absent the channels appear to 
enter a cycle of repeated internalisation and rapid recycling back to the plasma 
membrane. As mentioned above, when PKC activity is promoted the internalised 
channels appear to be sequestered in the perinuclear compartments. This may explain 
why PKC activation stimulates insulin secretion. PKC has been shown to augment 
the second phase of insulin secretion by potentiating the primary signals derived from 
fuel metabolism (see Nesher et al. 2002 for review). It has been suggested that PKC 
acts in this manner by recruiting secretory vesicles from a reserve pool in the cell into 
the readily releasable pool of vesicles close to the plasma membrane (Yaney et al. 
2002, Lee et al. 2003) and by sensitising the secretory machinery to Ca2+ (Wan et al. 
2004). If the action of elevated PKC activity is to augment insulin secretion it follows 
that KATP channel activity should preferably be suppressed. One way to achieve this 
is to reduce the overall KATP channel activity by removing the channels from the cell 
surface into an intracellular compartment or by inhibiting their return to the cell 
surface. This hypothesis offers a plausible explanation for both the apparent 
sequestration of the channels in the perinuclear compartment and for the regulation of 
this process by PKC. These findings were however made in a recombinant system 
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and it would be necessary to attempt to replicate these findings in a native cell line, 
such as the INS-le cells or in isolated pancreatic 0-cells. 
Trafficking motifs of SURI and Kir6.2 which may mediate channel trafficking 
The targeting of proteins into the various compartments of the endocytic trafficking 
system relies on a number of specific signalling motifs located in the cytoplasmic 
domains of membrane bound proteins. These motifs consist of short stretches of 
protein sequence which are recognised by various components of the trafficking 
machinery, for example the adaptor protein complexes API - 4. They allow cargo 
proteins to be concentrated into specific membrane domains of each compartment 
where the recruitment of the accessory proteins necessary for movement to the next 
destination occurs (see Bonifacino & Traub 2003 for a comprehensive review). 
Several different trafficking motifs have been identified which allow the 
internalisation of integral membrane proteins from the cell surface. One of these 
trafficking motifs is the YXX(D tyrosine based motif (where Y- tyrosine, X- any 
amino acid, (D - any amino acid with a bulky, hydrophobic sidechain; F, W, L, I) (Jadot 
et al. 1992). These trafficking motifs have been implicated in clathrin coated vesicle 
formation where they interact with the µ subunit of the adaptor protein complexes 
(Ohno et al. 1995, Boll et al. 1996, Honing et al. 1996), and they also may have a role 
in lysosomal targeting (Williams & Fukuda 1990, Harter & Mellman 1992, Marks et 
al. 1995, Gough et al. 1999). Those tyrosine based motifs which mediate lysosomal 
targeting commonly have a glycine residue immediately upstream of the tyrosine 
residue (Harter & Mellman 1992). The tyrosine residue of theses motifs is critical for 
function whereas the X positions can accommodate almost any amino acid, although 
the exact nature of these residues is believed to specify the properties of the motif 
(Gough et al. 1999, Rous et al. 2002). Most, but not all, of the YXX(D motifs 
responsible for mediating endocytosis are found within 10 - 40 residues of 
transmembrane domains whereas the majority of lysosomal targeting motifs are 
thought to be found either within 6-9 residues of transmembrane domains or in the 
distal C-terminus of proteins. 
Two candidate sequences can be found in the sequence of both Kir6.2 and SUR1. 
The motifs in SUR1 are -Y367VAI- and -Y386NKI- (numbering refers to hamster 
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SUR1) and are both located in a large cytoplasmic loop between TM 7 and 8 in 
TMD1. The motifs in Kir6.2 are -Y258HVI- and -Y330SKF- (numbering refers to 
mouse Kir6.2) and are both located in the C-terminus. If these motifs do indeed play 
a role in regulating the trafficking of KATP channels, it is likely that they are involved 
in the process of rapid internalisation from the cell surface. Further investigation is 
required in order to ascertain whether these motifs do indeed function in the endocytic 
trafficking of KATP channels at either the site of internalisation from the cell surface or 
during a particular sorting step in the endosomal system. 
A second class of trafficking motifs have been implicated in the initial endocytic 
event as well as several intracellular trafficking steps. These motifs are characterised 
by the presence of two leucine residues (-LL-) and are thus called dileucine motifs 
(Johnson & Kornfeld 1992). Since their initial discovery two distinct types of 
dileucine motifs have been found, one which allows interactions with the AP1-4 
adaptor complexes throughout the endocytic trafficking system (Heilker et al. 1996, 
Dietrich et al. 1997, Honing et al. 1998, Fujita et al. 1999, Peden et al. 2001) and a 
second motif which binds to the Golgi-localised 'y-ear containing ADP-ribosylation- 
factor binding proteins (GGAs), adaptor proteins which are thought to mediate 
trafficking from the trans-Golgi network to endosomes (Puertollano et al. 2001, Zhu 
et al. 2001, Jacobsen et al. 2002). The motif responsible for interacting with AP1-4 is 
the [D/E]XXXL[L/I] motif. In this motif, the first leucine residue is necessary for 
function but the second leucine can tolerate the change to isoleucine (Letourneur & 
Klausner 1992). The acidic residue at the beginning of the motif is not thought to be 
required for internalisation to occur, but is thought to target internalised proteins 
towards lysosomes (Pond et al. 1995, Sandoval et al. 2000). Some [D/E]XXXL[L/I] 
motifs have two arginine residues substituted for the acid residue at the beginning of 
the motif, although to date they have only been found in proteins which are targeted 
into insulin responsive storage compartments, for example GLUT4 and IRAP 
(Sandoval et al. 2000). The motif responsible for interactions with GGA proteins is 
DXXLL. As mentioned above these motifs appear to mediate trafficking from the 
TGN to the endosomes (Puertollano et al. 2001, Doray et al. 2002, Puertollano et al. 
2003). It has been shown that these motifs are recognised by the amino-terminal VHS 
domain of the GGA adaptor proteins (Zhu et al. 2001, Takatsu et al. 2001). This 
interaction is specific for the VHS domain of the GGAs since other VHS containing 
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proteins do not bind'to the DXXLL motif (Puertollano et al. 2001). The requirement 
for both the aspartate and the dileucine pair for this motif to function is absolute, with 
alanine substitutions of any of the three residues sufficient to abolish function, leading 
to an increased expression of the protein at the cell surface (Johnson & Kornfeld 
1992, Chen et al. 1997). 
Dileucine motifs are fairly common features in the cytoplasmic domains of most 
integral membrane proteins, and SUR1 and Kir6.2 are no different, with 11 such pairs 
in hamster SUR1 and 1 in the sequence of mouse Kir6.2. The role of each of these 
motifs in KATp internalisation and trafficking would have to be individually 
investigated. Of the motifs present in SUR1 only one motif shows significant 
similarities to the [D/E]XXXL[L/I] type motif whereas no motifs resemble the 
DXXLL type motif. The -E654EVRDLLG- motif of SUR1 is located in the large 
cytoplasmic loop between TMD1 and TMD2 and appears to resemble the dileucine 
motifs responsible for lysosomal targeting due to the presence of the glutamate 
residue at -4 positions from the dileucine pair. The dileucine pair contained within 
Kir6.2 conforms to the DXXLL type motif. The dileucine pair of the -D350RSLL- has 
previously been studied by Hu et al. (2003) who reported that substitution of the 
dileucine pair with alanine resulted in increased surface expression of KATp channels. 
Their interpretation of this was that internalisation was being interrupted, but it 
remains possible that the increase in apparent surface expression was due to decreased 
GGA binding in the TGN resulting in increased surface expression in a similar 
manner to that reported by Johnson & Kornfeld (1992) and Chen et al. (1997). If 
indeed the internalised channels are being trafficked to the TGN or into TGN-derived 
endosomal compartments (as shown in chapter 5), it is plausible that GGA binding 
may be required at some stage. In support of this motif being involved in traffic in 
and around the TGN as opposed to its involvement in channel internalisation from the 
cell membrane, unpublished work (by Mr J. Mankouri) from this laboratory has 
shown that channels composed of SUR1 and Kir6.2 containing a dileucine to 
dialanine substitution (-LL- to -AA-) are still able to internalise into the cell. The 
potential role of the motifs described here in regulating KATp channel traffic requires 
further investigation. 
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Proteins which traffic from the late endosome to the trans-Golgi network have been 
shown to contain acidic motifs (many D and E residues) in their cytoplasmic domains 
(Schafer et al. 1995, Voorhees et al. 1995, Alconada et al. 1996, Mauxion et al. 1996, 
Dittie et al. 1997). Also associated with the acidic motif is a casein kinase II (CKII) 
phosphorylation site (Meresse et al. 1990). When this CKII site is phosphorylated the 
acidic motif is able to interact with a similar acidic motif contained in a chaperone 
protein called PACS-1 (Wan et al. 1998). It is this interaction which allows 
trafficking to the TGN to occur via AP-1 or AP-3 binding to PACS-1 to allow clathrin 
coat formation (Crump et al. 2001). An almost identical acidic motif (- 
D971EEEEEAAESEEDDNL-) containing a CKII phosphorylation site (underlined) is 
contained within the cytoplasmic loop found between TMDI and TMD2 of SURI and 
its potential role in the late endosome to TGN trafficking of KATP channels could 
warrant further investigation. 
7.3 - Final summary 
In this thesis it was shown that a sudden decrease in glucose stimulated a rapid 
induction of KATP channel synthesis, but a similar increase in the cell surface channel 
density was not observed. This may imply that separate regulated insertion / removal 
mechanisms are involved in regulating the cell surface channel density. The data 
presented in chapter 5 did indeed show that this is the case. Recombinant KATP 
channels are rapidly internalised from the cell surface into a perinuclear compartment 
under basal conditions and into a rapid recycling pathway upon PKC inhibition. 
It is not clear how these two modes of regulation might interact directly. Certainly, 
further research must be undertaken to elucidate the individual roles of each 
mechanism in regulating the overall cell surface density of the KATp channel. What 
the current study does underline, however, is that the regulation of both expression 
and trafficking are likely to be very important factors in determining the overall 
numbers of KATP channels at the cell surface, and thus regulate overall channel 
function. 
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A. 1- Contents of the supplementary CD 
The CD contains two video clips which are the result of the live cell imaging experiments 
described in chapter 5. The clips are in the avi format. 
Animation 1- Visualising KATP channel movement 
A HEK293 cell stably expressing HA-tagged Kir6.2 and SURI was viewed as described 
in chapter 5.2.7. An image was taken every 2 seconds for 6 minutes in a single focal 
plane. The images were then reconstituted into a video clip running at 15 frames sec''. 
Still images from this video clip were included in figure 5.2, figure 5.15 and figure 5.16. 
Animation 2- Control cells 
A HEK293 cell which was not expressing HA-tagged KATP channels was imaged as 
described in chapter 5.2.7. An image was taken every 1 second for 6 minutes in a single 
focal plane. The images were then reconstituted into a video clip running at 15 frames 
sec-1. Still images from this video clip were included in figure 5.2. 
A. 2 - Plasmid maps 
Shown in figure A. 1, figure A. 2 and figure A. 3 are plasmid maps of the plasmid vectors 
used during the current investigations as well as maps of the Kir6.2-HA+I 1 aa- 
HMKFLAG and SURI constructs used. These maps contain details of restriction enzyme 
sites and PCR primer sites which were required for the manipulation of these constructs 
during the investigations described in the main body of the thesis. 
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Figure A. 1 - Maps of the plasmids used _for expression of 
the KATP channel subunits. 
Both pcDNA3. l (+) and pcDNA6 allow expression in mammalian expression systems and 
were both obtained from Invitrogen life technologies. pKSglobin allows high efficiency 
expression in the Xenopus laevis oocyte expression system. This is due to the presence of 
the 5' and 3' untranslated regions (UTR) of the oocyte ß-globin gene either side of the 
multiple cloning site (MCS). The unique restriction sites contained within the MCS of 
each plasmid vector are shown as well as the principal genes and associated promoter and 
polyadenylation sequences (pA) which have been used during cloning procedures. 
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Figure A. 2 - Plasmid maps of the Kir6.2-HA+Ilaa-HMKFLAG constructs. Kir6.2- 
HA+I laa-HMKFLAG was subcloned into both pcDNA3. I(+) for mammalian expression 
and pKSglobin for Xenopus oocyte expression between the unique BamHl and EcoRl 
sites found in these vectors. For cRNA template production the M 13 promoter sites in 
pKSglobin-Kir6.2-HA+I laa-HMKFLAG were used to isolate the construct via PCR. 
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Figure A. 3 - Plasmid maps of the His6-SURI constructs. His6-SURI was subcloned 
into both pcDNA6 for mammalian expression and pKSglobin for Xenopus oocyte 
expression into the unique EcoR1 site found in these vectors. For cRNA template 
production the pKSglobin-His6-SURI was linearised using Xhol. 
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